a3496378.s0	Prolonged VBN B-verb.communication	cholestasis NN B-noun.cognition	after IN 0	troleandomycin NNS B-noun.person	- : 0	induced VBN B-verb.creation	acute JJ B-adj.all	hepatitis NN B-noun.location	. . 0	. . 0
a1967484.s4	We PRP 0	could MD 0	not RB B-adv.all	find VB B-verb.change	any DT 0	previous JJ B-adj.all	reports NNS B-noun.artifact	of IN 0	sulpiride NN B-noun.food	- : 0	induced VBN B-verb.creation	tardive_dystonia NNP B-noun.location	. . 0	. . 0
a19445921.s1	The DT 0	present JJ B-adj.all	study NN B-noun.artifact	was VBD 0	designed VBN B-verb.creation	to TO 0	evaluate VB B-verb.communication	the DT 0	cardioprotective JJ B-adj.all	potential NN B-noun.person	of IN 0	salvianolic_acid NN B-noun.group	A DT 0	on IN 0	isoproterenol NN B-noun.act	- : 0	induced VBN B-verb.creation	myocardial_infarction NN B-noun.process	in IN 0	rats NNS B-noun.animal	. . 0	. . 0
a10579464.s9	These DT 0	findings NNS B-noun.act	suggest VBP B-verb.communication	that IN 0	NRA0160 NNP B-noun.person	may MD 0	have VB B-verb.possession	unique JJ B-adj.all	antipsychotic JJ B-adj.all	activities NNS B-noun.act	without IN 0	the DT 0	liability NN B-noun.possession	of IN 0	motor NN 0	side NN 0	effects NNS B-noun.phenomenon	typical JJ B-noun.process	of IN 0	classical JJ B-adj.all	antipsychotics NNS B-noun.person	. . 0	. . 0
a15572383.s6	n LS 0	= $ 0	18 CD B-adj.all	, , 0	controls NNS B-noun.artifact	, , 0	saline NN B-noun.act	i.v NNP I-noun.act	. . 0	. . 0
a18768591.s5	Doxorubicin NNP B-noun.person	treatment NN I-noun.person	resulted VBD B-verb.social	in IN 0	heavy JJ B-adj.all	proteinuria NNS B-noun.substance	( ( 0	> $ 0	100 CD 0	mg NN B-noun.quantity	protein NN B-noun.communication	/ '' 0	mg DT B-adj.all	crea NN B-noun.cognition	) ) 0	in IN 0	15/44 CD 0	of IN 0	sgk1(+/+ NNP B-noun.location	) ) 0	and CC 0	15/44 CD 0	of IN 0	sgk1(-/- NNP B-noun.location	) ) 0	mice NNS B-noun.animal	leading VBG B-verb.motion	to TO 0	severe JJ 0	nephrotic_syndrome NN 0	with IN 0	ascites NNS B-noun.person	, , 0	lipidemia NN B-noun.body	, , 0	and CC 0	hypoalbuminemia NN B-noun.person	in IN 0	both DT 0	genotypes NNS B-noun.feeling	. . 0	. . 0
a8386779.s0	Sodium_bicarbonate JJ B-adj.all	alleviates NNS B-noun.event	penile_pain VBP 0	induced VBN B-verb.creation	by IN 0	intracavernous JJ B-adj.all	injections NNS B-noun.motive	for IN 0	erectile_dysfunction NN B-noun.act	. . 0	. . 0
a19211690.s6	HS NNP 0	diet NN 0	for IN 0	4 CD B-adj.all	wk IN 0	increased VBN B-verb.change	renal JJ B-adj.all	cortical JJ B-adj.all	angiotensinogen NN B-noun.person	mRNA NNP I-noun.person	and CC 0	protein NN B-noun.person	only RB B-adv.all	in IN 0	male NN 0	DS NNP 0	, , 0	which WDT 0	was VBD 0	prevented VBN B-verb.creation	by IN 0	castration NN B-noun.person	. . 0	. . 0
a19356053.s5	METHODS NNS B-noun.attribute	, , 0	We PRP 0	analyzed VBD B-verb.cognition	the DT 0	clinical JJ B-adj.all	and CC 0	laboratory NN B-noun.possession	information NN B-noun.cognition	available JJ 0	for IN 0	all DT 0	119 CD 0	patients NNS B-noun.person	transplanted VBN B-verb.competition	at IN 0	the DT 0	Washington NNP B-noun.group	Hospital NNP I-noun.group	Center NNP I-noun.group	between IN 0	1999 CD 0	- : 0	2003 CD 0	for IN 0	whom WP 0	sirolimus NN B-noun.act	was VBD B-verb.stative	a DT 0	component NN B-noun.person	of IN 0	their PRP$ 0	immunosuppressant JJ B-adj.all	regimen NNS B-noun.person	. . 0	. . 0
a2054792.s6	Thermal JJ B-adj.pert	enhancement NN B-noun.person	ratios NNS B-noun.person	estimated VBN B-verb.cognition	for IN 0	" `` 0	acute VB B-verb.communication	" : 0	hematological JJ B-adj.all	changes NNS B-noun.phenomenon	were VBD B-verb.stative	1.3 CD 0	, , 0	whereas IN 0	those DT 0	estimated VBN B-verb.cognition	for IN 0	" `` 0	late RB B-adv.all	" JJ 0	damage NN 0	( ( 0	based VBN B-verb.cognition	on IN 0	morphological JJ B-adj.all	cardiac_and_renal_lesions NNS B-noun.group	) ) 0	varied VBN B-verb.stative	between IN 0	2.4 CD 0	and CC 0	4.3 CD 0	. . 0	. . 0
a17344566.s3	It PRP 0	is VBZ B-verb.stative	likely JJ B-adj.all	that IN 0	this DT 0	complication NN B-noun.act	will MD 0	be VB 0	seen VBN B-verb.perception	more RBR B-adv.all	often RB B-adv.all	with IN 0	the DT 0	increased VBN B-verb.change	worldwide JJ 0	use NN 0	of IN 0	this DT 0	drug NN B-noun.artifact	and CC 0	its PRP$ 0	approval NN B-noun.act	for IN 0	all DT 0	arteriopathic JJ B-adj.all	patients NNS B-noun.person	. . 0	. . 0
a7802851.s6	RESULTS NNS B-noun.artifact	, , 0	Mean JJ B-adj.all	alprazolam NN B-noun.artifact	dose NN I-noun.artifact	was VBD B-verb.stative	5 CD B-adj.all	mg NN B-noun.quantity	daily RB B-adv.all	. . 0	. . 0
a9390208.s6	Seven CD 0	patients NNS B-noun.person	had VBD 0	been VBN 0	treated VBN B-verb.change	with IN 0	anthracycline NN B-noun.attribute	. . 0	. . 0
a3425586.s0	Dapsone NNP B-noun.person	- : 0	associated VBN B-verb.cognition	Heinz NNP B-noun.person	body NN I-noun.person	hemolytic_anemia NN I-noun.person	in IN 0	a DT 0	Cambodian JJ B-noun.person	woman NN B-noun.person	with IN 0	hemoglobin NN 0	E NNP 0	trait NN B-noun.communication	. . 0	. . 0
a2355241.s1	Causes NNS B-noun.person	of IN 0	death NN B-noun.time	, , 0	with IN 0	special JJ B-adj.all	reference NN B-noun.act	to TO 0	cerebral_haemorrhage NN B-noun.location	, , 0	among IN 0	240 CD 0	patients NNS B-noun.person	with IN 0	pathologically RB B-adv.all	verified VBN B-verb.social	Parkinson's_disease NNP B-noun.person	were VBD 0	investigated VBN B-verb.contact	using VBG B-verb.consumption	the DT 0	Annuals NNPS B-noun.person	of IN 0	the DT 0	Pathological NNP B-noun.other	Autopsy NNP I-noun.other	Cases NNPS I-noun.other	in IN 0	Japan NNP B-noun.person	from IN 0	1981 CD 0	to TO 0	1985 CD 0	. . 0	. . 0
a20084309.s9	Mild JJ B-adj.all	hypoxia NN B-noun.person	( ( 0	SO2<90 CD 0	% NN 0	) ) 0	was VBD B-verb.stative	the DT 0	most RBS 0	common JJ 0	event NN 0	( ( 0	11 CD B-adj.all	patients NNS B-noun.artifact	) ) 0	, , 0	3 CD B-adj.all	patients NNS B-noun.person	( ( 0	2 CD B-adj.all	% NN 0	) ) 0	presented VBD B-verb.perception	transient JJ B-adj.all	hypoxia NN 0	due JJ 0	to TO 0	upper JJ B-noun.location	airway_obstruction NN I-noun.location	by IN 0	probe NN B-noun.person	introduction NN B-noun.person	and CC 0	8 CD B-adj.all	( ( 0	5.8 CD 0	% NN 0	) ) 0	due JJ 0	to TO 0	hypoxia NN 0	caused VBN B-verb.communication	by IN 0	MZ NNP 0	use NN 0	. . 0	. . 0
a9495837.s10	was VBD B-verb.stative	able JJ B-adj.all	to TO 0	prevent_amnesia NNP B-noun.person	induced VBD B-verb.creation	by_scopolamine JJ 0	( ( 0	1 CD 0	mg RB 0	kg-1 JJ B-noun.person	i.p NNP I-noun.person	. . 0	) ) 0	. . 0
a11672959.s4	She PRP 0	subsequently RB B-adv.all	died VBD B-verb.change	some DT 0	5 CD B-adj.all	weeks NNS B-noun.time	after IN 0	the DT 0	commencement NN B-noun.person	of IN 0	her PRP$ 0	drug NN B-noun.person	therapy NN 0	. . 0	. . 0
a11379838.s0	Antidepressant JJ B-adj.all	- : 0	induced VBN B-verb.creation	mania NN B-noun.process	in IN 0	bipolar JJ B-adj.all	patients NNS B-noun.person	, , 0	identification NN B-noun.person	of IN 0	risk NN B-noun.plant	factors NNS B-noun.person	. . 0	. . 0
a15863244.s5	Doses NNS B-noun.person	were VBD 0	set VBN B-verb.communication	at IN 0	0.3 CD 0	, , 0	3.0 CD 0	and CC 0	30.0mg NNP 0	/ : 0	kg CC 0	for IN 0	piroxicam NN B-noun.group	and CC 0	0.2 CD 0	, , 0	2.0 CD B-noun.quantity	and CC 0	20.0mg JJ 0	/ CD 0	kg NN B-noun.quantity	for IN 0	DFU NNP 0	. . 0	. . 0
a10669626.s6	Concurrent JJ B-adj.all	treatment NN B-noun.communication	of IN 0	both DT 0	dietary JJ B-adj.all	groups NNS B-noun.group	with IN 0	Warfarin NNP B-noun.person	produced VBD B-verb.creation	massive JJ B-adj.all	focal JJ B-adj.all	calcification_of_the_artery JJ B-adj.all	media NNS B-noun.person	in IN 0	the DT 0	ad NN 0	libitum NN 0	- : 0	fed VBN B-verb.consumption	rats NNS I-verb.consumption	but CC 0	no DT 0	detectable JJ B-adj.all	artery_calcification NN B-noun.act	in IN 0	the DT 0	restricted VBN B-verb.social	- : 0	diet NN B-noun.person	, , 0	growth NN B-noun.person	- : 0	inhibited JJ B-adj.all	group NN B-noun.person	. . 0	. . 0
a3856631.s7	High NNP B-noun.group	- : 0	dose RB B-verb.creation	intravenous JJ B-adj.all	methotrexate NN B-noun.attribute	is VBZ B-verb.stative	an DT 0	effective JJ B-adj.all	treatment NN B-noun.communication	for IN 0	the DT 0	induction NN B-noun.act	of IN 0	remission NN B-noun.act	after IN 0	meningeal JJ B-adj.all	relapse NN B-noun.act	in IN 0	acute_lymphoblastic_leukemia NNP B-noun.location	. . 0	. . 0
a15737522.s8	The DT 0	incidence NN B-noun.relation	of IN 0	pseudolithiasis NN B-noun.animal	is VBZ B-verb.stative	not RB B-adv.all	affected VBN B-verb.change	by IN 0	fasting VBG B-verb.creation	. . 0	. . 0
a11928786.s6	Two CD 0	patients NNS B-noun.person	developed VBD B-verb.creation	severe JJ B-adj.all	cardiac_arrhythmias NNS B-noun.other	, , 0	including VBG B-verb.social	one CD 0	patient NN B-noun.person	who WP 0	was VBD 0	resuscitated VBN B-verb.change	following VBG B-verb.stative	a DT 0	cardiac_arrest NN B-noun.person	. . 0	. . 0
a2484011.s10	Conversely RB B-adv.all	, , 0	brain NN B-noun.person	normetanephrine JJ B-adj.all	concentration NN B-noun.event	was VBD 0	increased VBN B-verb.change	from IN 0	saline NN B-noun.act	control NN B-noun.act	by IN 0	amantadine NN B-noun.person	in IN 0	the DT 0	BALB NNP B-noun.group	/ ( 0	C NNP 0	mice NNS B-noun.animal	. . 0	. . 0
a8410052.s5	Differences NNS B-noun.person	in IN 0	the DT 0	labelling NN B-noun.artifact	pattern NN I-noun.artifact	occurred VBD B-verb.cognition	with IN 0	different JJ B-adj.all	antibodies NNS B-noun.attribute	which WDT 0	apparently RB B-adv.all	depended VBD B-verb.motion	on IN 0	molecular JJ B-adj.all	weight NN B-noun.phenomenon	class NN B-noun.process	of IN 0	NFs NNP B-noun.person	and CC 0	phosphorylation NN B-noun.artifact	state NN B-noun.state	. . 0	. . 0
a7352670.s6	Following VBG 0	discontinuation NN B-noun.act	of IN 0	SNP NNP 0	, , 0	blood NN B-noun.phenomenon	pressure NN I-noun.phenomenon	in IN 0	the DT 0	control NN B-noun.group	animals NNS B-noun.person	rebounded VBD B-verb.communication	to TO 0	94 CD 0	torr NN B-noun.person	, , 0	as IN 0	compared VBN B-verb.creation	with IN 0	78 CD B-adj.all	torr NN B-noun.person	in IN 0	the DT 0	saralasin NN B-noun.person	- : 0	treated VBN B-verb.communication	rats NNS B-noun.person	. . 0	. . 0
a4812392.s1	Azathioprine JJ B-adj.all	treatment NN B-noun.person	benefited VBD B-verb.competition	19 CD 0	( ( 0	66 CD 0	% NN 0	) ) 0	out IN 0	of IN 0	29 CD B-adj.all	patients NNS B-noun.person	suffering VBG B-verb.body	from IN 0	severe JJ B-adj.all	psoriasis NN B-noun.state	. . 0	. . 0
a19759529.s10	However RB 0	, , 0	unlike IN 0	these DT 0	latter JJ B-adj.all	, , 0	SSR103800 NN 0	did VBD 0	not RB B-adv.all	produce VB B-verb.change	catalepsy NN B-noun.animal	( ( 0	retention NN B-noun.person	on IN 0	the DT 0	bar NN 0	test NN 0	) ) 0	up RB 0	to TO 0	30 CD 0	mg FW 0	/ FW 0	kg FW 0	p.o FW 0	. . 0	. . 0
a9587734.s3	Forty NNP B-noun.person	seconds NNS B-noun.act	after IN 0	injection NN B-noun.time	of IN 0	suxamethonium NN B-noun.artifact	, , 0	bradycardia NNS B-noun.person	and CC 0	cardiac_arrest NNP B-noun.person	occurred VBD B-verb.cognition	. . 0	. . 0
a15338796.s2	A DT 0	new JJ B-adj.all	method NN B-noun.food	using VBG B-verb.consumption	a DT 0	commercially RB B-adj.all	available JJ I-adj.all	, , 0	pen SYM 0	- : 0	shaped VBN B-verb.creation	laser NN B-adj.all	pointer NN B-noun.person	was VBD 0	developed VBN B-verb.creation	. . 0	. . 0
a1835291.s2	Mean JJ B-adj.all	peak NN 0	forced VBN B-verb.creation	expiratory JJ B-adj.all	volume NN B-noun.artifact	in IN 0	1 CD B-adj.all	second JJ B-adv.all	( ( 0	FEV1 NN 0	) ) 0	increases VBZ B-verb.stative	over IN 0	baseline NN B-noun.person	and CC 0	the DT 0	proportion NN B-noun.attribute	of IN 0	patients NNS B-noun.person	attaining VBG B-verb.social	at IN 0	least JJS 0	a DT 0	15 CD B-adj.all	% NN 0	increase NN B-noun.event	in IN 0	the DT 0	FEV1 NNP B-noun.person	( ( I-noun.person	responders NNS I-noun.person	) ) 0	were VBD B-verb.stative	31 CD B-adj.all	% NN 0	and CC 0	90 CD B-adj.all	% NN 0	, , 0	respectively RB B-adv.all	, , 0	for IN 0	ipratropium NN B-noun.person	and CC 0	17 CD B-adj.all	% NN 0	and CC 0	50 CD B-adj.all	% NN 0	, , 0	respectively RB B-adv.all	, , 0	for IN 0	theophylline NN 0	. . 0	. . 0
a20098969.s8	SUMMARY NNP B-noun.group	, , 0	The DT 0	patient NN B-noun.person	's POS 0	medical JJ B-adj.all	and CC 0	dental JJ B-adj.all	histories NNS B-noun.cognition	along IN 0	with IN 0	radiographic JJ B-adj.all	and CC 0	clinical JJ B-adj.all	findings NNS B-noun.act	lead VBP B-verb.stative	to TO 0	a DT 0	diagnosis NN B-noun.person	of IN 0	" : 0	meth_mouth NN B-noun.attribute	. . 0	" PRP 0	. . 0
a12536034.s0	Anti NNP B-noun.person	- : 0	epileptic JJ B-adj.all	drugs NNS B-noun.artifact	- : 0	induced VBN B-verb.creation	de IN 0	novo JJ B-adj.all	absence_seizures NNS B-noun.artifact	. . 0	. . 0
a19820426.s1	We PRP 0	report VBP B-verb.communication	twin JJ B-adj.all	neonates NNS B-noun.person	who WP 0	were VBD B-verb.change	born VBN I-verb.change	prematurely RB B-adv.all	at IN 0	32 CD 0	weeks NNS B-noun.time	of IN 0	gestation NN B-noun.act	to TO 0	a DT 0	mother NN B-noun.person	with IN 0	human_immunodeficiency_virus_infection NN B-noun.feeling	. . 0	. . 0
a19269743.s4	Pain NN B-noun.person	rating NN B-verb.motion	was VBD 0	performed VBN B-verb.change	using VBG B-verb.consumption	a DT 0	computerized JJ B-adj.all	visual JJ 0	analogue NN 0	scale NN 0	( ( 0	0 CD B-noun.quantity	- : 0	100 CD 0	) ) 0	digitized VBD B-verb.communication	at IN 0	1/s CD 0	, , 0	either CC 0	immediately RB B-adj.all	online JJ 0	or CC 0	one CD 0	hour NN B-noun.communication	or CC 0	one CD 0	day NN 0	after IN 0	injection NN B-noun.time	. . 0	. . 0
a4008111.s0	Amiodarone SYM 0	- : 0	induced VBN B-verb.creation	sinoatrial_block NN 0	. . 0	. . 0
a8372922.s7	Three CD 0	months NNS B-noun.person	after IN 0	deafening VBG B-verb.social	, , 0	A1 PRP 0	was VBD 0	remapped VBN B-verb.change	. . 0	. . 0
a8643971.s10	With IN 0	paclitaxel NN B-noun.artifact	doses NNS B-noun.artifact	of IN 0	200 CD 0	mg NN B-noun.quantity	/ '' 0	m2 : 0	and CC 0	higher JJR B-adj.all	, , 0	granulocyte NN B-noun.person	colony NN B-noun.person	- : 0	stimulating JJ B-verb.communication	factor NN B-noun.communication	5 CD B-adj.all	micrograms NNS B-noun.quantity	/ : 0	kg PRP 0	/ : 0	d PRP 0	is VBZ 0	given VBN B-verb.possession	( ( 0	days NNS B-noun.communication	4 CD 0	through IN 0	12 CD 0	) ) 0	. . 0	. . 0
a11773892.s8	Groups NNS B-noun.group	were VBD 0	compared VBN B-verb.change	for IN 0	preoperative JJ B-adj.all	laboratory NN B-noun.artifact	variables NNS I-noun.artifact	, , 0	diagnosis NN B-noun.person	, , 0	postoperative JJ B-adj.all	variables NNS B-noun.cognition	, , 0	survival NN B-noun.person	, , 0	type NN B-noun.person	of IN 0	ESRD NNP B-noun.other	therapy NN B-noun.artifact	, , 0	and CC 0	survival NN B-noun.person	from IN 0	onset NN B-noun.event	of IN 0	ESRD NNP B-noun.other	. . 0	. . 0
a9284778.s1	BACKGROUND NN 0	, , 0	Hydrochlorofluorocarbons NNP B-noun.person	( ( 0	HCFCs NNS B-noun.person	) ) 0	are VBP 0	used VBN B-verb.consumption	increasingly RB B-adv.all	in IN 0	industry NN B-noun.act	as IN 0	substitutes NNS B-noun.person	for IN 0	ozone NN 0	- : 0	depleting VBG B-verb.creation	chlorofluorocarbons NNS B-noun.substance	( ( 0	CFCs NNP B-noun.person	) ) 0	. . 0	. . 0
a12653683.s9	A DT 0	significant JJ B-adj.all	up RB B-adv.all	- : 0	regulation NN B-noun.act	of IN 0	alphaENaC NNP B-noun.other	and CC 0	betaENaC RB B-verb.stative	mRNA JJ B-adj.all	abundance NN B-noun.act	on IN 0	days NNS B-noun.time	1 CD 0	and CC 0	2 CD 0	preceded VBD B-verb.communication	sodium NN B-noun.person	retention NN B-noun.person	on IN 0	days NNS B-noun.time	2 CD 0	and CC 0	3 CD B-adj.all	. . 0	. . 0
a8864707.s3	Conventional JJ B-adj.all	spin NN 0	echo NN 0	images NNS B-noun.person	were VBD 0	acquired VBN B-verb.possession	in IN 0	the DT 0	sagittal NN B-noun.artifact	and CC 0	transverse NN B-noun.body	orientation NN I-noun.body	. . 0	. . 0
a9766615.s4	Conventional JJ B-adj.all	agents NNS B-noun.person	are VBP 0	associated VBN B-verb.cognition	with IN 0	unwanted JJ B-adj.all	central JJ B-noun.body	nervous JJ I-noun.body	system NN B-noun.substance	effects NNS B-noun.phenomenon	, , 0	including VBG B-verb.stative	extrapyramidal_symptoms NNS I-verb.stative	( ( 0	EPS NNP 0	) ) 0	, , 0	tardive_dyskinesia NN B-noun.location	, , 0	sedation NN B-noun.act	, , 0	and CC 0	possible JJ B-adj.all	impairment NN B-noun.attribute	of IN 0	some DT 0	cognitive JJ B-adj.all	measures NNS B-noun.food	, , 0	as RB 0	well RB 0	as IN 0	cardiac JJ 0	effects NNS B-noun.phenomenon	, , 0	orthostatic_hypotension NN 0	, , 0	hepatic JJ B-adj.all	changes NNS B-noun.relation	, , 0	anticholinergic JJ B-adj.all	side NN B-noun.body	effects NNS B-noun.phenomenon	, , 0	sexual_dysfunction NN 0	, , 0	and CC 0	weight_gain NNP B-noun.person	. . 0	. . 0
a14659530.s6	Plasma NNP B-noun.group	CGRP NNP I-noun.group	concentration NN B-noun.event	increased VBD B-verb.change	significantly RB B-adv.all	( ( 0	P<0.01 NNP 0	) ) 0	during IN 0	the DT 0	migraine NN B-noun.artifact	attack NN B-noun.artifact	and CC 0	returned VBD B-verb.motion	to TO 0	baseline NN B-verb.cognition	after IN 0	the DT 0	cessation NN B-noun.location	of IN 0	the DT 0	migraine NN B-noun.location	. . 0	. . 0
a16867021.s6	were VBD 0	used VBN B-verb.consumption	for IN 0	studying VBG B-verb.cognition	climbing VBG B-verb.creation	behavior NN B-noun.attribute	and CC 0	locomotor NN B-noun.location	activities NNS B-noun.person	, , 0	respectively RB B-adv.all	. . 0	( ( 0	. . 0
a16337777.s5	We PRP 0	did VBD 0	not RB B-adv.all	find VB B-verb.change	abnormalities NNS I-verb.change	in IN 0	the DT 0	expression NN B-noun.communication	and CC 0	distribution NN B-noun.act	of IN 0	an DT 0	mtDNA NNP B-noun.group	- : 0	encoded JJ B-adj.all	subunit NN B-noun.group	of IN 0	CCO NNP B-noun.other	( ( 0	CCO NNP B-noun.group	- : 0	I PRP 0	) ) 0	or CC 0	a DT 0	relative JJ B-adj.all	decrease NN B-noun.process	in IN 0	CCO NNP B-noun.other	- : 0	I PRP 0	when WRB 0	compared VBN B-verb.cognition	with IN 0	nuclear JJ B-adj.pert	- : 0	encoded VBD B-verb.communication	subunits NNS B-noun.person	( ( 0	CCO NNP B-noun.group	- : 0	IV NNP 0	and CC 0	SDH NNP B-noun.group	- : 0	fp NN 0	) ) 0	. . 0	. . 0
a18020536.s4	Of IN 0	these DT 0	, , 0	nearly RB B-adj.all	half NN B-noun.time	( ( 0	n UH 0	= $ 0	78 CD 0	) ) 0	had VBD 0	used VBN B-verb.consumption	BZDs NNP B-noun.other	/ NNP I-noun.other	RDs NNP I-noun.other	before IN 0	admission NN B-noun.time	, , 0	and CC 0	the DT 0	remainder NN B-noun.person	( ( 0	n UH 0	= $ 0	86 CD 0	) ) 0	were VBD B-verb.stative	non RB B-adv.all	- : 0	users NNS B-noun.person	. . 0	. . 0
a6747681.s8	Seventeen CD 0	of IN 0	these DT 0	had VBD 0	a DT 0	response NN B-noun.communication	or CC 0	were VBD B-verb.stative	stable JJ B-adj.all	for IN 0	a DT 0	median NN B-noun.communication	of IN 0	20 CD B-adj.all	weeks NNS B-noun.time	( ( 0	range VBP B-verb.stative	6 CD B-adj.all	to TO 0	more JJR B-noun.quantity	than IN 0	66 CD 0	weeks NNS B-noun.time	) ) 0	. . 0	. . 0
a20080419.s3	Spontaneous_recurrent_seizures NNS B-noun.artifact	( ( 0	SRS NNP 0	) ) 0	were VBD 0	monitored VBN B-verb.perception	using VBG B-verb.consumption	Racine NNP B-noun.person	's POS 0	seizure NN B-noun.body	severity NN 0	scale NN 0	. . 0	. . 0
a2425813.s4	This DT 0	view NN B-noun.group	supports VBZ B-verb.social	the DT 0	contention NN B-noun.communication	that IN 0	the DT 0	liver NN B-noun.person	and CC 0	muscle NN B-noun.body	are VBP B-verb.stative	independent JJ B-adj.all	sites NNS B-noun.location	of IN 0	prednisolone NN B-noun.substance	action NN B-noun.artifact	. . 0	. . 0
a15899738.s11	Vegetarians NNS B-noun.person	may MD 0	also RB 0	take VB 0	creatine NN 0	to TO 0	replace VB B-verb.social	what WP 0	they PRP 0	are VBP B-verb.stative	not RB I-verb.stative	consuming VBG B-verb.communication	from IN 0	meat NN B-noun.attribute	, , 0	fish NN B-noun.person	, , 0	and CC 0	other JJ 0	animal NN B-noun.animal	products NNS I-noun.animal	. . 0	. . 0
a3076126.s3	Lovastatin NNP B-noun.person	has VBZ 0	been VBN 0	marketed VBN B-verb.communication	in IN 0	the DT 0	United NNP B-noun.group	States NNPS I-noun.group	for IN 0	over IN 0	6 CD B-adj.all	months NNS B-noun.person	. . 0	. . 0
a2870085.s6	Flestolol NNP B-noun.person	produced VBD B-verb.creation	a DT 0	dose NN B-noun.person	- : 0	dependent JJ B-adj.all	attenuation NN B-noun.act	of IN 0	isoproterenol NN B-noun.feeling	- : 0	induced VBN B-verb.creation	tachycardia NN B-noun.feeling	. . 0	. . 0
a11773892.s13	Patients NNS B-noun.person	developing VBG B-verb.change	ESRD NNP B-noun.group	had VBD 0	a DT 0	6-year JJ B-adj.all	survival NN B-noun.artifact	after IN 0	onset NN B-noun.event	of IN 0	ESRD NNP B-noun.other	of IN 0	27 CD B-adj.all	% NN 0	for IN 0	the DT 0	patients NNS B-noun.person	receiving VBG B-verb.communication	hemodialysis NN I-verb.communication	versus NN 0	71.4 CD 0	% NN 0	for IN 0	the DT 0	patients NNS B-noun.person	developing VBG B-verb.communication	ESRD NNP B-noun.other	who WP 0	subsequently RB B-adv.all	received VBD B-verb.possession	kidney NN B-noun.person	transplants NNS B-noun.person	. . 0	. . 0
a9088814.s5	Measurements NNS B-noun.attribute	included VBD B-verb.stative	arterial JJ B-adj.all	ketone NN 0	body NN 0	ratio NN 0	( ( 0	AKBR NNP B-noun.group	, , 0	aceto NN B-noun.person	- : 0	acetate/3-hydroxybutyrate NN B-noun.time	) ) 0	and CC 0	clinical JJ B-adj.all	hepatic JJ B-adj.all	function NN B-noun.act	parameters NNS B-noun.event	. . 0	. . 0
a19308880.s8	The DT 0	occurrence NN B-noun.state	of IN 0	this DT 0	ADR NNP B-noun.group	was VBD B-verb.stative	more RBR B-adv.all	frequent JJ B-adj.all	in IN 0	patients NNS B-noun.person	aged VBN B-verb.contact	between IN 0	61 CD 0	and CC 0	80 CD B-adj.all	years NNS B-noun.time	. . 0	. . 0
a18410508.s9	The DT 0	effects NNS B-noun.phenomenon	of_METH RB 0	in IN 0	CX3CR1 JJ 0	knockout IN 0	mice NNS B-noun.person	were VBD B-verb.stative	not RB B-adv.all	gender VB B-verb.communication	- : 0	dependent JJ B-adj.all	and CC 0	did VBD 0	not RB B-adv.all	extend VB B-verb.stative	beyond IN 0	the DT 0	striatum NN B-noun.artifact	. . 0	. . 0
a9406968.s5	Plasma NNP B-noun.person	concentration NN B-noun.event	of IN 0	AVP NNP B-noun.group	and CC 0	transcripts NNS B-noun.act	of IN 0	AVP NNP B-noun.group	gene NN B-noun.artifact	in IN 0	the DT 0	PVN NNP B-noun.group	and CC 0	SON NNP B-noun.person	were VBD B-verb.stative	significantly RB B-adv.all	increased VBN B-verb.change	in IN 0	the DT 0	Li SYM 0	- : 0	treated VBN B-verb.communication	rats NNS B-noun.person	compared VBN B-verb.change	with IN 0	controls NNS B-noun.artifact	. . 0	. . 0
a17111419.s6	She PRP 0	then RB B-adv.all	very RB B-adv.all	rapidly RB B-adv.all	developed VBD B-verb.creation	acute JJ B-adj.all	onset NN B-noun.event	of IN 0	severe JJ B-adj.all	facial NN B-noun.state	and CC 0	extremity NN B-noun.attribute	tetany NN 0	. . 0	. . 0
a3076126.s11	Myopathy NNP B-noun.person	, , 0	associated VBN B-verb.cognition	in IN 0	some DT 0	cases NNS B-noun.person	with IN 0	myoglobinuria NNS B-noun.person	, , 0	and CC 0	in IN 0	2 CD B-adj.all	cases NNS B-noun.quantity	with IN 0	transient JJ B-adj.all	renal_failure NN B-noun.act	, , 0	has VBZ 0	been VBN 0	rarely RB B-adv.all	reported VBN B-verb.communication	with IN 0	lovastatin NN B-noun.feeling	, , 0	especially RB B-adv.all	in IN 0	patients NNS B-noun.person	concomitantly RB B-adv.all	treated VBN B-verb.change	with IN 0	cyclosporin NN B-noun.person	, , 0	gemfibrozil NN B-noun.artifact	or CC 0	niacin NN B-noun.substance	. . 0	. . 0
a9855119.s5	Of IN 0	the DT 0	nonepisode JJ B-adj.all	biopsies NNS B-noun.cognition	, , 0	7 CD 0	and CC 0	4 CD B-adj.all	biopsies NNS B-noun.person	showed VBD B-verb.communication	minimal JJ B-adj.pert	- : 0	type NN B-noun.person	and CC 0	mild JJ B-noun.person	- : 0	type NN B-noun.person	chronic NN B-adj.all	FK506 NNP B-noun.other	nephropathy JJ B-adj.all	, , 0	respectively RB B-adv.all	. . 0	. . 0
a9660111.s3	The DT 0	aim NN 0	of IN 0	the DT 0	present JJ B-adj.all	study NN B-noun.artifact	was VBD 0	to TO 0	find VB B-verb.change	out RP 0	whether IN 0	TRI NNP 0	given VBN B-verb.possession	repeatedly RB B-adv.all	was VBD B-verb.stative	able JJ B-adj.all	to TO 0	induce VB B-verb.cognition	adaptive JJ 0	changes NNS B-noun.food	in IN 0	the DT 0	dopaminergic NN B-noun.communication	and CC 0	alpha1-adrenergic JJ B-adj.all	systems NNS B-noun.body	, , 0	demonstrated VBN B-verb.cognition	by IN 0	us PRP 0	previously RB B-adv.all	for IN 0	various JJ B-adj.all	antidepressants NNS B-noun.location	. . 0	. . 0
a11250767.s0	Propylthiouracil NNP B-noun.person	- : 0	induced VBN B-verb.creation	perinuclear RB B-adv.all	- : 0	staining VBG B-verb.communication	antineutrophil RB 0	cytoplasmic JJ 0	autoantibody NN 0	- : 0	positive JJ B-adj.all	vasculitis NN B-noun.food	in IN 0	conjunction NN 0	with IN 0	pericarditis NN B-noun.person	. . 0	. . 0
a3101906.s2	By IN 0	November NNP B-noun.communication	1984 CD 0	the DT 0	Committee NNP B-noun.person	on IN 0	Safety NNP B-noun.person	of IN I-noun.person	Medicines NNP I-noun.person	had VBD 0	received VBN B-verb.possession	82 CD 0	reports NNS B-noun.communication	of IN 0	possible JJ B-adj.all	hepatotoxicity NN B-noun.attribute	associated VBN B-verb.cognition	with IN 0	the DT 0	drug NN B-noun.artifact	, , 0	including VBG B-verb.contact	five CD B-adj.all	deaths NNS B-noun.person	. . 0	. . 0
a11706060.s0	Combined VBN B-verb.change	antiretroviral JJ B-adj.all	therapy NN B-noun.act	causes VBZ B-verb.stative	cardiomyopathy JJ B-adj.all	and CC 0	elevates VBZ B-verb.change	plasma NN I-verb.change	lactate NN 0	in IN 0	transgenic JJ B-adj.all	AIDS NNP B-noun.group	mice NNS B-noun.animal	. . 0	. . 0
a12369736.s1	The DT 0	present JJ B-adj.all	study NN B-noun.artifact	was VBD 0	designed VBN B-verb.creation	to TO 0	examine VB B-verb.communication	the DT 0	effect NN B-noun.cognition	of IN 0	5-HT1B JJ B-adj.all	receptor NN B-noun.person	ligands NNS B-noun.person	microinjected VBN B-verb.social	into IN 0	the DT 0	subregions NNS B-noun.artifact	of IN 0	the DT 0	nucleus JJ B-noun.group	accumbens NNS B-noun.person	( ( 0	the DT 0	shell NN B-noun.person	and CC 0	the DT 0	core NN B-noun.group	) ) 0	on IN 0	the DT 0	locomotor_hyperactivity NN B-noun.location	induced VBN B-verb.creation	by IN 0	cocaine NN B-noun.person	in IN 0	rats NNS B-noun.animal	. . 0	. . 0
a2334618.s5	There EX 0	was VBD 0	also RB B-adv.all	a DT 0	higher JJR B-adj.all	incidence NN B-noun.relation	of IN 0	tachyarrhythmias NNS B-noun.cognition	( ( 0	P NNP 0	less JJR 0	than IN 0	0.05 CD 0	) ) 0	and CC 0	ventricular_ectopic_beats NNS B-noun.location	( ( 0	P NNP 0	less JJR 0	than IN 0	0.05 CD 0	) ) 0	in IN 0	the DT 0	morphine NN 0	infusion NN 0	group NN 0	. . 0	. . 0
a9351491.s4	Both DT 0	risperidone NN B-noun.attribute	and CC 0	haloperidol NN B-noun.person	produced VBD B-verb.creation	D2 JJ 0	occupancy NN B-noun.state	levels NNS B-noun.state	between IN 0	approximately RB B-adv.all	60 CD B-adj.all	and CC 0	90 CD B-adj.all	% NN 0	at IN 0	standard JJ B-adj.all	clinical JJ B-adj.all	doses NNS B-noun.event	. . 0	. . 0
a12757899.s4	SE NNP 0	was VBD 0	induced VBN B-verb.creation	20 CD B-adj.all	h NN 0	following VBG B-verb.stative	the DT 0	second JJ B-adj.all	injection NN B-noun.act	and CC 0	terminated VBD B-verb.stative	3 CD B-adj.all	h NN 0	later RB B-adv.all	. . 0	. . 0
a7582165.s4	Clinical JJ B-adj.all	examinations NNS B-noun.motive	and CC 0	skin NN B-noun.person	, , 0	oral JJ B-adj.all	and CC 0	parenteral JJ B-noun.body	challenges NNS I-noun.body	with IN 0	different JJ B-adj.all	corticosteroids NNS B-noun.artifact	and CC 0	ELISA NNP B-noun.person	tests NNS I-noun.person	were VBD 0	performed VBN B-verb.social	. . 0	. . 0
a16904497.s9	Three CD 0	hours NNS 0	later RB B-adv.all	, , 0	she PRP 0	complained VBD B-verb.stative	of IN 0	perineal JJ B-adj.all	numbness NN B-noun.attribute	and CC 0	lower_extremity_weakness JJ B-noun.feeling	. . 0	. . 0
a20722491.s4	We PRP 0	also RB B-adv.all	explore VB B-verb.cognition	different JJ B-adj.all	dosing NN B-noun.act	and CC 0	schedules NNS B-noun.person	of IN 0	capecitabine JJ B-adj.all	administration NN B-noun.person	. . 0	. . 0
a10901305.s5	A DT 0	board NN B-noun.substance	- : 0	certified JJ B-adj.all	emergency NN B-noun.person	physician NN B-noun.person	skilled VBN B-verb.communication	in IN 0	airway NN B-noun.animal	management NN B-noun.group	supervised VBD B-verb.social	administration NN B-noun.person	of IN 0	the DT 0	anesthetic JJ B-adj.all	, , 0	and CC 0	the DT 0	patients NNS B-noun.person	were VBD 0	monitored VBN B-verb.perception	by IN 0	a DT 0	registered JJ B-noun.artifact	nurse NN I-noun.artifact	. . 0	. . 0
a7265370.s1	A DT 0	case NN B-noun.state	of IN 0	triamterene CD B-adj.all	nephrolithiasis NN B-noun.person	is VBZ 0	reported VBN B-verb.communication	in IN 0	a DT 0	man NN 0	after IN 0	4 CD B-adj.all	years NNS B-noun.time	of IN 0	hydrochlorothiazide NN B-noun.person	- : 0	triamterene NN B-noun.person	therapy NN B-noun.person	for IN 0	hypertension NN B-noun.act	. . 0	. . 0
a18726058.s13	The DT 0	average JJ B-adj.all	recovery NN B-noun.process	time NN B-noun.time	of IN 0	BAEP NNP B-noun.group	waveforms NNS B-noun.body	to TO 0	pre VB B-verb.social	- : 0	papaverine NN B-noun.person	baseline NN B-noun.phenomenon	values NNS B-noun.attribute	was VBD B-verb.stative	39 CD 0	min NN 0	. . 0	. . 0
a8649546.s2	There EX 0	was VBD B-verb.stative	a DT 0	significant JJ B-noun.communication	40 CD B-adj.all	% NN 0	improvement NN B-noun.attribute	in IN 0	the DT 0	dyskinesia NN B-noun.artifact	score NN B-noun.person	without IN 0	increase NN B-noun.time	of IN 0	parkinsonian JJ B-adj.all	motor_disability NN B-noun.motive	. . 0	. . 0
a3503576.s8	A DT 0	dose NN B-noun.quantity	of IN 0	50 CD B-adj.all	mg NN B-noun.quantity	/ : 0	kg PRP 0	is VBZ 0	recommended VBN B-verb.communication	in IN 0	those DT 0	without IN 0	audiogram NN B-noun.animal	abnormalities NNS I-noun.animal	. . 0	. . 0
a19037603.s10	In IN 0	three CD 0	additional JJ B-adj.all	patients NNS B-noun.person	, , 0	HBV NNP 0	DNA NNP 0	levels NNS B-noun.state	were VBD 0	increased VBN B-verb.change	during IN 0	follow SYM 0	- : 0	up RB B-adv.all	. . 0	. . 0
a9812111.s5	Response NN B-noun.communication	rates NNS B-noun.time	according VBG 0	to TO 0	three CD 0	sets NNS B-noun.quantity	of IN 0	criteria NNS B-noun.person	were VBD B-verb.stative	greater JJR B-adj.all	with IN 0	the DT 0	standard JJ B-adj.all	dose NN B-noun.act	( ( 0	55%-60 CD 0	% NN 0	) ) 0	than IN 0	the DT 0	low JJ B-adj.all	dose NN B-noun.person	( ( 0	25%-35 CD 0	% NN 0	) ) 0	and CC 0	placebo NN B-noun.substance	( ( 0	25%-30 CD 0	% NN 0	) ) 0	. . 0	. . 0
a18809400.s7	Alpha NNP B-noun.person	- : 0	lipoic_acid JJ B-adj.all	protects NNS B-noun.substance	sensory JJ B-adj.all	neurons NNS B-noun.artifact	through IN 0	its PRP$ 0	anti NNS B-noun.attribute	- : 0	oxidant NN B-noun.person	and CC 0	mitochondrial JJ B-adj.all	regulatory JJ B-noun.body	functions NNS I-noun.body	, , 0	possibly RB 0	inducing VBG B-verb.communication	the DT 0	expression NN B-noun.communication	of IN 0	frataxin NN B-noun.person	. . 0	. . 0
a424937.s3	Jaundice NNP B-noun.person	with IN 0	tender NN B-noun.person	hepatomegaly RB B-adv.all	, , 0	usually RB B-adv.all	preceded VBN B-verb.cognition	by IN 0	symptoms NNS B-noun.communication	of IN 0	malaise NN B-noun.animal	, , 0	anorexia NN 0	, , 0	nausea NN B-noun.person	and CC 0	vomiting NN B-noun.act	, , 0	and CC 0	associated VBN B-verb.cognition	with IN 0	upper JJ B-adj.all	abdominal_pain NN B-noun.person	, , 0	was VBD B-verb.stative	an DT 0	invariable JJ B-adj.all	finding NN B-noun.act	in IN 0	all DT 0	patients NNS B-noun.person	. . 0	. . 0
a16403073.s3	Her PRP$ 0	QT NNP 0	interval NN 0	returned VBD B-verb.communication	to TO 0	normal JJ B-adj.all	upon IN 0	withdrawal NN B-noun.act	of IN 0	ketoconazole NN B-noun.communication	. . 0	. . 0
a18023325.s2	A DT 0	49-year JJ 0	- : 0	old JJ B-adj.all	woman NN B-noun.person	was VBD 0	transferred VBN B-verb.social	to TO 0	our PRP$ 0	department NN B-noun.artifact	because IN 0	of IN 0	quadriparesis NN B-noun.location	, , 0	lancinating VBG B-verb.motion	pain NN B-noun.person	, , 0	sensory_loss NNP B-noun.person	, , 0	and CC 0	paresthesia NN B-noun.person	of IN 0	the DT 0	distal JJ B-adj.all	limbs NNS B-noun.animal	. . 0	. . 0
a16867021.s11	1 CD B-adj.all	h NN 0	prior RB B-adj.all	to_haloperidol NN B-noun.person	resulted VBD B-verb.stative	in IN 0	a DT 0	dose NN B-noun.person	- : 0	dependent JJ B-adj.all	increase NN B-noun.event	in IN 0	the_catalepsy JJ 0	times NNS B-noun.event	( ( 0	P NNP 0	< $ 0	0.05 CD 0	) ) 0	. . 0	. . 0
a15515654.s5	Patients NNS B-noun.person	were VBD 0	followed VBN B-verb.stative	for IN 0	8 CD B-adj.all	- : 0	14 CD B-adj.all	years NNS B-noun.time	. . 0	. . 0
a3865016.s2	The DT 0	concomitant JJ B-adj.all	administration NN B-noun.time	of IN 0	etoposide NN 0	and CC 0	cyclosporin VB B-verb.consumption	A DT 0	resulted VBN B-verb.stative	in IN 0	eradication NN 0	of IN 0	hitherto PRP$ 0	refractory JJ B-adj.all	leukemic_infiltration NN B-noun.act	of IN 0	bone NN 0	marrow NN 0	. . 0	. . 0
a18083142.s4	RESULTS NNS B-noun.artifact	, , 0	We PRP 0	found VBD B-verb.cognition	that IN 0	cocaine NN 0	dose NN 0	- : 0	dependently RB B-adv.all	increased VBN B-verb.change	anxiety NN 0	- : 0	like IN 0	behavior NN B-noun.attribute	in IN 0	control NN B-noun.act	( ( 0	Dbh NNP B-noun.person	+ : 0	/- LS 0	) ) 0	mice NNS B-noun.animal	, , 0	as IN 0	measured VBN B-verb.cognition	by IN 0	a DT 0	decrease NN B-noun.event	in IN 0	open JJ B-adj.all	arm NN 0	exploration NN 0	. . 0	. . 0
a9245658.s4	Nicotine NN B-noun.person	does VBZ 0	not RB B-adv.all	appear VB B-verb.change	to TO 0	enhance VB B-verb.change	thrombosis NN I-verb.change	among IN 0	humans NNS B-noun.person	. . 0	. . 0
a9390208.s3	From IN 0	October NNP B-noun.communication	1993 CD 0	to TO 0	November NNP B-noun.communication	1995 CD 0	, , 0	we PRP 0	treated VBD B-verb.competition	13 CD B-adj.all	patients NNS B-noun.person	with IN 0	previously RB B-adv.all	chemotherapy JJ B-adj.pert	- : 0	treated VBN B-verb.body	metastatic JJ B-adj.all	breast_cancer NN B-noun.person	by IN 0	mitoxantrone NN B-noun.person	, , 0	12 CD B-adj.all	mg NN B-noun.quantity	/ : 0	m2 PRP 0	, , 0	on IN 0	day NN 0	1 CD 0	and CC 0	continuous JJ B-adj.all	infusion NN B-noun.cognition	of IN 0	5-FU NN B-noun.food	, , 0	3000 CD 0	mg NN B-noun.quantity	/ : 0	m2 PRP 0	, , 0	together RB 0	with IN 0	leucovorin NN B-noun.person	, , 0	300 CD 0	mg NN B-noun.quantity	/ : 0	m2 PRP 0	, , 0	for IN 0	48 CD 0	h NN 0	from IN 0	day NN 0	1 CD 0	to TO 0	2 CD 0	. . 0	. . 0
a1833784.s6	The DT 0	stimulant JJ B-adj.all	action NN B-noun.state	of IN 0	nicotine NN B-noun.person	was VBD 0	blocked VBN B-verb.contact	by IN 0	the DT 0	central JJ B-noun.body	nicotinic JJ I-noun.body	antagonist JJ B-adj.pert	mecamylamine NN B-noun.person	but CC 0	not RB B-adv.all	by IN 0	the DT 0	peripheral JJ B-adj.pert	nicotinic JJ B-adj.pert	blocker NN B-noun.person	hexamethonium NN B-noun.person	, , 0	indicating VBG B-verb.communication	that IN 0	the DT 0	response NN B-noun.communication	is VBZ B-verb.stative	probably RB B-adv.all	mediated VBN B-verb.social	by IN 0	central JJ B-adj.pert	nicotinic JJ B-adj.pert	receptors NNS B-noun.person	. . 0	. . 0
a3101906.s10	The DT 0	characteristics NNS B-noun.artifact	of IN 0	the DT 0	48 CD 0	patients NNS B-noun.person	in IN 0	the DT 0	possible JJ B-adj.all	cases NNS B-noun.state	were VBD B-verb.stative	similar JJ B-adj.all	. . 0	. . 0
a15804801.s5	The DT 0	patient NN B-noun.person	was VBD 0	successfully RB B-adv.all	treated VBN B-verb.social	with IN 0	a DT 0	graft NN B-noun.food	stent NN B-noun.artifact	. . 0	. . 0
a3107448.s3	Two CD 0	patients NNS B-noun.person	with IN 0	type_II_diabetes_mellitus NN B-noun.person	developed VBD B-verb.creation	an DT 0	acute_hepatitis NNP B-noun.person	- : 0	like_syndrome JJ 0	soon RB 0	after IN 0	initiation NN B-noun.time	of IN 0	glyburide NN 0	therapy NN 0	. . 0	. . 0
a11745184.s7	METHODS NNS B-noun.attribute	, , 0	A DT 0	Phase NNP B-noun.person	II NNP 0	study NN 0	of IN 0	the DT 0	combination NN B-noun.event	of IN 0	cisplatin NN B-noun.cognition	plus CC 0	amifostine NN B-noun.person	was VBD 0	conducted VBN B-verb.creation	in IN 0	patients NNS B-noun.person	with IN 0	progressive JJ B-adj.all	metastatic JJ B-adj.all	breast_carcinoma NN B-noun.person	who WP 0	had VBD 0	received VBN B-verb.possession	one CD 0	, , 0	but CC 0	not RB B-adv.all	more JJR B-noun.quantity	than IN 0	one CD 0	, , 0	chemotherapy NN B-noun.artifact	regimen NN B-noun.person	for IN 0	metastatic JJ B-adj.all	disease NN B-noun.state	. . 0	. . 0
a7582165.s8	These DT 0	results NNS B-noun.communication	suggest VBP B-verb.communication	that IN 0	paramethasone NN B-noun.person	caused VBD B-verb.creation	pseudoallergic JJ B-adj.all	reactions NNS B-noun.cognition	in IN 0	our PRP$ 0	patients NNS B-noun.person	. . 0	. . 0
a19356053.s11	Proteinuria NNP B-noun.person	correlated VBD B-verb.change	most RBS 0	strongly RB B-adv.all	with IN 0	sirolimus NN 0	therapy NN 0	when WRB 0	compared VBN B-verb.cognition	to TO 0	other JJ 0	demographic JJ B-adj.pert	and CC 0	clinical JJ B-adj.all	variables NNS B-noun.cognition	. . 0	. . 0
a15515654.s4	Subjects NNS B-noun.person	were VBD 0	receiving VBG B-verb.communication	desferrioxamine NN B-noun.person	( ( 0	DFO NNP 0	) ) 0	chelation NN B-noun.communication	treatment NN B-noun.communication	with IN 0	a DT 0	mean JJ B-adj.all	daily JJ 0	dose NN 0	of IN 0	50 CD B-adj.all	- : 0	60 CD B-adj.all	mg FW B-noun.quantity	/ FW 0	kg FW 0	, , 0	5 CD B-adj.all	- : 0	6 CD B-adj.all	days NNS B-noun.person	a DT 0	week NN B-noun.plant	during IN 0	the DT 0	first JJ B-adj.all	six CD 0	years NNS B-noun.time	of IN 0	the DT 0	study NN B-noun.artifact	, , 0	which WDT 0	was VBD 0	then RB B-adv.all	reduced VBN B-verb.change	to TO 0	40 CD B-adj.all	- : 0	50 CD B-adj.all	mg NN B-noun.quantity	/ : 0	kg CC 0	for IN 0	the DT 0	following VBG 0	eight CD 0	years NNS B-noun.time	. . 0	. . 0
a3985451.s2	Surgical JJ B-adj.all	exploration NN B-noun.person	revealed VBD B-verb.perception	an DT 0	iliopsoas JJ B-adj.all	hematoma NN B-noun.person	and CC 0	femoral JJ B-adj.all	nerve_entrapment NN B-noun.attribute	, , 0	resulting VBG B-verb.stative	in IN 0	a DT 0	femoral_nerve_palsy JJ B-noun.person	and CC 0	partial_loss_of_quadriceps_functions NNS B-noun.artifact	. . 0	. . 0
a354896.s0	Lidocaine SYM 0	- : 0	induced VBN B-verb.creation	cardiac_asystole NNP B-noun.group	. . 0	. . 0
a12639165.s5	Our PRP$ 0	patients NNS B-noun.person	developed VBD B-verb.creation	jaundice NN B-noun.act	following VBG 0	treatment NN B-noun.communication	with IN 0	ticlopidine NN B-noun.communication	and CC 0	showed VBD B-verb.communication	the DT 0	clinical JJ B-adj.all	and CC 0	laboratory NN B-noun.body	characteristics NNS I-noun.body	of IN 0	cholestatic_hepatitis NN B-noun.food	, , 0	which WDT 0	resolved VBD B-verb.communication	after IN 0	discontinuation NN B-noun.act	of IN 0	the DT 0	drug NN B-noun.artifact	. . 0	. . 0
a12617329.s4	The DT 0	results NNS B-noun.communication	indicated VBD B-verb.communication	that IN 0	concomitant JJ B-adj.all	treatment NN B-noun.communication	with IN 0	gum_Arabic JJ 0	and CC 0	GM NNP 0	significantly RB B-adv.all	increased VBN B-verb.change	creatinine NN 0	and CC 0	urea NN B-noun.act	by IN 0	about IN 0	183 CD 0	and CC 0	239 CD 0	% NN 0	, , 0	respectively RB B-adv.all	( ( 0	compared VBN 0	to TO 0	432 CD 0	and CC 0	346 CD 0	% NN 0	, , 0	respectively RB B-adv.all	, , 0	in IN 0	rats NNS B-noun.animal	treated VBN B-verb.change	with IN 0	cellulose NN B-noun.body	and CC 0	GM NNP 0	) ) 0	, , 0	and CC 0	decreased VBD B-verb.communication	that IN 0	of IN 0	cortical JJ B-adj.all	GSH NNP 0	by IN 0	21 CD B-adj.all	% NN 0	( ( 0	compared VBN 0	to TO 0	27 CD B-adj.all	% NN 0	in IN 0	the DT 0	cellulose NN B-noun.body	plus CC 0	GM NNP 0	group NN 0	) ) 0	The DT 0	GM NNP 0	- : 0	induced VBN B-verb.creation	proximal JJ B-adj.all	tubular_necrosis NN B-noun.other	appeared VBD B-verb.social	to TO 0	be VB B-verb.stative	slightly RB B-adv.all	less RBR 0	severe JJ 0	in IN 0	rats NNS B-noun.animal	given VBN B-verb.possession	GM NNP 0	together RB 0	with IN 0	gum_Arabic JJ 0	than IN 0	in IN 0	those DT 0	given VBN B-verb.possession	GM NNP 0	and CC 0	cellulose NN B-noun.body	. . 0	. . 0
a8319760.s2	The DT 0	results NNS B-noun.communication	suggest VBP B-verb.communication	a DT 0	possible JJ B-adj.all	involvement NN B-noun.person	of IN 0	the DT 0	renin NN B-noun.person	- : 0	angiotensin NN 0	system NN B-noun.cognition	in IN 0	the DT 0	development NN B-noun.process	of IN 0	puromycin_aminonucleoside JJ B-noun.other	- : 0	induced VBN B-verb.communication	nephrosis NN B-noun.person	. . 0	. . 0
a1919871.s1	Renal_papillary_necrosis NN B-noun.relation	( ( 0	RPN NNP 0	) ) 0	and CC 0	a DT 0	decreased VBN B-adj.all	urinary NN B-noun.possession	concentrating VBG B-verb.stative	ability NN B-adv.all	developed VBN B-verb.creation	during IN 0	continuous JJ 0	long RB 0	- : 0	term NN B-noun.time	treatment NN 0	with IN 0	aspirin NN B-noun.person	and CC 0	paracetamol NN B-noun.person	in IN 0	female NN 0	Fischer RB 0	344 CD 0	rats NNS B-noun.animal	. . 0	. . 0
a19058010.s3	for IN 0	2 CD B-adj.all	days NNS B-noun.person	at IN 0	an DT 0	interval NN B-noun.cognition	of IN 0	24 CD B-adj.all	h NN 0	caused VBD B-verb.communication	a DT 0	significant JJ B-adj.all	( ( 0	P<0.05 NN 0	) ) 0	elevation NN B-noun.act	of IN 0	heart NN B-noun.body	weight NN B-noun.attribute	, , 0	serum NN B-noun.body	marker NN I-noun.body	enzymes NNS B-noun.person	, , 0	lipid JJ B-adj.all	peroxidation NN B-noun.person	and CC 0	Ca+2 NNP B-noun.person	ATPase NNP I-noun.person	level NN I-noun.person	whereas IN 0	there EX 0	was VBD B-verb.stative	a DT 0	significant JJ B-adj.all	( ( 0	P<0.05 NN 0	) ) 0	decrease NN B-noun.state	in IN 0	body NN 0	weight NN B-noun.artifact	, , 0	endogenous JJ B-adj.all	antioxidants NNS B-noun.person	, , 0	Na+/ FW B-noun.other	_ FW I-noun.other	K+ FW I-noun.other	ATPase NNP I-noun.other	and CC I-noun.other	Mg+2 NNP I-noun.other	ATPase NNP I-noun.other	levels NNS B-noun.state	. . 0	. . 0
a9245658.s3	Almost RB B-adv.all	certainly RB I-adv.all	, , 0	nicotine JJ B-adj.all	via IN 0	its PRP$ 0	hemodynamic JJ B-adj.pert	effects NNS B-noun.phenomenon	contributes VBZ B-verb.communication	to TO 0	acute VB B-verb.change	cardiovascular JJ B-adj.all	events NNS B-noun.artifact	, , 0	although IN 0	current JJ B-adj.all	evidence NN B-noun.communication	suggests VBZ B-verb.communication	that IN 0	the DT 0	effects NNS B-noun.phenomenon	of IN 0	nicotine NN B-noun.person	are VBP B-verb.stative	much RB 0	less RBR B-adv.all	important JJ B-adj.all	than IN 0	are VBP B-verb.stative	the DT 0	prothrombotic JJ B-adj.all	effects NNS B-noun.phenomenon	of IN 0	cigarette NN B-noun.animal	smoking NN B-verb.consumption	or CC 0	the DT 0	effects NNS B-noun.phenomenon	of IN 0	carbon_monoxide NN 0	. . 0	. . 0
a6640832.s3	Instillation NN B-noun.person	was VBD 0	repeated VBN B-verb.communication	twice RB I-verb.communication	during IN 0	the DT 0	first JJ B-adj.all	week NN B-noun.time	, , 0	then RB B-adv.all	weekly RB B-adv.all	during IN 0	the DT 0	first JJ B-adj.all	month NN B-noun.motive	and CC 0	afterwards RB B-adv.all	monthly RB B-adv.all	for IN 0	1 CD B-adj.all	year NN B-noun.time	. . 0	. . 0
a17532790.s1	L SYM 0	- : 0	DOPA NN B-noun.group	- : 0	induced VBN B-verb.creation	dyskinesia NN B-noun.substance	( ( 0	LID NNP 0	) ) 0	is VBZ B-verb.stative	among IN 0	the DT 0	motor NN B-noun.person	complications NNS B-noun.person	that WDT 0	arise VBP B-verb.stative	in IN 0	Parkinson's_disease NNP 0	( ( 0	PD NNP 0	) ) 0	patients NNS B-noun.location	after IN 0	a DT 0	prolonged VBN B-verb.creation	treatment NN I-verb.creation	with IN 0	L SYM 0	- : 0	DOPA NN B-noun.group	. . 0	. . 0
a8829025.s0	Effect NN 0	of IN 0	nifedipine NN B-noun.person	on IN 0	renal JJ B-adj.all	function NN B-noun.act	in IN 0	liver NN B-noun.animal	transplant NN I-noun.animal	recipients NNS B-noun.person	receiving VBG B-verb.communication	tacrolimus NN I-verb.communication	. . 0	. . 0
a3560096.s1	Hyperkalemia NNP B-noun.person	has VBZ 0	recently RB B-adv.all	been VBN 0	recognized VBN B-verb.cognition	as IN 0	a DT 0	complication NN B-noun.person	of IN 0	nonsteroidal JJ B-adj.all	antiinflammatory JJ B-adj.all	agents NNS B-noun.person	( ( 0	NSAID NNP B-noun.group	) ) 0	such JJ 0	as IN 0	indomethacin NN 0	. . 0	. . 0
a11706060.s11	After IN 0	10 CD B-adj.all	days NNS B-noun.time	, , 0	only RB B-adv.all	ANF NNP 0	was VBD 0	elevated VBN B-verb.social	, , 0	and CC 0	only RB B-adv.all	in IN 0	the DT 0	TG NNP 0	+ , 0	HAART NNP 0	cohort NN 0	. . 0	. . 0
a19269743.s8	Subjects NNS B-noun.person	were VBD B-verb.stative	able JJ B-adj.all	to TO 0	reliably RB B-adj.pert	discriminate JJ B-adj.all	pain NN B-noun.person	magnitude NN B-noun.person	and CC 0	duration NN 0	across IN 0	capsaicin NN B-noun.animal	doses NNS I-noun.animal	( ( 0	both DT 0	p<0.001 NNP B-noun.location	) ) 0	, , 0	regardless RB 0	of IN 0	whether IN 0	first JJ B-verb.competition	- : 0	time NN B-noun.time	ratings NNS B-noun.time	were VBD 0	requested VBN B-verb.communication	immediately RB B-adv.all	, , 0	after IN 0	one CD 0	hour NN B-noun.communication	or CC 0	after IN 0	one CD 0	day NN 0	. . 0	. . 0
a20003049.s5	RESULTS NNS B-noun.artifact	, , 0	Unexpectedly RB B-adj.all	high JJ B-adj.all	concentrations NNS B-noun.attribute	of IN 0	argatroban JJ B-adj.all	were VBD 0	measured VBN B-verb.change	in IN 0	these DT 0	samples NNS B-noun.cognition	( ( 0	range NN B-noun.person	, , 0	0 CD B-noun.quantity	- : 0	32 CD 0	microg NN B-noun.quantity	/ : 0	mL LS 0	) ) 0	, , 0	and CC 0	a DT 0	prolonged VBN B-verb.creation	plasma NN B-noun.substance	argatroban JJ B-noun.phenomenon	half NN I-noun.phenomenon	life NN B-noun.phenomenon	( ( 0	t(1/2 NNP 0	) ) 0	) ) 0	of IN 0	514 CD 0	minutes NNS B-noun.time	was VBD 0	observed VBN B-verb.perception	( ( 0	published VBN B-verb.creation	elimination NN B-noun.group	t(1/2 NNP I-noun.group	) ) 0	is VBZ B-verb.stative	39 CD 0	- : 0	51 CD 0	minutes NNS B-noun.time	[ : 0	< PRP 0	or CC 0	= $ 0	181 CD 0	minutes NNS B-noun.time	with IN 0	hepatic_impairment NNP B-noun.person	] : 0	) ) 0	. . 0	. . 0
a12589964.s18	cTnI NNS 0	( ( 0	ng UH 0	/ : 0	ml LS 0	) ) 0	, , 0	CK NNP 0	- : 0	MB NN 0	mass NN B-noun.act	and CC 0	CK NNP 0	remained VBD B-verb.stative	unchanged JJ B-adj.all	in IN 0	DOX NNP 0	rats NNS 0	compared VBN B-verb.stative	with IN 0	controls NNS B-noun.artifact	. . 0	. . 0
a2375138.s1	Midazolam_hydrochloride NN 0	is VBZ B-verb.stative	commonly RB B-adv.all	used VBN B-verb.consumption	for IN 0	dental JJ B-adj.all	or CC 0	endoscopic JJ B-adj.all	procedures NNS B-noun.person	. . 0	. . 0
a2559236.s4	Groups NNS B-noun.group	1 CD 0	and CC 0	2 CD B-adj.all	underwent NN B-noun.quantity	micropuncture NN B-noun.phenomenon	studies NNS B-noun.artifact	after IN 0	10 CD B-adj.all	days NNS B-noun.time	. . 0	. . 0
a17343925.s7	RESULTS NNS B-noun.artifact	, , 0	In IN 0	exposed VBN B-verb.perception	neonates NNS B-noun.artifact	, , 0	TEOAEs NNP B-noun.person	mean JJ B-adj.all	response NN B-noun.communication	( ( 0	across IN 0	frequency NN B-noun.quantity	) ) 0	and CC 0	mean JJ B-adj.all	amplitude NN B-noun.person	at IN 0	4000Hz CD 0	was VBD B-verb.stative	significantly RB B-adv.all	lower JJR B-adj.all	than IN 0	in IN 0	non NN B-noun.person	- : 0	exposed VBN B-verb.communication	neonates NNS B-noun.person	. . 0	. . 0
a11961407.s4	Puromycin_aminonucleoside JJ B-adj.all	nephrosis NN B-noun.person	was VBD 0	induced VBN B-verb.creation	by IN 0	single JJ B-adj.all	intraperitoneal JJ B-adj.all	injection NN B-noun.act	of IN 0	puromycin_aminonucleoside JJ B-noun.other	( ( 0	PAN NNP 0	, , 0	20 CD B-adj.all	mg/100 CD B-noun.quantity	g IN 0	BW NNP 0	) ) 0	. . 0	. . 0
a8955532.s3	Permeability NN B-noun.person	of IN 0	the DT 0	blood NN B-noun.act	- : 0	brain NN B-noun.person	barrier NN B-noun.person	was VBD 0	quantitated VBN B-verb.change	by IN 0	clearance NN B-noun.person	of IN 0	fluorescent NN B-noun.person	- : 0	labeled VBN B-verb.communication	dextran NN B-noun.feeling	before IN 0	and CC 0	during IN 0	phenylephrine NN B-noun.person	- : 0	induced VBN B-verb.creation	acute JJ B-adj.all	hypertension NN B-noun.person	in IN 0	rats NNS B-noun.animal	treated VBN B-verb.change	with IN 0	vehicle NN B-noun.communication	and CC 0	Hoe-140 NNP B-noun.person	( ( 0	0.1 CD 0	microM NNS B-noun.attribute	) ) 0	. . 0	. . 0
a10743446.s1	We PRP 0	have VBP 0	examined VBN B-verb.communication	the DT 0	effect NN B-noun.cognition	of IN 0	systemic JJ B-adj.all	administration NN B-noun.time	of IN 0	ketamine NN B-noun.person	and CC 0	lidocaine NN B-noun.person	on IN 0	brush NN B-noun.person	- : 0	evoked VBD B-verb.communication	( ( 0	dynamic JJ 0	) ) 0	pain NN B-noun.quantity	and CC 0	punctate VB B-verb.social	- : 0	evoked VBD B-verb.communication	( ( 0	static JJ B-adj.all	) ) 0	hyperalgesia NN 0	induced VBN B-verb.creation	by IN 0	capsaicin NN B-noun.person	. . 0	. . 0
a8739323.s0	Effect NN 0	of IN 0	some DT 0	anticancer NN B-adj.all	drugs NNS B-noun.artifact	and CC 0	combined VBN B-verb.change	chemotherapy NN B-noun.artifact	on IN 0	renal_toxicity NN B-noun.act	. . 0	. . 0
a10193204.s1	Tetrandrine NNP B-noun.person	( ( 0	TET NNP 0	) ) 0	and CC 0	fangchinoline NN B-noun.person	( ( 0	FAN NNP 0	) ) 0	are VBP B-verb.stative	two CD 0	naturally RB B-adj.all	occurring VBG B-verb.stative	analogues NNS 0	with IN 0	a DT 0	bisbenzylisoquinoline NN B-noun.act	structure NN B-noun.attribute	. . 0	. . 0
a18410508.s3	Nat NNP B-noun.person	. . 0	. . 0
a10193204.s4	of IN 0	TET NNP B-noun.group	and CC 0	FAN NNP B-noun.person	in IN 0	mice NNS B-noun.person	showed VBD B-verb.communication	the DT 0	inhibition NN B-noun.attribute	of IN 0	thrombosis NN B-noun.communication	by IN 0	55 CD 0	% NN 0	and CC 0	35 CD 0	% NN 0	, , 0	respectively RB B-adv.all	, , 0	while IN 0	acetylsalicylic_acid NNP B-noun.person	( ( 0	ASA NNP 0	, , 0	50 CD B-adj.all	mg FW B-noun.quantity	/ FW 0	kg FW 0	, , 0	i.p NNP B-noun.person	. . 0	) ) 0	, , 0	. . 0
a19889778.s4	Replication NN B-noun.person	- : 0	competent JJ B-adj.all	HBV NNP B-noun.group	strains VBZ B-verb.competition	with IN 0	sG145R JJ B-noun.feeling	or CC 0	sP120 JJ 0	T NNP 0	and CC 0	LAM NNP B-noun.other	resistance NN B-noun.phenomenon	( ( 0	rtM204I JJ 0	or CC 0	rtL180M VB 0	/ DT 0	rtM204V NNP B-noun.location	) ) 0	were VBD 0	generated VBN B-verb.communication	on IN 0	an DT 0	HBeAg NNP B-noun.person	- : 0	positive JJ B-adj.all	and CC 0	an DT 0	HBeAg NNP B-noun.person	- : 0	negative JJ B-adj.all	background NN B-noun.event	with IN 0	precore NN B-noun.substance	( ( 0	PC NN 0	) ) 0	and CC 0	basal NN B-adj.all	core NN B-noun.group	promoter NN B-noun.person	( ( 0	BCP NNP 0	) ) 0	mutants NNS B-noun.quantity	. . 0	. . 0
a8410052.s4	Immunohistochemical JJ B-adj.all	staining NN B-noun.act	for IN 0	NFs NNP B-noun.person	showed VBD B-verb.communication	characteristic JJ B-adj.all	terminal NN B-noun.artifact	clubs NNS B-noun.group	of IN 0	axons NNS B-noun.food	in IN 0	the DT 0	borderzone NN 0	of IN 0	lesions NNS B-noun.communication	. . 0	. . 0
a234669.s1	Cardiac_arrhythmias NNS B-noun.artifact	have VBP 0	frequently RB B-adv.all	been VBN 0	reported VBN B-verb.communication	in IN 0	association NN 0	with IN 0	respiratory_failure NN B-noun.act	. . 0	. . 0
a9199746.s0	Macula NNP B-noun.person	toxicity NN I-noun.person	after IN 0	intravitreal JJ B-adj.all	amikacin NN B-noun.person	. . 0	. . 0
a12084448.s3	He PRP 0	was VBD B-verb.stative	awake RB B-adj.all	, , 0	revealed VBD B-verb.perception	no DT 0	changes NNS B-noun.phenomenon	of IN 0	mental JJ B-adj.all	status NN B-noun.state	and CC 0	at IN 0	rest NN B-noun.artifact	there EX 0	were VBD B-verb.stative	no DT 0	further JJ B-adj.all	motor NN B-noun.artifact	symptoms NNS I-noun.artifact	. . 0	. . 0
a3856631.s5	The DT 0	most RBS 0	common JJ B-noun.person	toxicities NNS B-noun.person	encountered VBN B-verb.social	were VBD B-verb.stative	transient JJ B-adj.all	serum NN B-noun.artifact	transaminase NN I-noun.artifact	and CC 0	bilirubin NN B-noun.person	elevations NNS B-noun.person	, , 0	neutropenia NN B-noun.person	, , 0	and CC 0	mucositis NN B-noun.act	. . 0	. . 0
a20196116.s15	CONCLUSION NN B-noun.group	, , 0	ATT NNP B-noun.group	- : 0	ALF NNP B-noun.group	constituted VBD B-verb.stative	5.7 CD 0	% NN 0	of IN 0	ALF NNP B-noun.group	at IN 0	our PRP$ 0	center NN B-noun.artifact	and CC 0	had VBD 0	a DT 0	high JJ B-adj.all	mortality NN B-noun.attribute	rate NN B-noun.time	. . 0	. . 0
a10706004.s9	After IN 0	recovery NN B-noun.person	from IN 0	hypertension NN B-noun.act	, , 0	the DT 0	activity NN B-noun.process	of IN 0	( ( 0	Na,,K)-ATPase JJ 0	increased VBN B-verb.change	, , 0	due JJ 0	to TO 0	higher JJR B-adj.all	affinity NN B-noun.attribute	of IN 0	the_ATP SYM 0	- : 0	binding JJ B-verb.contact	site NN 0	, , 0	as IN 0	revealed VBN B-verb.perception	from IN 0	the DT 0	lowered VBN B-verb.motion	Km NNP 0	value NN B-noun.possession	for IN 0	ATP NNP 0	. . 0	. . 0
a1592014.s8	Electrical JJ B-adj.all	recordings NNS B-noun.artifact	from IN 0	the DT 0	hippocampus NN B-noun.person	showed VBD B-verb.communication	a DT 0	rhythmic JJ B-adj.all	progression NN B-noun.act	in IN 0	EEG NNP 0	frequency NN B-noun.quantity	and CC 0	voltage NN B-noun.artifact	with IN 0	clinical JJ B-adj.all	seizure NN B-noun.communication	expression NN B-noun.communication	. . 0	. . 0
a11206082.s0	Two CD 0	mouse NN 0	lines NNS B-noun.communication	selected VBN B-verb.cognition	for IN 0	differential JJ B-adj.all	sensitivities NNS B-noun.person	to TO 0	beta JJ 0	- : 0	carboline NN B-noun.person	- : 0	induced VBN B-verb.creation	seizures NNS B-noun.feeling	are VBP 0	also RB B-adv.all	differentially RB B-adv.all	sensitive JJ 0	to TO 0	various JJ B-adj.all	pharmacological JJ B-adj.pert	effects NNS B-noun.phenomenon	of IN 0	other JJ 0	GABA(A NNP B-noun.location	) ) 0	receptor NN B-noun.person	ligands NNS B-noun.person	. . 0	. . 0
a137340.s5	Pretreatment NNP B-noun.person	of IN 0	mice NNS B-noun.person	with IN 0	alpha NN B-noun.feeling	- : 0	methyltyrosine NN B-noun.attribute	( ( 0	20 CD 0	mg FW 0	/ FW 0	kg FW 0	i.p FW 0	. . 0	, , 0	. . 0
a11928786.s10	Zyban NNP B-noun.person	caused VBD B-verb.communication	significant JJ B-adj.all	neurological_and_cardiovascular_toxicity NN B-noun.attribute	in IN 0	overdose NN 0	. . 0	. . 0
a17879945.s9	E2 PRP 0	decreased VBD B-verb.communication	the DT 0	accumulation NN B-noun.act	of IN 0	cholesteryl_esters NNS B-noun.person	in IN 0	macrophages NNS B-noun.artifact	following VBG B-verb.stative	ritonavir JJ B-adj.all	treatment NN B-noun.plant	. . 0	. . 0
a7881871.s1	Reactive JJ B-adj.all	oxygen NN B-noun.substance	species NNS B-noun.artifact	have VBP 0	been VBN 0	implicated VBN B-verb.communication	in IN 0	the DT 0	pathogenesis NN B-noun.location	of IN 0	acute JJ B-adj.all	puromycin_aminonucleoside NN B-noun.other	( ( 0	PAN)-induced JJ 0	nephropathy JJ B-adj.all	, , 0	with IN 0	antioxidants NNS B-noun.person	significantly RB B-adv.all	reducing VBG B-verb.change	the DT 0	proteinuria NN B-noun.person	. . 0	. . 0
a16337777.s4	DNA NN 0	analysis NN 0	revealed VBD B-verb.communication	low JJ 0	amounts NNS B-noun.quantity	of IN 0	a DT 0	4.8 CD 0	kb IN 0	mtDNA JJ B-adj.all	deletion NN B-noun.act	but CC 0	with IN 0	no DT 0	differences NNS B-noun.person	in IN 0	frequency NN B-noun.quantity	or CC 0	quantity NN B-noun.attribute	in IN 0	the DT 0	control NN B-noun.act	and CC 0	experimental JJ B-adj.all	groups NNS B-noun.group	. . 0	. . 0
a6466532.s3	A DT 0	control NN B-noun.location	group NN B-noun.person	was VBD 0	included VBN B-verb.stative	for IN 0	comparison NN B-noun.person	with IN 0	the DT 0	lower JJR B-adj.all	dose NN B-noun.state	range NN I-noun.state	of IN 0	glycopyrrolate NN B-noun.person	and CC 0	atropine NN B-noun.act	. . 0	. . 0
a20003049.s0	Prolonged VBN B-verb.communication	elevation NN B-noun.cognition	of IN 0	plasma NN B-noun.plant	argatroban NN B-noun.body	in IN 0	a DT 0	cardiac JJ B-adj.all	transplant NN B-noun.person	patient NN B-noun.person	with IN 0	a DT 0	suspected VBN B-verb.cognition	history NN B-noun.cognition	of IN 0	heparin NN B-noun.person	- : 0	induced VBN B-verb.creation	thrombocytopenia NN I-verb.creation	with IN 0	thrombosis NN B-noun.food	. . 0	. . 0
a11928786.s3	In IN 0	the DT 0	initial JJ B-adj.all	6 CD B-adj.all	months NNS B-noun.person	since IN 0	it PRP 0	's VBZ 0	introduction NN 0	, , 0	12 CD B-adj.all	overdose JJ B-adj.all	cases NNS B-noun.artifact	have VBP 0	been VBN 0	reported VBN B-verb.communication	to TO 0	The DT 0	National NNP B-noun.group	Poisons NNP I-noun.group	Information NNP I-noun.group	Centre NNP I-noun.group	. . 0	. . 0
a15338796.s6	Subjects NNS B-noun.person	were VBD 0	asked VBN B-verb.communication	to TO 0	aim VB B-verb.communication	at IN 0	the DT 0	centre NN B-noun.location	of IN 0	a DT 0	target NN B-noun.location	, , 0	subdivided VBN B-verb.contact	in IN 0	concentric JJ B-adj.all	circles NNS B-noun.group	, , 0	from IN 0	5 CD B-adj.all	m NN B-noun.quantity	distance NN B-noun.act	. . 0	. . 0
a16904497.s17	CONCLUSION NN B-noun.group	, , 0	Complications NNS B-noun.person	associated VBN B-verb.cognition	with IN 0	epidural JJ B-adj.all	steroid JJ B-noun.act	injections NNS I-noun.act	are VBP B-verb.stative	rare JJ B-adj.all	. . 0	. . 0
a12639165.s1	OBJECTIVE NNP B-noun.group	, , 0	To TO 0	report VB B-verb.stative	2 CD B-adj.all	cases NNS B-noun.quantity	of IN 0	ticlopidine NN B-noun.communication	- : 0	induced VBN B-verb.creation	cholestatic_hepatitis NN 0	, , 0	investigate VB B-verb.stative	its PRP$ 0	mechanism NN B-noun.attribute	, , 0	and CC 0	compare VB B-verb.stative	the DT 0	observed JJ B-adj.all	main JJ B-adj.all	characteristics NNS B-noun.person	with IN 0	those DT 0	of IN 0	the DT 0	published VBN B-verb.creation	cases NNS B-noun.artifact	. . 0	. . 0
a7292072.s0	Variant NNP B-noun.person	ventricular_tachycardia NNP I-noun.person	in IN 0	desipramine NN 0	toxicity NN B-noun.attribute	. . 0	. . 0
a9727773.s8	The DT 0	patients NNS B-noun.person	who WP 0	had VBD 0	been VBN 0	exposed VBN B-verb.perception	to TO 0	appetite_suppressants NNS B-noun.person	tended VBD B-verb.social	to TO 0	be VB B-verb.stative	on IN 0	average NN B-noun.act	more RBR B-adv.all	severely RB B-adj.all	ill JJ I-adj.all	, , 0	and CC 0	to TO 0	have VB B-verb.social	a DT 0	shorter JJR B-adj.all	median JJ B-adj.all	delay NN B-noun.act	between IN 0	onset NN B-noun.event	of IN 0	symptoms NNS B-noun.body	and CC 0	diagnosis NN B-noun.person	. . 0	. . 0
a20098969.s7	She PRP 0	reported VBD B-verb.communication	her PRP$ 0	use NN 0	of IN 0	methamphetamine NN B-noun.attribute	for IN 0	five CD B-adj.all	years NNS B-noun.time	and CC 0	had VBD 0	not RB B-adv.all	experienced VBN B-verb.perception	any DT 0	major JJ B-adj.all	carious_episodes NNS B-noun.group	before IN 0	she PRP 0	started VBD B-verb.change	using VBG B-verb.consumption	the DT 0	drug NN B-noun.artifact	. . 0	. . 0
a9495837.s2	30 SYM 0	- : 0	60 CD B-adj.all	mg RB B-noun.quantity	kg-1 JJ B-adj.all	p.o NN B-noun.artifact	. . 0	, , 0	. . 0
a17532790.s5	In IN 0	the DT 0	present JJ B-adj.all	study NN B-noun.artifact	, , 0	we PRP 0	investigated VBD B-verb.communication	the DT 0	changes NNS B-noun.artifact	occurring VBG B-verb.stative	at IN 0	the DT 0	protein NN B-adj.all	level NN B-noun.state	in IN 0	striatal JJ B-adj.all	samples NNS B-noun.cognition	obtained VBN B-verb.change	from IN 0	the DT 0	unilaterally RB B-adj.all	6-hydroxydopamine JJ 0	- : 0	lesion NN 0	rat NN 0	model NN 0	of IN 0	PD NNP 0	treated VBD B-verb.change	with IN 0	saline NN B-noun.act	, , 0	L NNP 0	- : 0	DOPA NN B-noun.group	or CC 0	bromocriptine NN B-noun.substance	using VBG B-verb.consumption	two CD I-verb.consumption	- : 0	dimensional JJ B-adj.all	difference NN B-noun.state	gel NN 0	electrophoresis NN 0	and CC 0	mass NN B-noun.act	spectrometry NN B-noun.possession	( ( 0	MS NNP 0	) ) 0	. . 0	. . 0
a19346865.s3	They PRP 0	had VBD 0	been VBN 0	taking VBG B-verb.cognition	metronidazole NN B-noun.attribute	( ( 0	total JJ B-adj.all	dosage NN B-noun.possession	, , 0	45 CD 0	- : 0	120 CD 0	g NN B-noun.quantity	, , 0	duration NN 0	, , 0	30 CD B-adj.all	days NNS B-noun.person	to TO 0	2 CD B-adj.all	months NNS B-noun.quantity	) ) 0	to TO 0	treat VB B-verb.body	the DT 0	infection NN B-noun.cognition	in IN 0	various JJ B-adj.all	organs NNS B-noun.body	. . 0	. . 0
a1720453.s2	Total JJ B-adj.all	cumulative JJ B-adj.all	doses NNS B-noun.person	were VBD B-verb.stative	36 CD 0	or CC 0	60 CD B-adj.all	g PRP 0	/ $ 0	m2 CD 0	of IN 0	ifosfamide NN B-noun.cognition	( ( 0	six CD 0	or CC 0	10 CD B-adj.all	cycles NNS B-noun.quantity	of IN 0	ifosfamide,_vincristine,_and_dactinomycin NN B-noun.food	[ '' 0	IVA NNP B-noun.group	] : 0	) ) 0	. . 0	. . 0
a10091617.s0	Selegiline SYM 0	- : 0	induced VBN B-verb.creation	postural_hypotension NN B-noun.process	in IN 0	Parkinson's_disease NNP B-noun.location	, , 0	a DT 0	longitudinal JJ B-adj.all	study NN B-noun.artifact	on IN 0	the DT 0	effects NNS B-noun.phenomenon	of IN 0	drug NN B-noun.phenomenon	withdrawal NN 0	. . 0	. . 0
a16740173.s4	The DT 0	mode NN B-noun.attribute	of IN 0	action NN B-noun.person	was VBD 0	said VBN B-verb.communication	to TO 0	be VB B-verb.stative	comparable JJ B-adj.all	to TO 0	that DT 0	of IN 0	the DT 0	synthetic JJ B-adj.all	compound NN B-noun.event	' POS 0	carbamylcholin NN B-noun.communication	' '' 0	, , 0	that WDT 0	is VBZ B-verb.stative	, , 0	carbachol NN 0	. . 0	. . 0
a19269743.s5	Subjects NNS B-noun.person	also RB B-adv.all	recalled VBD B-verb.communication	their PRP$ 0	pains NNS B-noun.cognition	one CD 0	week NN 0	later RB B-adv.all	. . 0	. . 0
a17639754.s3	While IN 0	small JJ B-adj.all	prospective JJ B-adj.all	studies NNS B-noun.group	have VBP 0	not RB B-adv.all	revealed VBN B-verb.perception	any DT 0	significant JJ B-adj.all	drug NN B-noun.person	- : 0	drug NN 0	interaction NN 0	between IN 0	warfarin NN B-noun.location	and CC 0	levofloxacin NN B-noun.state	, , 0	several JJ B-adj.all	case NN B-noun.state	reports NNS B-noun.communication	have VBP 0	indicated VBN B-verb.cognition	that IN 0	levofloxacin NN B-noun.state	may MD 0	significantly RB 0	potentiate VB B-verb.communication	the DT 0	anticoagulation NN B-noun.location	effect NN 0	of IN 0	warfarin NN B-noun.act	. . 0	. . 0
a3437726.s6	Two CD 0	days NNS 0	before IN 0	admission NN 0	diltiazem NN 0	( ( 0	60 CD 0	mg IN 0	b.i.d NNP B-noun.person	. . 0	) ) 0	. . 0
a17437408.s4	However RB 0	, , 0	one CD 0	drawback NN B-noun.person	of IN 0	such JJ B-adj.all	studies NNS B-noun.group	in IN 0	genetically RB B-adv.all	deficient JJ B-adj.all	rats NNS B-noun.animal	is VBZ B-verb.stative	the DT 0	fact NN B-noun.state	that IN 0	compensatory JJ B-adj.pert	changes NNS B-noun.phenomenon	with IN 0	upregulation NN B-noun.act	of IN 0	other JJ 0	transporters NNS B-noun.person	can MD 0	occur VB B-verb.cognition	. . 0	. . 0
a2054792.s7	Thus RB 0	, , 0	while IN 0	whole JJ B-adj.all	body NN 0	hyperthermia NN 0	enhances VBZ B-verb.stative	Adriamycin NNP B-noun.person	- : 0	mediated VBN B-verb.cognition	antitumor NN 0	effect NN 0	, , 0	normal JJ B-adj.all	tissue NN B-noun.phenomenon	toxicity NN B-noun.phenomenon	is VBZ B-verb.stative	also RB B-adv.all	increased VBD B-verb.change	, , 0	and CC 0	the DT 0	potential JJ B-adj.all	therapeutic JJ B-adj.pert	gain NN B-noun.attribute	of IN 0	the DT 0	combined VBN B-verb.change	modality NN B-noun.person	treatment NN B-noun.person	is VBZ 0	eroded VBN B-verb.change	. . 0	. . 0
a9855119.s2	METHODS NNS B-noun.attribute	, , 0	Twenty CD 0	- : 0	six CD 0	renal JJ B-adj.all	allograft NN B-noun.act	biopsy NN I-noun.act	specimens VBZ B-verb.stative	from IN 0	1 CD B-adj.all	9 CD 0	renal JJ B-adj.all	transplant NN B-noun.person	patients NNS B-noun.person	who WP 0	underwent VBD B-verb.social	transplantations NNS B-noun.communication	between IN 0	1991 CD 0	and CC 0	1993 CD 0	were VBD 0	evaluated VBN B-verb.communication	. . 0	. . 0
a9587734.s6	Apart RB 0	from IN 0	the DT 0	reduction NN B-noun.act	in IN 0	the DT 0	patient NN B-noun.person	's POS 0	level NN B-noun.state	of IN 0	consciousness NN B-noun.cognition	, , 0	there EX 0	were VBD B-verb.stative	no DT 0	signs NNS B-noun.communication	of IN 0	motor NN 0	neurone NN 0	damage NN B-noun.event	or CC 0	of IN 0	any DT 0	of IN 0	the DT 0	other JJ B-adj.all	known JJ I-adj.all	predisposing NN B-noun.person	conditions NNS B-noun.person	for IN 0	hyperkalaemia NN 0	following VBG 0	the DT 0	administration NN B-noun.time	of IN 0	suxamethonium NN B-noun.artifact	. . 0	. . 0
a16330293.s2	The DT 0	increased VBN B-verb.change	nicotine JJ B-adj.all	exposure NN B-noun.person	from IN 0	the DT 0	lozenge NN B-noun.group	has VBZ 0	raised VBN B-verb.change	questions NNS B-noun.communication	about IN 0	the DT 0	relative JJ B-adj.pert	safety NN B-noun.person	of IN 0	the DT 0	lozenge NN B-noun.artifact	and CC 0	gum NN B-noun.person	. . 0	. . 0
a3425586.s7	Given VBN B-verb.possession	the DT 0	influx NN B-noun.cognition	of IN 0	Southeast NNP B-noun.person	Asians NNPS I-noun.person	into IN 0	the DT 0	United NNP B-noun.other	States NNPS I-noun.other	, , 0	oxidant JJ B-adj.all	medications NNS B-noun.communication	should MD 0	be VB 0	used VBN B-verb.consumption	with IN 0	caution NN B-noun.cognition	, , 0	especially RB B-adv.all	if IN 0	an DT 0	infection NN B-noun.cognition	is VBZ B-verb.stative	present JJ B-adj.all	, , 0	in IN 0	individuals NNS 0	of IN 0	ethnic JJ B-adj.pert	backgrounds NNS B-noun.communication	that WDT 0	have VBP B-verb.stative	an DT 0	increased VBN B-adj.all	prevalence NN B-noun.attribute	of IN 0	hemoglobin NN B-noun.person	E. NNP I-noun.person	. . 0
a11250767.s5	Serologic JJ B-adj.all	evaluation NN B-noun.act	revealed VBD B-verb.perception	the DT 0	presence NN B-noun.person	of IN 0	perinuclear JJ B-adj.pert	- : 0	staining VBG B-verb.communication	antineutrophil RB 0	cytoplasmic JJ B-adj.all	autoantibodies NNS B-noun.person	( ( 0	pANCA NN B-noun.attribute	) ) 0	against IN 0	myeloperoxidase NN B-noun.person	( ( 0	MPO NNP 0	) ) 0	. . 0	. . 0
a20084309.s1	BACKGROUND NN 0	, , 0	TEE NNP B-noun.group	is VBZ B-verb.stative	a DT 0	semi NN B-noun.person	- : 0	invasive JJ B-adj.all	tool NN B-noun.act	broadly RB B-adv.all	used VBN B-verb.consumption	and CC 0	its PRP$ 0	utilization NN B-noun.act	associated VBN B-verb.cognition	to TO 0	sedatives NNS B-noun.artifact	drugs NNS B-noun.artifact	might MD 0	to TO 0	affect VB B-verb.change	the DT 0	procedure NN B-noun.person	safety NN B-noun.person	. . 0	. . 0
a16867021.s17	Pretreatment NNP B-noun.person	with_RAMH NNP I-noun.person	( ( 0	5 CD B-adj.all	microg NN B-noun.act	i.c.v NNP I-noun.act	. . 0	) ) 0	. . 0
a11581460.s1	Sedation NN B-noun.person	has VBZ 0	been VBN 0	commonly RB B-adv.all	used VBN B-verb.consumption	in IN 0	the DT 0	neonate NN B-noun.artifact	to TO 0	decrease VB B-verb.communication	the DT 0	stress NN B-noun.artifact	and CC 0	pain NN B-noun.person	from IN 0	the DT 0	noxious JJ B-adj.all	stimuli NNS B-noun.person	and CC 0	invasive JJ B-adj.all	procedures NNS B-noun.person	in IN 0	the DT 0	neonatal JJ B-adj.all	intensive JJ B-adj.all	care NN B-noun.group	unit NN B-noun.artifact	, , 0	as RB 0	well RB 0	as IN 0	to TO 0	facilitate VB B-verb.communication	synchrony NN B-noun.person	between IN 0	ventilator NN B-noun.person	and CC 0	spontaneous JJ B-adj.all	breaths NNS B-noun.person	. . 0	. . 0
a18768591.s4	To TO 0	this DT 0	end NN B-noun.event	, , 0	doxorubicin NN 0	( ( 0	15 CD B-adj.all	mug NN B-noun.quantity	/ ( 0	g IN 0	body NN 0	wt NN 0	) ) 0	was VBD 0	injected VBN B-verb.change	intravenously RB B-adv.all	into IN 0	gene NN B-noun.person	- : 0	targeted JJ B-adj.all	mice NNS B-noun.person	lacking VBG B-verb.stative	SGK1 NN 0	( ( 0	sgk1(-/- NNP 0	) ) 0	) ) 0	and CC 0	their PRP$ 0	wild JJ B-noun.group	- : 0	type NN B-noun.person	littermates VBZ B-verb.communication	( ( 0	sgk1(+/+ NNP 0	) ) 0	) ) 0	. . 0	. . 0
a137340.s2	The DT 0	subcutaneous JJ B-adj.all	administration NN B-noun.time	of IN 0	10 CD B-adj.all	mg RB B-noun.quantity	/ JJ 0	kg NN 0	of IN 0	morphine NN B-noun.person	- : 0	HC1 NN B-noun.person	produced VBD B-verb.creation	a DT 0	marked VBN B-adj.all	increase_in_locomotor_activity NN B-noun.quantity	in IN 0	mice NNS B-noun.animal	. . 0	. . 0
a19843802.s5	The DT 0	catheters NNS B-noun.person	were VBD 0	changed VBN B-verb.change	, , 0	and CC 0	hemodynamics NNS B-noun.person	stabilized VBD B-verb.communication	at IN 0	lower JJR B-adj.all	catecholamine NN B-noun.location	doses NNS B-noun.person	. . 0	. . 0
a19657887.s0	Disulfiram SYM 0	- : 0	like IN 0	syndrome NN B-noun.person	after IN 0	hydrogen_cyanamide JJ 0	professional JJ B-adj.pert	skin NN B-noun.person	exposure NN B-noun.person	, , 0	two CD 0	case NN 0	reports VBZ B-verb.stative	in IN 0	France NNP B-noun.other	. . 0	. . 0
a12757899.s3	Rats NNS B-noun.person	received VBD B-verb.possession	subcutaneous JJ B-adj.all	injections NNS B-noun.event	of IN 0	17beta JJ 0	- : 0	estradiol NN B-noun.substance	( ( 0	2 CD B-adj.all	microg NNS B-noun.quantity	/ POS 0	rat NN 0	) ) 0	or CC 0	oil NN B-noun.body	once RB B-adv.all	daily RB B-adv.all	for IN 0	four CD 0	consecutive JJ B-adj.all	days NNS B-noun.person	. . 0	. . 0
a88336.s1	Four CD 0	patients NNS B-noun.person	who WP 0	were VBD 0	rendered VBN B-verb.creation	comatose JJ B-adj.all	or CC 0	stuporous JJ B-noun.possession	by IN 0	drug NN 0	intoxication NN 0	, , 0	but CC 0	who WP 0	were VBD B-verb.stative	not RB B-adv.all	hypoxic JJ B-adj.all	, , 0	are VBP 0	described VBN B-verb.communication	. . 0	. . 0
a2425813.s3	It PRP 0	is VBZ 0	suggested VBN B-verb.communication	that IN 0	the DT 0	drug NN B-noun.person	acted VBN B-verb.body	in IN 0	a DT 0	selective JJ B-noun.person	and CC 0	tissue NN B-noun.body	- : 0	specific JJ B-adj.all	manner NN B-noun.person	to TO 0	enhance VB B-verb.social	ribosomal JJ 0	RNA NNP 0	synthesis NN 0	in IN 0	the DT 0	liver NN B-noun.person	and CC 0	depress NN B-noun.state	such JJ B-adj.all	synthesis NN B-noun.cognition	in IN 0	the DT 0	muscle NN B-noun.body	. . 0	. . 0
a9721172.s1	Acute NNP B-noun.person	vanishing_bile_duct NNP I-noun.person	syndrome NN I-noun.person	is VBZ B-verb.stative	a DT 0	rare JJ B-adj.all	but CC 0	established VBN B-verb.social	cause NN B-noun.act	of IN 0	progressive JJ B-adj.all	cholestasis NN B-noun.food	in IN 0	adults NNS B-noun.animal	, , 0	is VBZ B-verb.stative	most RBS B-adv.all	often RB B-adv.all	drug NN B-noun.person	or CC 0	toxin NN B-noun.communication	related VBN B-verb.communication	, , 0	and CC 0	is VBZ B-verb.stative	of IN 0	unknown JJ B-adj.all	pathogenesis NN B-noun.location	. . 0	. . 0
a8752018.s0	Lithium NNP B-noun.person	- : 0	associated VBN B-verb.cognition	cognitive_and_functional_deficits NNS B-noun.person	reduced VBN B-verb.change	by IN 0	a DT 0	switch NN B-noun.time	to TO 0	divalproex_sodium NN B-noun.artifact	, , 0	a DT 0	case NN B-noun.communication	series NN B-noun.communication	. . 0	. . 0
a3403780.s0	Paracetamol NNP B-noun.person	- : 0	associated VBN B-verb.cognition	coma NN B-noun.person	, , 0	metabolic_acidosis NN B-noun.location	, , 0	renal_and_hepatic_failure NN B-noun.act	. . 0	. . 0
a10835440.s14	These DT 0	results NNS B-noun.event	do VBP 0	not RB 0	confirm VB B-verb.communication	or CC 0	exclude VB B-verb.social	a DT 0	neuroprotective JJ B-adj.all	property NN B-noun.possession	of IN 0	nimodipine NN B-noun.person	. . 0	. . 0
a12653683.s2	The DT 0	molecular JJ B-adj.all	mechanism(s NN B-noun.location	) ) 0	leading VBG B-verb.stative	to TO 0	salt VB B-verb.social	retention NN B-noun.act	has VBZ 0	not RB 0	been VBN 0	completely RB B-adv.all	elucidated VBN B-verb.change	. . 0	. . 0
a809711.s3	Ten CD 0	patients NNS B-noun.person	with IN 0	acute JJ B-adj.all	transmural JJ B-noun.body	myocardial_infarctions NNS I-noun.body	received VBD B-verb.possession	intravenous JJ B-adj.all	nitroglycerin NN B-noun.person	, , 0	sufficient JJ B-adj.all	to TO 0	reduce VB B-verb.change	mean JJ B-adj.all	arterial JJ B-adj.all	pressure NN B-noun.person	from IN 0	107 CD 0	+ . 0	/- $ 0	6 CD B-adj.all	to TO 0	85 CD 0	+ SYM 0	/- $ 0	6 CD B-adj.all	mm NN B-noun.quantity	Hg NNP 0	( ( 0	P NNP 0	less JJR 0	than IN 0	0.001 CD 0	) ) 0	, , 0	for IN 0	60 CD B-adj.all	minutes NNS B-noun.time	. . 0	. . 0
a2505783.s2	The DT 0	data NNS B-noun.cognition	demonstrate VBP B-verb.communication	that IN 0	CAA NNP B-noun.group	after IN 0	i.v CD 0	. . 0	. . 0
a1967484.s2	Although IN 0	initially RB B-adv.all	thought VBD B-verb.cognition	to TO 0	be VB B-verb.stative	free JJ B-adj.all	of IN 0	extrapyramidal JJ B-adj.all	side NN B-noun.location	effects NNS B-noun.phenomenon	, , 0	sulpiride NN B-noun.person	- : 0	induced VBN B-verb.creation	tardive_dyskinesia NN B-noun.location	and CC 0	parkinsonism NN B-noun.artifact	have VBP 0	been VBN 0	reported VBN B-verb.communication	occasionally RB B-adv.all	. . 0	. . 0
a10669626.s10	High JJ B-adj.all	doses NNS B-noun.attribute	of IN 0	vitamin NN 0	D NNP 0	are VBP 0	known VBN B-verb.cognition	to TO 0	cause VB B-verb.creation	calcification_of_the_artery JJ B-adj.all	media NNS B-noun.person	in IN 0	as RB 0	little JJ 0	as IN 0	3 CD 0	to TO 0	4 CD B-adj.all	days NNS B-noun.phenomenon	. . 0	. . 0
a19269743.s2	Systematic JJ B-adj.all	investigations NNS B-noun.relation	of IN 0	the DT 0	human JJ B-adj.all	capacity NN B-noun.quantity	to TO 0	remember VB B-verb.cognition	sensory JJ B-adj.all	features NNS B-noun.cognition	of IN 0	experimental JJ B-adj.all	pain NN B-noun.cognition	are VBP B-verb.stative	sparse JJ B-adj.all	. . 0	. . 0
a2304736.s5	Her PRP$ 0	incontinence NN B-noun.motive	resolved VBN B-verb.change	with IN 0	the DT 0	change NN B-noun.act	of IN 0	medication NN B-noun.person	. . 0	. . 0
a2505783.s1	Based VBN B-verb.cognition	on IN 0	clinical JJ B-adj.all	data NNS B-noun.cognition	, , 0	indicating VBG B-verb.communication	that IN 0	chloroacetaldehyde NN 0	( ( 0	CAA NNP 0	) ) 0	is VBZ B-verb.stative	an DT 0	important JJ B-adj.all	metabolite NN B-noun.attribute	of IN 0	oxazaphosphorine NN B-noun.person	cytostatics NNS B-noun.person	, , 0	an DT 0	experimental JJ B-adj.all	study NN B-noun.artifact	was VBD 0	carried VBN B-verb.change	out RP I-verb.change	in IN 0	order NN 0	to TO 0	elucidate VB B-verb.communication	the DT 0	role NN B-noun.attribute	of IN 0	CAA NNP B-noun.group	in IN 0	the DT 0	development NN B-noun.process	of IN 0	hemorrhagic_cystitis NNP B-noun.location	. . 0	. . 0
a14659530.s7	In IN 0	addition NN 0	, , 0	both DT 0	change NN B-noun.artifact	and CC 0	peak NN B-noun.person	, , 0	showed VBD B-verb.communication	significant JJ B-adj.all	positive JJ B-adj.all	correlations NNS B-noun.artifact	with IN 0	migraine NN 0	headache NN 0	intensity NN 0	( ( 0	P<0.001 NNP 0	) ) 0	. . 0	. . 0
a16938416.s9	CONCLUSION NN B-noun.group	, , 0	Our PRP$ 0	results NNS B-noun.communication	suggest VBP B-verb.communication	that IN 0	high JJ B-noun.group	- : 0	dose NN 0	testosterone NN 0	therapy NN 0	may MD 0	adversely RB 0	affect VB B-verb.body	atherosclerosis NN I-verb.body	in IN 0	postmenopausal JJ B-adj.all	women NNS B-noun.person	and CC 0	indicate VBP B-verb.cognition	that DT 0	androgen NN B-noun.person	replacement NN B-noun.person	in IN 0	these DT 0	women NNS B-noun.person	may MD 0	not RB 0	be VB B-verb.stative	harmless JJ B-adj.all	. . 0	. . 0
a12921865.s4	Allopregnanolone NNP B-noun.person	( ( 0	3alpha JJ B-noun.group	- : I-noun.group	hydroxy-5alpha SYM I-noun.group	- : 0	pregnan-20-one NN 0	) ) 0	, , 0	pregnanolone NN B-noun.person	( ( 0	3alpha JJ 0	- : 0	hydroxy-5beta JJ B-noun.other	- : 0	pregnan-20-one NN 0	) ) 0	and CC 0	ganaxolone NN B-noun.person	( ( 0	a DT 0	synthetic JJ B-adj.all	derivative NN B-noun.state	of IN 0	allopregnanolone NN B-noun.artifact	3alpha SYM 0	- : 0	hydroxy-3beta JJ B-noun.group	- : I-noun.group	methyl-5alpha SYM I-noun.group	- : 0	pregnan-20-one NN 0	) ) 0	were VBD 0	tested VBN B-verb.social	for IN 0	their PRP$ 0	ability NN B-noun.cognition	to TO 0	suppress VB B-verb.social	the DT 0	expression NN B-noun.communication	( ( 0	anticonvulsant JJ B-adj.all	effect NN B-noun.cognition	) ) 0	and CC 0	development NN B-noun.person	( ( 0	antiepileptogenic JJ B-adj.all	effect NN B-noun.cognition	) ) 0	of IN 0	cocaine NN B-noun.person	- : 0	kindled VBD B-verb.communication	seizures NNS B-noun.person	in IN 0	male NN 0	, , 0	Swiss JJ B-noun.person	- : 0	Webster JJ B-adj.all	mice NNS B-noun.person	. . 0	. . 0
a19308880.s3	We PRP 0	performed VBD B-verb.communication	this DT 0	study NN B-noun.artifact	in IN 0	order NN 0	to TO 0	describe VB B-verb.communication	the DT 0	main JJ B-adj.all	characteristics NNS B-noun.attribute	of IN 0	this DT 0	adverse JJ B-adj.all	drug NN B-noun.phenomenon	reaction NN B-noun.process	. . 0	. . 0
a17343925.s9	However RB 0	, , 0	by IN 0	comparing VBG B-verb.cognition	each DT 0	subgroup NN B-noun.person	to TO 0	control VB B-verb.consumption	group NN I-verb.consumption	, , 0	we PRP 0	found VBD B-verb.cognition	statistically RB B-adv.all	significant JJ B-adj.all	decreases_of_TEOAEs_amplitudes NNS B-noun.time	at IN 0	4000Hz NNP B-noun.location	for IN 0	all DT 0	three CD B-adj.all	groups NNS B-noun.substance	. . 0	. . 0
a11773892.s1	BACKGROUND NN 0	, , 0	The DT 0	calcineurin NN B-noun.communication	inhibitors NNS B-noun.person	cyclosporine VBP B-verb.social	and CC 0	tacrolimus NN B-noun.person	are VBP B-verb.stative	both DT 0	known VBN B-verb.cognition	to TO 0	be VB B-verb.stative	nephrotoxic JJ B-adj.all	. . 0	. . 0
a18020536.s10	RESULTS NNS B-noun.artifact	, , 0	The DT 0	mean NN B-noun.attribute	+ : 0	/- '' 0	SD NNP 0	duration NN 0	of IN 0	BZD NNP 0	/ ( 0	RD NNP 0	use NN 0	was VBD B-verb.stative	7 CD B-adj.all	+ SYM 0	/- $ 0	7 CD B-adj.all	years NNS B-noun.time	( ( 0	range NN B-noun.communication	1 CD B-adj.all	- : 0	31 CD 0	) ) 0	. . 0	. . 0
a12464714.s10	More JJR B-adj.all	patients NNS B-noun.person	were VBD B-verb.stative	( ( 0	completely RB B-adv.all	, , 0	very RB B-adv.all	or CC 0	somewhat RB 0	) ) 0	satisfied VBD B-verb.stative	2 CD B-adj.all	h NN 0	after IN 0	treatment NN B-noun.plant	with IN 0	rizatriptan JJ 0	( ( 0	69.8 CD 0	% NN 0	) ) 0	than IN 0	at IN 0	2 CD B-adj.all	h NN 0	after IN 0	treatment NN B-noun.plant	with IN 0	ergotamine NN 0	/ : 0	caffeine NN B-noun.substance	( ( 0	38.6 CD 0	% NN 0	, , 0	p UH 0	< : 0	or CC 0	= $ 0	0.001 CD 0	) ) 0	. . 0	. . 0
a347884.s7	The DT 0	results NNS B-noun.communication	of IN 0	detailed JJ B-adj.all	laboratory NN B-noun.artifact	tests NNS I-noun.artifact	and CC 0	evaluations NNS B-noun.cognition	of IN 0	various JJ B-adj.all	quantitative JJ B-adj.all	and CC 0	qualitative JJ B-adj.all	tolerability NN B-noun.attribute	parameters NNS B-noun.person	were VBD B-verb.stative	not RB B-adv.all	indicative JJ B-adj.all	of IN 0	toxic JJ B-adj.all	effects NNS B-noun.phenomenon	. . 0	. . 0
a20067456.s5	Participants NNS B-noun.person	were VBD 0	followed VBN B-verb.contact	biweekly RB B-adv.all	during IN 0	study NN B-noun.artifact	period NN B-noun.person	. . 0	. . 0
a12523465.s0	Visual_hallucinations NNS B-noun.artifact	associated VBN B-verb.cognition	with IN 0	zonisamide NN B-noun.person	. . 0	. . 0
a1428568.s1	Depression NN B-noun.person	and CC 0	sexual_dysfunction CD 0	have VBP 0	been VBN 0	related VBN B-verb.communication	to TO 0	side VB B-verb.creation	effects NNS B-noun.phenomenon	of IN 0	topical JJ B-adj.all	beta NN B-noun.act	- : 0	blockers NNS B-noun.person	. . 0	. . 0
a12523465.s2	Although IN 0	visual_hallucinations NNS B-noun.group	have VBP 0	not RB 0	been VBN 0	reported VBN B-verb.communication	as IN 0	an DT 0	adverse JJ B-adj.all	effect NN B-noun.cognition	of IN 0	this DT 0	agent NN B-noun.person	, , 0	we PRP 0	describe VBP B-verb.creation	three CD 0	patients NNS B-noun.person	who WP 0	experienced VBD B-verb.perception	complex JJ B-adj.all	visual_hallucinations NNS B-noun.artifact	and CC 0	altered VBD B-verb.change	mental JJ B-adj.all	status NN B-noun.communication	after IN 0	zonisamide JJ B-adj.all	treatment NN B-noun.plant	was VBD 0	begun VBN B-verb.change	or CC 0	its PRP$ 0	dosage NN B-noun.artifact	increased VBD B-verb.change	. . 0	. . 0
a424937.s5	Most JJS 0	patients NNS B-noun.person	showed VBD B-verb.communication	moderate JJ B-adj.all	to TO 0	severe VB B-verb.contact	acute_hepatitis NN I-verb.contact	or CC 0	chronic_active_hepatitis NN 0	with IN 0	associated JJ B-adj.all	cholestasis NN B-noun.person	. . 0	. . 0
a983936.s5	Infusions NNS B-noun.person	of IN 0	calcium_chloride JJ B-noun.phenomenon	sufficient JJ I-noun.phenomenon	to TO 0	raise VB B-verb.social	serum NN 0	calcium NN 0	concentrations NNS B-noun.communication	2 CD B-adj.all	mEq CD 0	. . 0	. . 0
a18162529.s3	We PRP 0	first RB 0	tested VBD B-verb.social	whether IN 0	chronic JJ B-adj.all	hyperprolactinemia NN B-noun.person	inhibited VBD B-verb.possession	two CD 0	neuroendocrine JJ B-adj.all	parameters NNS B-noun.event	necessary JJ B-adj.all	for IN 0	female JJ B-adj.all	fertility NN B-noun.state	, , 0	pulsatile VB B-verb.creation	LH NNP 0	secretion NN B-noun.act	and CC 0	the DT 0	estrogen NN B-noun.person	- : 0	induced VBN B-verb.creation	LH NNP 0	surge NN 0	. . 0	. . 0
a12369736.s6	Such JJ B-adj.all	attenuation NN B-noun.act	was VBD B-verb.stative	not RB B-adv.all	found VBN B-verb.possession	in IN 0	animals NNS B-noun.animal	which WDT 0	had VBD 0	been VBN 0	injected VBN B-verb.change	with IN 0	GR_55562 NNP 0	into IN 0	the DT 0	accumbens JJ B-adj.all	core NN B-noun.group	. . 0	. . 0
a2334618.s2	infusion NN B-noun.cognition	of IN 0	morphine NN B-noun.phenomenon	( ( 0	mean VB B-verb.stative	73.6 CD 0	mg NN B-noun.quantity	) ) 0	and CC 0	five CD B-adj.all	patients NNS B-noun.person	receiving VBG B-verb.communication	a DT 0	continuous JJ B-adj.all	extradural JJ B-adj.all	infusion NN B-noun.cognition	of IN 0	0.25 CD 0	% NN 0	bupivacaine NN B-noun.substance	( ( 0	mean VB B-verb.stative	192 CD 0	mg NN B-noun.quantity	) ) 0	in IN 0	the DT 0	24-h JJ B-adj.all	period NN B-noun.time	following VBG B-verb.stative	upper JJ B-adj.all	abdominal NN B-adj.pert	surgery NN B-noun.state	. . 0	. . 0
a15188772.s4	Our PRP$ 0	case NN B-noun.state	illustrates VBZ B-verb.change	the DT 0	serious JJ B-adj.all	consequences NNS B-noun.attribute	of IN 0	medical JJ B-adj.all	errors NNS B-noun.cognition	that WDT 0	can MD 0	be VB 0	avoided VBN B-verb.social	through IN 0	improved VBN B-verb.change	medication NN B-noun.artifact	labeling NN B-noun.artifact	and CC 0	staff NN 0	supervision NN 0	. . 0	. . 0
a11752354.s6	Among IN 0	women NNS B-noun.person	who WP 0	used VBD B-verb.consumption	oral_contraceptives NNS I-verb.consumption	, , 0	the DT 0	odds NNS B-noun.artifact	ratio NN I-noun.artifact	was VBD B-verb.stative	2.1 CD 0	( ( 0	95 CD 0	percent NN B-noun.quantity	confidence NN B-noun.relation	interval NN I-noun.relation	, , 0	1.5 CD 0	to TO 0	3.0 CD 0	) ) 0	for IN 0	those DT 0	without IN 0	a DT 0	prothrombotic JJ B-adj.all	mutation NN B-noun.act	and CC 0	1.9 CD 0	( ( 0	95 CD 0	percent NN B-noun.quantity	confidence NN B-noun.relation	interval NN I-noun.relation	, , 0	0.6 CD 0	to TO 0	5.5 CD 0	) ) 0	for IN 0	those DT 0	with IN 0	a DT 0	mutation NN B-noun.act	CONCLUSIONS NNP B-noun.group	, , 0	The DT 0	risk NN 0	of IN 0	myocardial_infarction NN B-noun.act	was VBD 0	increased VBN B-verb.change	among IN 0	women NNS B-noun.person	who WP 0	used VBD B-verb.consumption	second JJ B-adj.all	- : 0	generation NN B-noun.time	oral_contraceptives NNS B-noun.event	. . 0	. . 0
a16167916.s3	Twenty CD 0	- : 0	five CD B-adj.all	women NNS B-noun.person	were VBD 0	given VBN B-verb.possession	raloxifene_hydrochloride NN 0	( ( 0	60 CD 0	mg RB 0	/ JJ 0	day NN 0	) ) 0	plus CC 0	calcium NN B-noun.communication	( ( 0	500 CD 0	mg RB 0	/ JJ 0	day NN 0	) ) 0	. . 0	. . 0
a18439803.s3	In IN 0	vivo JJ B-adj.all	microdialysis NN B-noun.person	demonstrated VBD B-verb.cognition	that IN 0	an DT 0	intraperitoneal JJ B-adj.all	administration NN B-noun.time	of IN 0	pilocarpine NN B-noun.person	induced VBD B-verb.creation	a DT 0	pronounced JJ B-adj.all	increment NN B-noun.shape	of IN 0	hippocampal JJ B-adj.pert	glutamate NN B-noun.person	and CC 0	aspartate VB B-verb.communication	whereas IN 0	no DT 0	significant JJ B-adj.all	change NN B-noun.phenomenon	was VBD 0	observed VBN B-verb.perception	on IN 0	the DT 0	level NN B-noun.state	of IN 0	glycine NN B-noun.person	and CC 0	GABA NNP B-noun.other	. . 0	. . 0
a3800626.s1	Fibrous_myopathy JJ 0	is VBZ B-verb.stative	a DT 0	common JJ B-noun.person	, , 0	well UH 0	- : 0	known JJ B-adj.all	side NN B-noun.location	effect NN 0	of IN 0	repeated VBN B-verb.communication	pentazocine NN B-noun.person	injection NN B-noun.event	. . 0	. . 0
a16337777.s2	Increased VBN B-verb.change	production NN B-noun.artifact	of IN 0	FRs NNP B-noun.person	may MD 0	cause VB B-verb.cognition	mtDNA JJ 0	damage NN 0	leading VBG B-verb.stative	to TO 0	decreased VBN B-verb.communication	activities NNS B-noun.person	of IN 0	oxidative JJ B-adj.all	phosphorylation NN B-noun.artifact	complexes NNS B-noun.artifact	containing VBG B-verb.stative	mtDNA NNP I-verb.stative	- : 0	encoded VBD B-verb.communication	subunits NNS B-noun.person	. . 0	. . 0
a12684739.s2	This DT 0	non NN B-noun.communication	- : 0	receptor NN B-noun.person	mediated VBD B-verb.change	inhibition NN B-noun.communication	requires VBZ B-verb.stative	de IN 0	novo JJ B-adj.all	synthesis NN B-noun.cognition	for IN 0	restoration NN B-noun.act	of IN 0	functional JJ B-adj.all	GABA NNP B-noun.other	catabolism NN B-noun.artifact	. . 0	. . 0
a15863244.s2	Unlike IN 0	general JJ B-adj.all	toxicity NN B-noun.cognition	data NNS I-noun.cognition	, , 0	their PRP$ 0	prenatal JJ B-adj.all	toxic JJ B-adj.all	effects NNS B-noun.phenomenon	were VBD B-verb.stative	not RB B-adv.all	extensively RB B-adv.all	studied VBN B-verb.cognition	before RB 0	. . 0	. . 0
a18308784.s2	Previous JJ B-adj.all	studies NNS B-noun.group	have VBP 0	demonstrated VBN B-verb.cognition	that IN 0	Rg1 NNP 0	might MD 0	be VB B-verb.stative	a DT 0	useful JJ B-adj.all	agent NN B-noun.person	for IN 0	the DT 0	prevention NN B-noun.person	and CC 0	treatment NN B-noun.act	of IN 0	the DT 0	adverse JJ B-adj.all	effects NNS B-noun.phenomenon	of IN 0	morphine NN B-noun.person	. . 0	. . 0
a8741744.s1	Partial JJ B-adj.all	lesions NNS B-noun.state	were VBD 0	made VBN B-verb.social	with IN 0	kainic_acid NNP B-noun.person	in IN 0	the DT 0	interpeduncular JJ B-adj.all	nucleus NN B-noun.group	of IN 0	the DT 0	ventral JJ B-noun.body	midbrain NN I-noun.body	of IN 0	the DT 0	rat NN B-noun.artifact	. . 0	. . 0
a10743446.s7	Ketamine NNP B-noun.person	reduced VBD B-verb.change	both DT 0	the DT 0	area NN B-noun.cognition	of IN 0	brush NN B-noun.person	- : 0	evoked JJ B-verb.emotion	and CC 0	punctate VB B-verb.social	- : 0	evoked JJ B-adj.all	hyperalgesia NN B-noun.person	significantly RB B-adv.all	and CC 0	it PRP 0	tended VBD B-verb.stative	to TO 0	reduce VB B-verb.change	brush NN B-noun.person	- : 0	evoked VBD B-verb.communication	pain NN B-noun.person	. . 0	. . 0
a18442015.s6	After IN 0	gastric JJ B-adj.pert	surgery NN B-noun.state	, , 0	rat VBD 0	stomachs NNS B-noun.person	were VBD 0	irrigated VBN B-verb.communication	for IN 0	3 CD B-adj.all	h NN 0	with IN 0	either DT 0	simulated JJ B-adj.all	gastric JJ B-adj.all	juice NN B-noun.act	or CC 0	normal JJ B-adj.all	saline NN B-noun.act	. . 0	. . 0
a322550.s8	During IN 0	nitroprusside JJ B-adj.all	infusion NN B-noun.cognition	low JJ B-adj.all	levels NNS B-noun.state	of IN 0	CPAP NNP B-noun.group	do VBP 0	not RB B-adv.all	markedly RB B-adv.all	alter VB B-verb.change	cardiovascular JJ B-adj.all	dynamics NNS B-noun.artifact	, , 0	but CC 0	high JJ B-adj.all	levels NNS B-noun.attribute	of IN 0	CPAP NNP B-noun.group	( ( 0	10 CD B-adj.all	cm IN 0	H2O NNP 0	) ) 0	, , 0	while IN 0	decreasing VBG B-verb.change	QS NNP 0	/ NNP 0	QT NNP 0	, , 0	produce VB B-adv.all	marked VBN B-verb.cognition	decreases_in_arterial_blood_pressure_and_cardiac_output NN I-verb.cognition	. . 0	. . 0
a14596845.s8	These DT 0	results NNS B-noun.communication	suggest VBP B-verb.communication	that IN 0	a DT 0	diet NN B-noun.person	comprised VBN B-verb.stative	of IN 0	alternating VBG B-verb.change	deprivation NN B-noun.act	and CC 0	access NN B-noun.person	to TO 0	a DT 0	sugar NN B-noun.person	solution NN B-noun.person	and CC 0	chow NN B-noun.artifact	produces VBZ I-noun.artifact	bingeing VBG B-verb.social	on IN 0	sugar NN B-noun.artifact	that WDT 0	leads VBZ B-verb.stative	to TO 0	a DT 0	long JJ B-adj.all	lasting JJ B-adj.all	state NN B-noun.state	of IN 0	increased VBN B-verb.change	sensitivity NN B-noun.feeling	to TO 0	amphetamine VB B-verb.social	, , 0	possibly RB 0	due JJ 0	to TO 0	a DT 0	lasting JJ B-adj.all	alteration NN B-noun.person	in IN 0	the DT 0	dopamine NN 0	system NN 0	. . 0	. . 0
a2265898.s2	The DT 0	first JJ B-adj.all	patient NN B-noun.person	died VBD B-verb.change	without IN 0	a DT 0	diagnosis NN B-noun.person	, , 0	the DT 0	second JJ B-adj.all	patient NN B-noun.person	had VBD 0	a DT 0	dramatic JJ B-adj.all	recovery NN B-noun.artifact	following VBG B-verb.stative	the DT 0	administration NN B-noun.time	of IN 0	vitamin_B6 NNP B-noun.person	. . 0	. . 0
a17020434.s3	Overall RB 0	, , 0	in IN 0	high JJ B-adj.all	- : 0	risk NN 0	patients NNS B-noun.person	, , 0	warfarin NN B-noun.person	is VBZ B-verb.stative	superior JJ B-adj.all	to TO 0	aspirin VB B-verb.communication	in IN 0	preventing VBG B-verb.creation	strokes NNS I-verb.creation	, , 0	with IN 0	a DT 0	relative JJ B-adj.all	risk NN B-noun.phenomenon	reduction NN B-noun.process	of IN 0	36 CD 0	% NN 0	. . 0	. . 0
a10835440.s3	METHODS NNS B-noun.attribute	, , 0	Patients NNPS B-noun.person	with IN 0	a DT 0	clinical JJ B-adj.all	diagnosis NN B-noun.cognition	of IN 0	ischemic_stroke NNP B-noun.person	( ( 0	within IN 0	24 CD B-adj.all	hours NNS B-noun.artifact	) ) 0	were VBD B-verb.stative	consecutively RB B-adv.all	allocated VBN B-verb.communication	to TO 0	receive VB B-verb.consumption	placebo NN I-verb.consumption	( ( 0	n=100 NN 0	) ) 0	, , 0	1 CD 0	mg FW 0	/ FW 0	h FW 0	( ( 0	low JJ B-adv.all	- : 0	dose NN B-noun.quantity	) ) 0	nimodipine NN B-noun.quantity	( ( 0	n=101 NNP 0	) ) 0	, , 0	or CC 0	2 CD 0	mg FW 0	/ FW 0	h FW 0	( ( 0	high JJ B-adv.all	- : 0	dose NN B-noun.quantity	) ) 0	nimodipine NN B-noun.quantity	( ( 0	n=94 NNP 0	) ) 0	. . 0	. . 0
a11379838.s7	In IN 0	contrast NN 0	, , 0	mood NN 0	switches NNS B-noun.artifact	were VBD B-verb.stative	less RBR B-adv.all	frequent JJ B-adj.all	in IN 0	patients NNS B-noun.person	receiving VBG B-verb.social	lithium NN B-noun.substance	( ( 0	15 CD B-adj.all	% NN 0	, , 0	4/26 CD 0	) ) 0	than IN 0	in IN 0	patients NNS B-noun.person	not RB B-adv.all	treated VBN B-verb.change	with IN 0	lithium NN B-noun.substance	( ( 0	44 CD 0	% NN 0	, , 0	8/18 CD 0	, , 0	p UH 0	= : 0	.04 LS 0	) ) 0	. . 0	. . 0
a8170551.s3	Three CD 0	patients NNS B-noun.person	on IN 0	acetazolamide NN 0	( ( 0	15 CD B-adj.all	% NN 0	) ) 0	developed VBD B-verb.creation	renal_calculi NNP B-noun.person	. . 0	. . 0
a9727773.s7	In IN 0	8 CD B-adj.all	patients NNS B-noun.quantity	the DT 0	diagnosis NN B-noun.cognition	of IN 0	primary_pulmonary_hypertension NN B-noun.person	was VBD B-verb.stative	uncertain JJ B-adj.all	, , 0	5 CD 0	of IN 0	them PRP 0	had VBD 0	taken VBN B-verb.possession	appetite_suppressants NNS B-noun.person	. . 0	. . 0
a7292072.s1	We PRP 0	report VBP B-verb.communication	a DT 0	case NN B-noun.state	of IN 0	variant JJ B-adj.all	ventricular_tachycardia NNS B-noun.communication	induced VBN B-verb.creation	by IN 0	desipramine NN B-noun.phenomenon	toxicity NN B-noun.attribute	. . 0	. . 0
a20619828.s6	CONCLUSIONS NNS B-noun.artifact	, , 0	This DT 0	is VBZ B-verb.stative	the DT 0	first JJ B-adj.all	demonstration NN B-noun.communication	of IN 0	multiple JJ B-adj.all	symptoms NNS B-noun.relation	consistent JJ I-noun.relation	with IN 0	an DT 0	OCD NNP B-noun.group	- : 0	like IN 0	profile NN B-noun.person	in IN 0	animals NNS B-noun.animal	. . 0	. . 0
a11334364.s14	Additionally RB B-adv.all	, , 0	this DT 0	may MD 0	have VB 0	been VBN B-verb.stative	the DT 0	first JJ B-adj.all	report NN B-noun.communication	on IN 0	AMI NNP B-noun.group	- : 0	induced VBN B-verb.creation	apoptotic JJ B-adj.all	death NN B-noun.state	in IN 0	the DT 0	lung NN B-noun.body	tissue NN I-noun.body	. . 0	. . 0
a20588063.s8	The DT 0	other JJ 0	proteins NNS B-noun.person	showed VBD B-verb.communication	few JJ 0	changes NNS B-noun.artifact	, , 0	which WDT 0	were VBD 0	limited VBN B-verb.change	to TO 0	diseased VBN B-verb.possession	areas NNS B-noun.location	. . 0	. . 0
a18560792.s2	However RB 0	, , 0	the DT 0	incidence NN B-noun.communication	and CC 0	severity NN B-noun.attribute	of IN 0	these DT 0	abnormalities NNS B-noun.person	vary VBP B-verb.stative	from IN 0	study NN B-noun.artifact	to TO 0	study VB B-verb.cognition	and CC 0	their PRP$ 0	course NN B-noun.location	after IN 0	drug NN B-noun.person	withdrawal NN B-noun.person	has VBZ 0	not RB 0	been VBN 0	systematically RB B-adv.all	assessed VBN B-verb.cognition	. . 0	. . 0
a3970039.s5	Since IN 0	it PRP 0	takes VBZ B-verb.possession	three CD 0	to TO 0	12 CD B-adj.all	months NNS B-noun.person	to TO 0	achieve VB B-verb.social	maximal JJ B-adj.pert	effects NNS B-noun.phenomenon	, , 0	those DT 0	patients NNS B-noun.person	who WP 0	are VBP B-verb.stative	unable JJ B-adj.all	to TO 0	continue VB B-verb.stative	the DT 0	drug NN B-noun.group	receive VBP B-verb.possession	little JJ B-adj.all	benefit NN B-noun.person	from IN 0	it PRP 0	. . 0	. . 0
a19767176.s6	In IN 0	vehicle NN B-noun.communication	- : 0	treated VBN B-verb.communication	rats NNS B-noun.person	, , 0	status_epilepticus NN B-noun.person	caused VBD B-verb.communication	pronounced JJ B-adj.all	neuronal_damage NN B-noun.artifact	in IN 0	the DT 0	piriform NN B-noun.group	cortex NN 0	comprising VBG B-verb.stative	both DT 0	pyramidal JJ B-noun.body	cells NNS I-noun.body	and CC 0	interneurons NNS B-noun.person	. . 0	. . 0
a9390208.s4	Each DT 0	course NN B-noun.object	of IN 0	chemotherapy NN B-noun.phenomenon	was VBD 0	given VBN B-verb.possession	every DT 0	4 CD B-adj.all	weeks NNS B-noun.time	. . 0	. . 0
a14657095.s2	His PRP$ 0	echocardiographic JJ B-adj.all	abnormalities NNS B-noun.person	and CC 0	heart_failure NN B-noun.body	resolved VBN B-verb.body	after IN 0	posaconazole NN B-noun.person	was VBD 0	substituted VBN B-verb.social	for IN 0	AmB. NN 0	It PRP 0	is VBZ B-verb.stative	important JJ B-adj.all	to TO 0	recognize VB B-verb.perception	the DT 0	rare JJ B-adj.all	and CC 0	potentially RB B-adv.all	reversible JJ B-adj.all	toxicity NN B-noun.attribute	of IN 0	AmB. NNP B-noun.person	. . 0
a12684739.s5	Finally RB B-adv.all	, , 0	we PRP 0	examined VBD B-verb.perception	the DT 0	low JJ B-adj.all	dose NN B-noun.quantity	of IN 0	150 CD 0	mg FW 0	/ FW 0	kg FW 0	( ( 0	50 CD 0	mg FW 0	/ FW 0	kg FW 0	per FW 0	day NN 0	) ) 0	using VBG B-verb.consumption	a DT 0	similar JJ B-adj.all	washout NN B-noun.act	period NN B-noun.person	. . 0	. . 0
a16858720.s1	PURPOSE NN B-noun.attribute	, , 0	To TO 0	evaluate VB B-verb.communication	the DT 0	frequency NN B-noun.person	, , 0	severity NN B-noun.attribute	and CC 0	preventability NN B-noun.attribute	of IN 0	warfarin NN B-noun.act	- : 0	induced VBN B-verb.creation	cerebral_haemorrhages NNS 0	due JJ 0	to TO 0	warfarin VB B-verb.communication	and CC 0	warfarin NN B-noun.act	- : 0	drug NN B-noun.person	interactions NNS I-noun.person	in IN 0	patients NNS B-noun.artifact	living VBG B-verb.stative	in IN 0	the DT 0	county NN B-noun.attribute	of IN 0	Osterg NNP B-noun.person	_ POS 0	tland NN B-noun.act	, , 0	Sweden NNP B-noun.person	. . 0	. . 0
a12198388.s7	Hippocampal NNP B-noun.person	ACh NNP I-noun.person	also RB I-noun.person	was VBD 0	measured VBN B-verb.cognition	during IN 0	testing VBG B-verb.social	for IN 0	handling VBG B-verb.social	- : 0	induced VBN B-verb.creation	convulsions NNS B-noun.artifact	. . 0	. . 0
a18329269.s1	A DT 0	series NN B-noun.communication	of IN 0	N NNP 0	- : 0	pyrimidinyl-2-phenoxyacetamide JJ 0	adenosine JJ B-adj.all	A(2A NN B-noun.artifact	) ) 0	antagonists NNS B-noun.person	is VBZ 0	described VBN B-verb.communication	. . 0	. . 0
a15649445.s5	Haloperidol NNP B-noun.person	administration NN I-noun.person	( ( 0	one CD 0	dose NN B-noun.event	of IN 0	12 CD 0	mg FW 0	/ FW 0	kg FW 0	once RB B-adv.all	a DT 0	week NN B-noun.time	s.c RB 0	. . 0	) ) 0	. . 0
a8092427.s13	Challenge NN B-noun.artifact	tests NNS B-noun.person	with IN 0	AX NNP 0	were VBD 0	performed VBN B-verb.social	in IN 0	23 CD B-adj.all	subjects NNS B-noun.person	( ( 0	43 CD 0	% NN 0	) ) 0	to TO 0	establish VB B-verb.cognition	the DT 0	diagnosis NN B-noun.cognition	of IN 0	immediate JJ B-adj.all	allergic_reaction NN B-noun.act	to TO 0	AX NNP 0	, , 0	and CC 0	in IN 0	15 CD B-adj.all	cases NNS B-noun.quantity	( ( 0	28 CD B-adj.all	% NN 0	) ) 0	both DT 0	skin NN B-noun.state	test NN I-noun.state	and CC 0	RAST NNP B-noun.group	for IN 0	AX NNP 0	were VBD B-verb.stative	negative JJ B-adj.all	. . 0	. . 0
a12684739.s0	Sub SYM 0	- : 0	chronic JJ B-adj.all	low JJ B-adj.all	dose NN 0	gamma NN B-noun.act	- : 0	vinyl_GABA NN 0	( ( 0	vigabatrin NN 0	) ) 0	inhibits VBZ B-verb.stative	cocaine NN I-verb.stative	- : 0	induced VBN B-verb.creation	increases NNS B-noun.event	in IN 0	nucleus NN B-noun.group	accumbens VBZ B-verb.social	dopamine NN I-verb.social	. . 0	. . 0
a234669.s4	The DT 0	ventricular_fibrillation NN B-noun.artifact	threshold NN B-noun.artifact	was VBD 0	measured VBN B-verb.cognition	by IN 0	passing VBG B-verb.motion	a DT 0	gated VBN B-noun.artifact	train NN I-noun.artifact	of IN 0	12 CD B-adj.all	constant JJ B-adj.all	current JJ B-adj.all	pulses NNS B-noun.artifact	through IN 0	the DT 0	ventricular JJ B-adj.all	myocardium NN B-noun.artifact	during IN 0	the DT 0	vulnerable JJ B-adj.all	period NN B-noun.time	of IN 0	the DT 0	cardiac JJ B-adj.all	cycle NN B-noun.person	. . 0	. . 0
a8996652.s3	Our PRP$ 0	observations NNS B-noun.group	demonstrated VBD B-verb.cognition	an DT 0	association NN B-noun.cognition	of IN 0	hearing_loss NN 0	with IN 0	a DT 0	higher JJR B-adj.all	incidence NN B-noun.relation	of IN 0	perinatal JJ B-adj.all	complications NNS B-noun.person	. . 0	. . 0
a19346865.s10	CONCLUSIONS NNS B-noun.artifact	, , 0	Reversible JJ B-noun.person	inferior_colliculus_lesions NNS I-noun.person	could MD 0	be VB 0	considered VBN B-verb.cognition	as IN 0	the DT 0	characteristic JJ B-adj.all	for IN 0	metronidazole NN B-noun.attribute	- : 0	induced VBN B-verb.creation	encephalopathy JJ B-adj.all	, , 0	next JJ B-adj.all	to TO 0	the DT 0	dentate JJ B-adj.all	nucleus JJ B-noun.relation	involvement NN I-noun.relation	. . 0	. . 0
a1833784.s2	In IN 0	the DT 0	present JJ B-adj.all	study NN B-noun.artifact	the DT 0	role NN B-noun.attribute	of IN 0	habituation NN 0	to TO 0	the DT 0	experimental JJ B-adj.all	environment NN B-noun.person	on IN 0	the DT 0	stimulant JJ B-adj.all	effect NN B-noun.cognition	of IN 0	nicotine NN B-noun.person	in IN 0	rats NNS B-noun.animal	was VBD 0	examined VBN B-verb.communication	. . 0	. . 0
a16574712.s4	Compared VBN B-verb.cognition	with IN 0	MDMA NNP B-noun.group	- : 0	free JJ B-adj.all	polydrug NN B-noun.body	controls NNS I-noun.body	, , 0	MDMA NNP B-noun.person	polydrug NN I-noun.person	users NNS B-noun.person	showed VBD B-verb.communication	impairments NNS B-noun.person	in IN 0	set VBN 0	shifting VBG B-verb.body	and CC 0	memory NN B-noun.artifact	updating NN I-noun.artifact	, , 0	and CC 0	also RB B-adv.all	in IN 0	social JJ B-adj.all	and CC 0	emotional JJ B-adj.all	judgement NN B-noun.person	processes NNS B-noun.person	. . 0	. . 0
a11135224.s12	There EX 0	was VBD B-verb.stative	one CD 0	treatment NN B-noun.communication	- : 0	related JJ B-adj.all	death NN 0	. . 0	. . 0
a11007689.s2	Treatments NNS B-noun.person	have VBP 0	included VBN B-verb.cognition	discontinuation NN B-noun.act	or CC 0	reduction NN B-noun.act	of IN 0	cyclosporine NN 0	dose NN 0	with IN 0	or CC 0	without IN 0	concurrent JJ B-adj.all	plasma NN B-noun.substance	exchange NN I-noun.substance	, , 0	plasma NN 0	infusion NN 0	, , 0	anticoagulation NN B-noun.attribute	, , 0	and CC 0	intravenous JJ B-adj.all	immunoglobulin NN B-noun.event	G NNP 0	infusion NN 0	. . 0	. . 0
a3865016.s3	Severe JJ 0	side NN 0	effects NNS B-noun.phenomenon	in IN 0	terms NNS B-noun.communication	of IN 0	mental JJ B-adj.all	confusion NN B-noun.cognition	and CC 0	progressive JJ B-adj.all	hyperbilirubinemia NN B-noun.person	, , 0	however RB 0	, , 0	point NN 0	to TO 0	an DT 0	enhancement NN B-noun.person	not RB 0	only RB 0	of IN 0	antineoplastic JJ B-adj.all	effects NNS B-noun.phenomenon	but CC 0	also RB 0	of IN 0	toxicity NN B-noun.attribute	in IN 0	normal JJ B-adj.all	tissues NNS B-noun.body	. . 0	. . 0
a18821488.s7	Furthermore RB B-adv.all	, , 0	transient JJ B-adj.all	hemoglobinuria NN B-noun.person	was VBD 0	noted VBN B-verb.perception	approximately RB B-adv.all	60 CD B-adj.all	minutes NNS B-noun.time	postinjection NN B-noun.attribute	of IN 0	WR242511 NN B-noun.other	( ( 0	3.5 CD 0	or CC 0	7.0 CD 0	mg PRP 0	/ : 0	kg LS 0	) ) 0	, , 0	and CC 0	2 CD B-adj.all	lethalities NNS B-noun.communication	occurred VBD B-verb.stative	( ( 0	one CD 0	IV NNP 0	and CC 0	one CD 0	PO NNP 0	) ) 0	following VBG B-verb.stative	the DT 0	7.0 CD 0	mg FW B-noun.quantity	/ FW 0	kg FW 0	dose FW 0	. . 0	. . 0
a3780846.s12	Nevertheless RB B-adv.all	, , 0	there EX 0	occurs VBZ B-verb.stative	some DT 0	real JJ B-adj.all	tolerance NN B-noun.act	to TO 0	this DT 0	effect NN B-noun.cognition	. . 0	. . 0
a16858720.s5	RESULTS NNS B-noun.artifact	, , 0	Among IN 0	593 CD 0	patients NNS B-noun.person	with IN 0	cerebral_haemorrhage NN B-noun.food	, , 0	59 CD 0	( ( 0	10 CD B-adj.all	% NN 0	) ) 0	were VBD 0	assessed VBN B-verb.cognition	as IN 0	related VBN B-verb.communication	to TO 0	warfarin VB B-verb.consumption	treatment NN I-verb.consumption	. . 0	. . 0
a9862868.s9	Immunostaining VBG B-verb.cognition	for IN 0	7H6 NNP B-noun.person	, , 0	not RB B-adv.all	ZO-1 JJ B-adj.all	, , 0	decreased VBD B-verb.change	and CC 0	predominantly RB B-adv.all	appeared VBD B-verb.change	as IN 0	discrete JJ B-adj.all	signals NNS B-noun.food	in IN 0	the DT 0	submembranous JJ B-adj.all	cytoplasm NN B-noun.state	of IN 0	periportal JJ B-adj.all	hepatocytes NNS B-noun.location	after IN 0	BDL NNP B-noun.group	. . 0	. . 0
a9812111.s0	A DT 0	randomized JJ B-adj.all	, , 0	placebo NN B-noun.person	- : 0	controlled VBN B-verb.social	dose NN B-noun.act	- : 0	comparison NN B-noun.person	trial NN B-noun.act	of IN 0	haloperidol NN B-noun.food	for IN 0	psychosis NN B-noun.person	and CC 0	disruptive_behaviors NNS B-noun.person	in IN 0	Alzheimer's_disease NNP 0	. . 0	. . 0
a12639165.s9	Immune NNP B-noun.person	mechanisms NNS I-noun.person	may MD 0	be VB 0	involved VBN B-verb.stative	in IN 0	the DT 0	drug NN B-noun.person	's POS 0	hepatotoxicity NN B-noun.attribute	, , 0	as IN 0	suggested VBN B-verb.communication	by IN 0	the DT 0	T NNP 0	- : 0	cell NN 0	stimulation NN 0	study NN B-noun.artifact	reported VBD B-verb.communication	here RB B-adv.all	. . 0	. . 0
a8372922.s2	In IN 0	A1 NN 0	of IN 0	macaque JJ B-adj.all	monkeys NNS B-noun.person	, , 0	low JJ B-adj.all	frequencies NNS B-noun.person	are VBP 0	represented VBN B-verb.social	rostrolaterally RB B-adv.all	and CC 0	high JJ B-adj.all	frequencies NNS B-noun.person	are VBP 0	represented VBN B-verb.social	caudomedially RB B-adv.all	. . 0	. . 0
a16904497.s18	Clinical JJ B-adj.all	examination NN B-noun.motive	and CC 0	continued VBD B-verb.stative	vigilance NN B-noun.person	for IN 0	neurologic_deterioration NN B-noun.act	after IN 0	epidural JJ B-adj.all	steroid JJ B-noun.body	injections NNS I-noun.body	is VBZ B-verb.stative	important JJ B-adj.all	. . 0	. . 0
a17343925.s13	Further JJ B-adj.all	studies NNS B-noun.plant	are VBP 0	needed VBN B-verb.consumption	in IN 0	order NN 0	to TO 0	establish VB B-verb.cognition	a DT 0	potential JJ B-adj.all	negative JJ B-adj.all	effect NN B-noun.phenomenon	of IN 0	maternal JJ B-adj.pert	smoking NN B-verb.consumption	on IN 0	the DT 0	neonate NN B-noun.person	's POS 0	hearing NN B-verb.perception	acuity NN B-noun.process	. . 0	. . 0
a17931375.s15	RELEVANCE NN B-noun.group	TO TO 0	CLINICAL NNP B-noun.group	PRACTICE NNP I-noun.group	, , 0	When WRB 0	administering VBG B-verb.communication	subcutaneous JJ B-adj.all	heparin NN B-noun.person	injections NNS I-noun.person	, , 0	it PRP 0	is VBZ B-verb.stative	important JJ B-adj.all	to TO 0	extend VB B-verb.stative	the DT 0	duration NN 0	of IN 0	the DT 0	injection NN B-noun.act	. . 0	. . 0
a16167916.s8	RESULTS NNS B-noun.artifact	, , 0	Three CD 0	months NNS B-noun.person	of IN 0	raloxifene NN B-noun.person	treatment NN B-noun.person	was VBD 0	associated VBN B-verb.cognition	with IN 0	a DT 0	significant JJ B-adj.all	decrease NN B-noun.state	in IN 0	the DT 0	plasma NN B-noun.substance	TAFI NNP 0	antigen NN B-noun.animal	concentrations NNS I-noun.animal	( ( 0	16 CD B-adj.all	% NN 0	change NN B-noun.attribute	, , 0	P NNP 0	< $ 0	0.01 CD 0	) ) 0	, , 0	and CC 0	a DT 0	significant JJ B-adj.all	increase NN B-noun.event	in IN 0	tPA CD 0	antigen NN B-noun.animal	concentrations NNS I-noun.animal	( ( 0	25 CD B-adj.all	% NN 0	change NN B-noun.attribute	, , 0	P NNP 0	< $ 0	0.05 CD 0	) ) 0	. . 0	. . 0
a6640832.s0	Early RB B-adv.all	adjuvant JJ B-adj.all	adriamycin NN B-noun.person	in IN 0	superficial JJ B-adj.all	bladder_carcinoma NN B-noun.object	. . 0	. . 0
a8919272.s5	Organelles NNP B-noun.group	of IN 0	these DT 0	cells NNS B-noun.body	, , 0	in IN 0	particular JJ B-adj.all	the DT 0	mitochondria NNS B-noun.person	( ( 0	increased VBN B-verb.change	number NN B-noun.attribute	and CC 0	size NN B-noun.attribute	, , 0	distinct JJ B-adj.all	degeneration NN B-noun.communication	of IN 0	their PRP$ 0	matrix NN B-noun.communication	and CC 0	cristae NN B-noun.act	) ) 0	and CC 0	Golgi NNP B-noun.person	apparatus NN I-noun.person	were VBD 0	altered VBN B-verb.change	. . 0	. . 0
a12198388.s2	Thus RB 0	, , 0	the DT 0	relationship NN B-noun.state	between IN 0	cholinergic JJ B-adj.pert	activity NN B-noun.state	and CC 0	responsiveness NN B-noun.act	and CC 0	alcohol NN B-noun.person	withdrawal NN B-noun.person	was VBD 0	investigated VBN B-verb.communication	in IN 0	a DT 0	genetic JJ B-adj.all	animal NN B-adj.all	model NN B-noun.person	of IN 0	ethanol NN 0	withdrawal NN 0	severity NN 0	. . 0	. . 0
a14568327.s1	Levodopa NN B-noun.person	- : 0	induced VBN B-verb.creation	dyskinesias NNS B-noun.substance	( ( 0	LIDs NNP B-noun.person	) ) 0	present VBP B-verb.stative	a DT 0	major JJ B-adj.all	problem NN B-noun.communication	for IN 0	the DT 0	long JJ B-noun.body	- : 0	term NN B-noun.time	management NN B-noun.act	of IN 0	Parkinson's_disease NNP B-noun.person	( ( 0	PD NNP 0	) ) 0	patients NNS B-noun.person	. . 0	. . 0
a2054792.s1	Thermal JJ B-adj.pert	enhancement NN B-noun.act	of IN 0	Adriamycin NNP B-noun.person	- : 0	mediated VBN B-verb.cognition	antitumor NN B-noun.attribute	activity NN B-noun.process	and CC 0	normal JJ B-adj.all	tissue NN B-noun.body	toxicities NNS I-noun.body	by IN 0	whole JJ B-adj.all	body NN 0	hyperthermia NN 0	were VBD 0	compared VBN B-verb.change	using VBG B-verb.consumption	a DT 0	F344 JJ B-noun.artifact	rat NN I-noun.artifact	model NN B-noun.person	. . 0	. . 0
a4812392.s2	Haematological JJ B-adj.all	complications NNS B-noun.person	were VBD B-verb.stative	not RB B-adv.all	troublesome JJ B-adj.all	and CC 0	results NNS B-noun.communication	of IN 0	biochemical JJ B-adj.all	liver NN B-noun.possession	function NN B-noun.act	tests NNS B-noun.cognition	remained VBD B-verb.stative	normal JJ B-adj.all	. . 0	. . 0
a1601297.s1	The DT 0	electrocardiograms NNS B-noun.cognition	( ( 0	ECG NNP 0	) ) 0	of IN 0	99 CD 0	cocaine NN 0	- : 0	abusing VBG B-verb.cognition	patients NNS B-noun.person	were VBD 0	compared VBN B-verb.change	with IN 0	the DT 0	ECGs NNP B-noun.person	of IN 0	50 CD B-adj.all	schizophrenic JJ B-adj.pert	controls NNS B-noun.cognition	. . 0	. . 0
a347884.s8	In IN 0	the DT 0	double JJ B-adj.all	blind JJ B-adj.all	study NN B-noun.artifact	with IN 0	haloperidol NN B-noun.person	, , 0	both DT 0	substances NNS B-noun.group	were VBD 0	found VBN B-verb.perception	to TO 0	be VB B-verb.stative	highly RB B-adv.all	effective JJ B-adj.all	in IN 0	the DT 0	treatment NN B-noun.communication	of IN 0	psychotic_syndromes_belonging_predominantly_to_the_schizophrenia_group NN B-noun.food	. . 0	. . 0
a9931093.s9	FK_506 NNP B-noun.person	decreased VBD B-verb.change	eNOS JJ B-adj.all	activity NN B-noun.state	and CC 0	the DT 0	levels NNS B-noun.state	of IN 0	eNOS JJ B-noun.person	mRNA NNP I-noun.person	in IN 0	the DT 0	aorta NN B-noun.cognition	( ( 0	48 CD 0	% NN 0	and CC 0	55 CD 0	% NN 0	, , 0	respectively RB B-adv.all	) ) 0	. . 0	. . 0
a17244258.s9	In IN 0	contrast NN 0	to TO 0	controls NNS B-noun.artifact	, , 0	methoctramine NN B-noun.person	increased VBD B-verb.change	-- : 0	instead RB 0	of IN 0	decreased VBN B-verb.cognition	-- : 0	the DT 0	tonic JJ B-adj.all	responses NNS B-noun.act	at IN 0	high JJ B-adj.all	frequencies NNS B-noun.person	. . 0	. . 0
a19058010.s7	These DT 0	findings NNS B-noun.act	indicate VBP B-verb.communication	the DT 0	synergistic JJ B-adj.all	protective JJ B-adj.all	effect NN B-noun.cognition	of IN 0	green_tea NN B-noun.food	and CC 0	vitamin NN 0	E NN 0	during IN 0	ISO NNP B-noun.other	induced VBD B-verb.creation	myocardial_infarction NN B-noun.artifact	in IN 0	rats NNS B-noun.animal	. . 0	. . 0
a12464714.s12	Both DT 0	active JJ B-adj.all	treatments NNS B-noun.plant	were VBD B-verb.stative	well RB 0	tolerated VBN 0	. . 0	. . 0
a7988234.s2	Her PRP$ 0	medical JJ B-adj.all	history NN B-noun.cognition	included VBD B-verb.stative	coronary_artery_disease NN 0	with IN 0	previous JJ B-adj.all	myocardial_infarctions NNS B-noun.artifact	, , 0	hypertension NN 0	, , 0	and CC 0	diabetes_mellitus NN B-noun.other	. . 0	. . 0
a18023325.s3	One CD 0	month NN 0	previously RB B-adv.all	, , 0	she PRP 0	had VBD 0	taken VBN B-verb.possession	a DT 0	single JJ B-adj.all	high JJ B-adj.all	dose NN B-noun.quantity	of IN 0	disulfiram NN B-noun.person	( ( 0	130 CD 0	tablets NNS B-noun.quantity	of IN 0	ALCOHOL NNP B-noun.group	STOP NNP B-noun.group	TAB NNP I-noun.group	, , 0	Shin NNP B-noun.person	- : 0	Poong NNP B-noun.person	Pharm NNP I-noun.person	. . 0	. . 0
a2266990.s4	The DT 0	study NN B-noun.artifact	was VBD 0	designed VBN B-verb.creation	to TO 0	have VB B-verb.social	a DT 0	power NN B-noun.person	of IN 0	greater JJR B-adj.all	than IN 0	0.90 CD 0	to TO 0	detect VB B-verb.cognition	a DT 0	slowing VBG 0	to TO 0	25 CD B-adj.all	% NN 0	of IN 0	the DT 0	expected VBN B-adj.all	rate NN B-noun.time	of IN 0	progression NN B-noun.act	of IN 0	weakness NN B-noun.feeling	at IN 0	P NNP 0	less JJR 0	than IN 0	0.05 CD 0	. . 0	. . 0
a1664218.s5	Neutropenia NNP B-noun.person	grade NN 0	greater JJR 0	than IN 0	or CC 0	equal JJ B-adj.all	to TO 0	3 CD 0	was VBD 0	seen VBN B-verb.perception	in IN 0	15 CD B-adj.all	patients NNS B-noun.person	, , 0	infections NNS B-noun.person	with IN 0	recovery NN B-noun.act	in IN 0	3 CD B-adj.all	, , 0	and CC 0	grand JJ B-adj.all	mal NN B-noun.object	seizures NNS I-noun.object	in IN 0	1 CD B-adj.all	patient NN B-noun.person	. . 0	. . 0
a2375138.s4	Information NN 0	regarding VBG B-verb.stative	midazolam NN 0	use NN 0	is VBZ 0	reviewed VBN B-verb.change	to TO 0	provide VB B-verb.social	recommendation NN B-noun.act	for IN 0	safe JJ B-adj.all	administration NN B-noun.time	. . 0	. . 0
a20880751.s5	Recent JJ B-adj.all	preclinical JJ B-adj.all	and CC 0	clinical JJ B-adj.all	data NNS B-noun.cognition	from IN 0	promising VBG B-verb.social	lines NNS B-noun.group	of IN 0	research NN B-noun.person	focus NN B-noun.person	on IN 0	the DT 0	differential JJ B-adj.all	role NN B-noun.attribute	of IN 0	presynaptic JJ B-adj.all	versus CC 0	postsynaptic JJ B-adj.all	mechanisms NNS B-noun.person	, , 0	dopamine NN B-noun.person	receptor NN B-noun.person	subtypes NNS B-noun.person	, , 0	ionotropic NN B-noun.person	and CC 0	metabotropic JJ B-adj.all	glutamate NN B-noun.person	receptors NNS B-noun.person	, , 0	and CC 0	non NN B-noun.person	- : 0	dopaminergic JJ B-adj.all	neurotransmitter NN B-noun.plant	systems NNS B-noun.body	in IN 0	the DT 0	pathophysiology NN B-noun.attribute	of IN 0	levodopa NN B-noun.attribute	- : 0	induced VBN B-verb.creation	dyskinesias NNS B-noun.artifact	. . 0	. . 0
a14659530.s12	In IN 0	contrast NN 0	, , 0	serotonin NN B-adj.all	release NN B-noun.state	from IN 0	platelets NNS B-noun.person	does VBZ 0	not RB B-adv.all	provoke VB B-verb.creation	migraine NN I-verb.creation	, , 0	it PRP 0	may MD 0	even RB 0	counteract VB B-verb.contact	the DT 0	headache NN B-noun.state	and CC 0	the DT 0	concomitant JJ B-adj.all	CGRP NNP B-noun.other	release NN B-noun.process	in IN 0	this DT 0	model NN B-noun.person	. . 0	. . 0
a20520283.s5	Treatment NN B-noun.person	- : 0	related JJ B-adj.all	adverse JJ 0	events NNS 0	( ( 0	AEs NNP 0	) ) 0	occurred VBD B-verb.stative	in IN 0	44 CD B-adj.all	% NN 0	and CC 0	52 CD B-adj.all	% NN 0	, , 0	57 CD 0	% NN 0	, , 0	and CC 0	41 CD 0	% NN 0	of IN 0	the DT 0	asenapine NN B-noun.location	at IN 0	5 CD B-adj.all	and CC 0	10 CD B-adj.all	mg IN 0	BID NNP B-noun.group	, , 0	haloperidol NN B-noun.person	, , 0	and CC 0	placebo NN B-noun.plant	groups NNS B-noun.group	, , 0	respectively RB B-adv.all	. . 0	. . 0
a3076126.s4	Both DT 0	agents NNS B-noun.person	show VBP B-verb.communication	substantial JJ B-adj.all	clinical JJ B-adj.all	efficacy NN B-noun.person	, , 0	with IN 0	reductions NNS B-noun.group	in IN 0	total JJ B-adj.all	cholesterol NN B-noun.act	of IN 0	over IN 0	30 CD B-adj.all	% NN 0	and CC 0	in IN 0	LDL NNP 0	- : 0	cholesterol NN B-noun.act	of IN 0	40 CD B-adj.all	% NN 0	in IN 0	clinical JJ B-adj.all	studies NNS B-noun.communication	. . 0	. . 0
a9199746.s1	BACKGROUND NN 0	, , 0	Although IN 0	intravitreal JJ B-adj.all	aminoglycosides NNS B-noun.artifact	have VBP 0	substantially RB B-adv.all	improved VBN B-verb.change	visual JJ B-adj.pert	prognosis NN B-noun.cognition	in IN 0	endophthalmitis NN B-noun.location	, , 0	macular JJ B-adj.all	infarction NN B-noun.act	may MD 0	impair VB B-verb.change	full JJ B-adj.all	visual JJ B-adj.pert	recovery NN B-noun.process	. . 0	. . 0
a18726058.s12	One CD 0	patient NN B-noun.person	showed VBD B-verb.communication	no DT 0	recovery NN B-noun.process	of IN 0	later JJ B-adj.all	waves NNS B-noun.event	and CC 0	a DT 0	delayed VBN B-verb.stative	profound JJ B-adj.all	sensorineural_hearing_loss NN B-noun.time	. . 0	. . 0
a11745184.s9	After IN 0	completion NN B-noun.act	of IN 0	the DT 0	amifostine JJ B-adj.all	infusion NN B-noun.cognition	, , 0	cisplatin VBP B-verb.contact	120 CD 0	mg NN B-noun.quantity	/ : 0	m2 PRP 0	was VBD 0	administered VBN B-verb.possession	over IN 0	30 CD B-adj.all	minutes NNS B-noun.time	. . 0	. . 0
a12639165.s8	The DT 0	mechanisms NNS B-noun.person	of IN 0	this DT 0	ticlopidine NN B-noun.communication	- : 0	induced VBN B-verb.creation	cholestasis NN B-noun.process	are VBP B-verb.stative	unclear JJ B-adj.all	. . 0	. . 0
a8643971.s8	The DT 0	dose NN B-noun.state	levels NNS B-noun.state	incorporate VBP B-verb.change	escalating VBG B-verb.communication	paclitaxel NN B-noun.artifact	doses NNS I-noun.artifact	, , 0	and CC 0	intrapatient JJ B-adj.all	escalations NNS B-noun.act	within IN 0	a DT 0	given VBN B-verb.possession	dose NN B-noun.quantity	level NN B-noun.state	are VBP 0	permitted VBN B-verb.communication	if IN 0	toxicity NN B-noun.person	permits NNS B-noun.person	. . 0	. . 0
a8955532.s4	Phenylephrine JJ 0	infusion NN 0	increased VBD B-verb.change	arterial JJ B-adj.all	pressure NN B-noun.act	, , 0	arteriolar JJ B-adj.all	diameter NN B-noun.attribute	and CC 0	clearance NN B-noun.act	of IN 0	fluorescent JJ B-adj.all	dextran NN B-noun.communication	by IN 0	a DT 0	similar JJ B-adj.all	magnitude NN B-noun.person	in IN 0	both DT 0	groups NNS B-noun.group	. . 0	. . 0
a19657887.s5	In IN 0	less JJR 0	than IN 0	1 CD B-adj.all	hour NN B-noun.communication	after IN 0	the DT 0	ingestion NN B-noun.act	of IN 0	alcohol NN B-noun.food	, , 0	he PRP 0	developed VBD B-verb.creation	malaise NN I-verb.creation	with IN 0	flushing_of_the_face NN B-noun.attribute	, , 0	tachycardia NN B-noun.person	, , 0	and CC 0	dyspnea NN B-noun.person	. . 0	. . 0
a10579464.s5	NRA0160 NN B-noun.artifact	and CC 0	clozapine NN B-noun.person	antagonized VBN B-verb.communication	MAP NNP B-noun.person	- : 0	induced VBN B-verb.creation	stereotyped JJ B-adj.all	behavior NN B-noun.attribute	in IN 0	mice NNS B-noun.animal	, , 0	although IN 0	their PRP$ 0	effects NNS B-noun.phenomenon	did VBD 0	not RB B-adv.all	exceed VB B-verb.stative	50 CD B-adj.all	% NN 0	inhibition NN B-noun.attribute	, , 0	even RB B-adv.all	at IN 0	the DT 0	highest JJS B-adj.all	dose NN B-noun.act	given VBN B-verb.possession	. . 0	. . 0
a2696505.s5	Arterial JJ B-adj.all	PO2 NN B-noun.person	decreased VBD B-verb.change	in IN 0	both DT 0	groups NNS B-noun.group	. . 0	. . 0
a15859940.s13	In IN 0	the DT 0	current JJ B-adj.all	study NN B-noun.artifact	, , 0	the DT 0	frequency NN B-noun.person	of IN 0	thrombotic_microangiopathy JJ 0	was VBD B-verb.stative	similar JJ B-adj.all	to TO 0	the DT 0	percentage NN B-noun.person	reported VBN B-verb.communication	in IN 0	the DT 0	literature NN B-noun.act	( ( 0	20 CD B-adj.all	% NN 0	) ) 0	. . 0	. . 0
a16337777.s7	Although IN 0	evidences NNS B-noun.time	of IN 0	mitochondrial_abnormalities NNS B-noun.food	were VBD 0	found VBN B-verb.possession	in IN 0	previously RB B-adv.all	published VBN B-verb.creation	studies NNS B-noun.artifact	, , 0	our PRP$ 0	results NNS B-noun.communication	do VBP 0	not RB B-adv.all	suggest VB B-verb.communication	that IN 0	the DT 0	FRs NNP B-noun.person	, , 0	generated VBN B-verb.communication	during IN 0	the DT 0	acute JJ B-adj.all	phase NN B-noun.time	, , 0	determined VBN B-verb.cognition	important JJ B-adj.all	abnormalities NNS B-noun.person	in IN 0	mtDNA NNP B-noun.location	, , 0	in IN 0	expression NN B-noun.communication	of IN 0	CCO NNP B-noun.group	- : 0	I PRP 0	, , 0	and CC 0	in IN 0	CCO NNP B-noun.other	activity NN B-noun.process	. . 0	. . 0
a11426838.s9	To TO 0	further RBR B-adv.all	validate VB B-verb.communication	the DT 0	hypothesis NN B-noun.cognition	that IN 0	the DT 0	anti NNS B-noun.person	- : 0	cocaine NN 0	effects NNS B-noun.phenomenon	of IN 0	the DT 0	novel NN B-noun.artifact	ligands NNS I-noun.artifact	involved JJ B-adj.all	antagonism NN B-noun.attribute	of IN 0	sigma NN B-noun.communication	receptors NNS B-noun.person	, , 0	an DT 0	antisense JJ B-adj.all	oligodeoxynucleotide NN 0	against IN 0	sigma1 CD 0	receptors NNS B-noun.person	was VBD B-verb.stative	also RB B-adv.all	shown VBN B-verb.perception	to TO 0	significantly RB 0	attenuate VB B-verb.stative	the DT 0	convulsive JJ B-adj.all	and CC 0	locomotor NN B-noun.person	stimulatory JJ B-adj.all	effects NNS B-noun.phenomenon	of IN 0	cocaine NN 0	. . 0	. . 0
a19269743.s7	The DT 0	strong JJ B-adj.all	burning NN B-verb.change	pain NN B-noun.person	decayed VBD B-verb.communication	exponentially RB B-adv.all	within IN 0	a DT B-adj.all	few JJ I-adj.all	minutes NNS B-noun.time	. . 0	. . 0
a12589964.s19	All DT 0	markers NNS B-noun.person	remained VBD B-verb.stative	stable JJ B-adj.all	in IN 0	controls NNS B-noun.artifact	. . 0	. . 0
a17615423.s10	CONCLUSIONS NNS B-noun.artifact	, , 0	Pharmacokinetic JJ B-adj.all	differences NNS B-noun.event	in IN 0	statins NNS B-noun.animal	are VBP B-verb.stative	an DT 0	important JJ B-adj.all	consideration NN B-noun.act	for IN 0	assessing VBG B-verb.social	the DT I-verb.social	risk NN I-verb.social	of IN 0	potential JJ B-adj.all	drug NN B-noun.person	interactions NNS I-noun.person	. . 0	. . 0
a2054792.s3	Acute NNP B-noun.person	normal JJ B-adj.all	tissue NN B-noun.body	toxicities NNS I-noun.body	( ( 0	i.e. FW B-adv.all	, , 0	leukopenia NN B-noun.person	and CC 0	thrombocytopenia NN B-noun.artifact	) ) 0	and CC 0	late RB B-adv.all	normal JJ B-adj.all	tissue NN B-noun.body	toxicities NNS I-noun.body	( ( 0	i.e. FW B-adv.all	, , 0	myocardial_and_kidney_injury NNP B-noun.location	) ) 0	were VBD 0	evaluated VBN B-verb.communication	by IN 0	functional JJ B-adj.all	/ : 0	physiological JJ B-adj.pert	assays NNS B-noun.act	and CC 0	by IN 0	morphological JJ B-adj.all	techniques NNS B-noun.cognition	. . 0	. . 0
a7234705.s6	In IN 0	two CD 0	patients NNS B-noun.person	, , 0	the DT 0	arrhythmia NN B-noun.person	degenerated VBD B-verb.change	into IN 0	irreversible JJ B-adj.all	ventricular_fibrillation NN B-noun.artifact	and CC 0	both DT 0	patients NNS B-noun.person	died VBD B-verb.change	. . 0	. . 0
a18791946.s0	Severe JJ B-adj.all	thrombocytopenia NN B-noun.state	and CC 0	haemolytic_anaemia NN 0	associated VBN B-verb.cognition	with IN 0	ciprofloxacin NN B-noun.person	, , 0	a DT 0	case NN B-noun.state	report NN B-noun.person	with IN 0	fatal JJ B-adj.all	outcome NN 0	. . 0	. . 0
a17111419.s3	Past NNP 0	medical JJ B-adj.all	history NN B-noun.cognition	was VBD B-verb.stative	remarkable JJ B-adj.all	for IN 0	hypertension NN B-noun.act	, , 0	hyperlipidemia NN B-noun.person	, , 0	and CC 0	depression NN B-noun.act	. . 0	. . 0
a1720453.s8	Two CD 0	subsets NNS B-noun.person	of IN 0	patients NNS B-noun.person	were VBD 0	identified VBN B-verb.cognition	from IN 0	this DT 0	latter JJ B-adj.all	group NN B-noun.group	, , 0	the DT 0	first JJ B-noun.person	included VBD B-verb.stative	four CD 0	patients NNS B-noun.person	( ( 0	5 CD B-adj.all	% NN 0	of IN 0	the DT 0	total JJ B-adj.all	population NN B-noun.possession	) ) 0	who WP 0	developed VBD B-verb.creation	major JJ B-adj.all	toxicity NN B-noun.artifact	resulting VBG B-verb.stative	in IN 0	Fanconi's_syndrome NNP 0	( ( 0	TDFS NNP B-noun.group	) ) 0	, , 0	and CC 0	the DT 0	second JJ B-adj.all	group NN 0	included VBD B-verb.stative	five CD B-adj.all	patients NNS B-noun.person	with IN 0	elevated JJ B-adj.all	beta NN B-noun.communication	2 CD B-adj.all	microglobulinuria NNS B-noun.person	and CC 0	low JJ B-adj.all	phosphate JJ B-adj.all	reabsorption NN B-noun.process	. . 0	. . 0
a2484011.s6	Subsequent JJ B-adj.all	amantadine NN B-noun.person	treatments NNS B-noun.person	produced VBD B-verb.creation	enhancement NN B-noun.person	of IN 0	motility NN B-noun.phenomenon	from IN 0	corresponding VBG B-verb.social	control NN B-noun.act	in IN 0	all DT 0	mouse NN B-noun.animal	strains VBZ B-verb.contact	with IN 0	the DT 0	BALB NNP B-noun.group	/ ( 0	C NNP 0	mice NNS 0	being VBG B-verb.stative	the DT 0	least JJS 0	sensitive JJ B-adj.all	. . 0	. . 0
a20880751.s2	However RB 0	, , 0	the DT 0	long JJ B-noun.body	- : 0	term NN B-noun.time	use NN 0	of IN 0	this DT 0	dopamine NN B-noun.cognition	precursor NN I-noun.cognition	is VBZ 0	complicated VBN B-verb.change	by IN 0	highly RB 0	disabling VBG B-verb.communication	fluctuations NNS B-noun.person	and CC 0	dyskinesias NNS B-noun.artifact	. . 0	. . 0
a16867021.s9	per IN 0	se PRP 0	did VBD 0	not RB B-adv.all	cause_catalepsy JJ B-adj.all	. . 0	. . 0
a12716030.s6	Data NNS B-noun.cognition	suggest VBP B-verb.communication	that IN 0	this DT 0	sensitive JJ B-adj.all	hemoglobin NN B-noun.person	assay NN B-noun.cognition	is VBZ B-verb.stative	useful JJ B-adj.all	for IN 0	ICH NNP 0	detection NN B-noun.communication	, , 0	and CC 0	that IN 0	a DT 0	model NN B-noun.person	with IN 0	a DT 0	small JJ B-noun.person	ICH NNP I-noun.person	induced VBN B-verb.creation	with IN 0	a DT 0	low JJ B-adj.all	- : 0	dose NN 0	collagenase NN 0	should MD 0	be VB 0	used VBN B-verb.consumption	for IN 0	evaluation NN B-noun.act	of IN 0	drugs NNS B-noun.artifact	that WDT 0	may MD 0	affect VB B-verb.change	ICH NNP 0	. . 0	. . 0
a11135224.s6	RESULTS NNS B-noun.artifact	, , 0	All PDT 0	the DT 0	patients NNS B-noun.person	were VBD 0	examined VBN B-verb.communication	for IN 0	toxicity NN B-noun.attribute	, , 0	34 CD 0	were VBD B-verb.stative	examinable JJ B-adj.all	for IN 0	response NN B-noun.communication	. . 0	. . 0
a15338796.s0	Tremor NNP 0	side NN 0	effects NNS B-noun.phenomenon	of IN 0	salbutamol NN B-noun.act	, , 0	quantified VBN B-verb.change	by IN 0	a DT 0	laser NN B-adj.all	pointer NN B-noun.attribute	technique NN I-noun.attribute	. . 0	. . 0
a20619828.s3	METHODS NNS B-noun.attribute	, , 0	Neonatal JJ B-adj.all	rats NNS B-noun.person	were VBD 0	treated VBN B-verb.change	with IN 0	the DT 0	tricyclic JJ B-adj.all	antidepressant JJ B-adj.all	clomipramine NN B-noun.state	or CC 0	vehicle NN B-noun.communication	between IN 0	days NNS B-noun.time	9 CD 0	and CC 0	16 CD B-adj.all	twice RB B-adv.all	daily JJ B-adj.all	and CC 0	behaviorally RB B-adv.all	tested VBN B-verb.social	in IN 0	adulthood NN B-noun.act	. . 0	. . 0
a11431197.s6	Allograft NNP B-noun.person	function NN B-noun.act	improved VBD B-verb.change	rapidly RB B-adv.all	and CC 0	returned VBD B-verb.motion	to TO 0	baseline NN B-verb.cognition	after IN 0	stopping VBG B-verb.motion	the DT 0	drug NN B-noun.artifact	. . 0	. . 0
a2234245.s8	The DT 0	data NNS B-noun.cognition	indicate VBP B-verb.communication	that DT 0	audiovisual_toxicity NN B-noun.group	is VBZ B-verb.stative	not RB B-adv.all	an DT 0	infrequent JJ B-adj.all	complication NN B-noun.person	in IN 0	hemodialyzed VBN B-verb.social	patients NNS B-noun.person	receiving VBG B-verb.communication	desferrioxamine NN B-noun.person	. . 0	. . 0
a17147461.s5	However RB 0	, , 0	clinical JJ B-adj.all	reports NNS B-noun.communication	suggest VBP B-verb.communication	that IN 0	, , 0	under IN 0	some DT 0	circumstances NNS B-noun.state	, , 0	sirolimus NN 0	is VBZ 0	associated VBN B-verb.cognition	with IN 0	proteinuria NNS B-noun.person	and CC 0	acute_renal_dysfunction NN B-noun.act	. . 0	. . 0
a1616457.s3	In IN 0	Group NNP 0	1 CD 0	the DT 0	rats NNS B-noun.plant	were VBD 0	trained VBN B-verb.cognition	under IN 0	the DT 0	influence NN B-noun.cognition	of IN 0	pentobarbital JJ 0	to TO 0	run VB 0	to TO 0	the DT 0	same JJ B-adj.all	shelf NN B-noun.artifact	as IN 0	in IN 0	the DT 0	normal JJ B-adj.all	state NN B-noun.location	. . 0	. . 0
a17147461.s8	It PRP 0	has VBZ 0	also RB B-adv.all	been VBN 0	suggested VBN B-verb.communication	that DT 0	sirolimus NN 0	directly RB B-adv.all	causes VBZ B-verb.communication	increased VBN B-verb.change	glomerular JJ B-adj.all	permeability NN B-noun.attribute	/ : 0	injury NN B-noun.possession	, , 0	but CC 0	evidence NN B-noun.attribute	for IN 0	this DT 0	mechanism NN B-noun.attribute	is VBZ B-verb.stative	currently RB B-adv.all	inconclusive VBP B-verb.stative	. . 0	. . 0
a16904497.s2	Cauda_equina_syndrome DT 0	is VBZ B-verb.stative	a DT 0	rare JJ B-adj.all	complication NN B-noun.act	of IN 0	epidural JJ B-adj.all	anesthesia NN B-noun.state	. . 0	. . 0
a19957053.s4	Heart NN B-noun.body	rate NN B-noun.time	( ( 0	HR NNP 0	) ) 0	, , 0	MAP NNP B-noun.person	, , 0	stroke VBD B-verb.communication	volume NN I-verb.communication	( ( 0	SV NNP 0	) ) 0	, , 0	cardiac JJ 0	output NN 0	( ( 0	CO NNP 0	) ) 0	, , 0	and CC 0	frontal JJ B-adj.all	lobe NN B-noun.person	oxygenation NN B-noun.person	( ( 0	S(c)O(2 NNP 0	) ) 0	) ) 0	were VBD 0	registered VBN B-verb.communication	. . 0	. . 0
a17931375.s3	DESIGN NN B-noun.artifact	, , 0	This DT 0	study NN B-noun.artifact	was VBD 0	designed VBN B-verb.creation	as IN 0	within IN 0	- : 0	subject NN B-noun.artifact	, , 0	quasi UH 0	- : 0	experimental JJ B-adj.all	research NN B-noun.act	. . 0	. . 0
a3560096.s3	We PRP 0	describe VBP B-verb.stative	4 CD B-adj.all	patients NNS B-noun.person	in IN 0	whom JJ 0	hyperkalemia NN 0	ranging VBG B-verb.stative	from IN 0	6.1 CD 0	to TO 0	6.9 CD 0	mEq CD 0	/ : 0	l PRP 0	developed VBD B-verb.creation	within IN 0	3 CD 0	to TO 0	8 CD B-adj.all	days NNS B-noun.time	of IN 0	sulindac JJ B-adj.all	administration NN B-noun.person	. . 0	. . 0
a354896.s1	Intravenous JJ B-adj.all	administration NN B-noun.event	of IN 0	a DT 0	single JJ B-adj.all	50-mg JJ B-noun.body	bolus NN I-noun.body	of IN 0	lidocaine NN B-noun.person	in IN 0	a DT 0	67-year JJ 0	- : 0	old JJ B-adj.all	man NN B-noun.person	resulted VBD B-verb.communication	in IN 0	profound JJ B-adj.all	depression NN B-noun.act	of IN 0	the DT 0	activity NN B-noun.process	of IN 0	the DT 0	sinoatrial JJ B-adj.all	and CC 0	atrioventricular JJ B-adj.all	nodal NN B-noun.artifact	pacemakers NNS B-noun.artifact	. . 0	. . 0
a9199746.s5	CONCLUSIONS NNS B-noun.artifact	, , 0	Currently RB B-adv.all	accepted VBN B-verb.possession	intravitreal JJ B-adj.all	antibiotic JJ B-adj.all	regimens NNS B-noun.animal	may MD 0	cause VB B-verb.communication	retinal_toxicity NN B-noun.person	and CC 0	macular JJ B-adj.all	ischaemia NN B-noun.artifact	. . 0	. . 0
a2234245.s6	Desferrioxamine JJ B-adj.all	withdrawal NN B-noun.person	resulted VBD B-verb.communication	in IN 0	a DT 0	complete JJ B-adj.all	recovery NN B-noun.process	of IN 0	visual JJ B-adj.pert	function NN B-noun.act	in IN 0	1 CD B-adj.all	patient NN B-noun.person	and CC 0	partial JJ B-adj.all	recovery NN B-noun.process	in IN 0	3 CD B-adj.all	, , 0	and CC 0	a DT 0	complete JJ B-adj.all	reversal NN B-noun.person	of IN 0	hearing_loss NN B-noun.location	in IN 0	3 CD B-adj.all	patients NNS B-noun.person	and CC 0	partial JJ B-adj.all	recovery NN B-noun.process	in IN 0	3 CD B-adj.all	. . 0	. . 0
a15899738.s7	However RB 0	, , 0	when WRB 0	the DT 0	patient NN B-noun.person	was VBD 0	questioned VBN B-verb.communication	about IN 0	use NN 0	of IN 0	herbal JJ B-adj.pert	products NNS B-noun.person	and CC 0	supplements NNS B-noun.artifact	, , 0	the DT 0	use NN 0	of IN 0	creatine NN B-noun.person	monohydrate NN B-noun.person	was VBD 0	revealed VBN B-verb.perception	. . 0	. . 0
a8092427.s5	When WRB 0	both DT 0	skin NN B-noun.state	test NN I-noun.state	and CC 0	RAST NNP B-noun.group	for IN 0	BPO NNP 0	were VBD B-verb.stative	negative JJ B-adj.all	, , 0	single JJ B-adj.all	- : 0	blind NN B-noun.person	, , 0	placebo NN B-noun.person	- : 0	controlled VBN B-verb.social	challenge NN B-noun.act	tests NNS B-noun.person	were VBD 0	done VBN B-verb.social	to TO 0	ensure VB B-verb.change	tolerance NN B-noun.act	of IN 0	PG NNP 0	or CC 0	sensitivity NN B-noun.feeling	to TO 0	AX NNP 0	. . 0	. . 0
a16755009.s10	and CC 0	diazepam NN B-noun.person	( ( 0	1 CD 0	mg FW 0	/ FW 0	kg FW 0	, , 0	i.p NNP B-noun.person	. . 0	) ) 0	. . 0	. . 0
a4812392.s0	Treatment NN B-noun.person	of IN 0	psoriasis NN B-noun.food	with IN 0	azathioprine NN B-noun.person	. . 0	. . 0
a12617329.s3	Nephrotoxicity NN B-noun.person	was VBD 0	assessed VBN B-verb.cognition	by IN 0	measuring VBG B-verb.cognition	the DT 0	concentrations NNS B-noun.cognition	of IN 0	creatinine NN B-noun.person	and CC 0	urea NN B-noun.person	in IN 0	the DT 0	plasma NN B-noun.plant	and CC 0	reduced VBD B-verb.change	glutathione NN 0	( ( 0	GSH NNP 0	) ) 0	in IN 0	the DT 0	kidney NN B-noun.person	cortex NN B-noun.person	, , 0	and CC 0	by IN 0	light JJ B-adj.all	microscopic JJ B-noun.phenomenon	examination NN I-noun.phenomenon	of IN 0	kidney NN B-noun.act	sections NNS B-noun.object	. . 0	. . 0
a18703024.s2	The DT 0	goal NN B-noun.cognition	of IN 0	these DT 0	studies NNS B-noun.act	was VBD B-verb.stative	to TO 0	use VB B-verb.consumption	an DT 0	animal NN B-adj.all	model NN B-noun.person	to TO 0	examine VB B-verb.communication	the DT 0	effects NNS B-noun.phenomenon	of IN 0	prenatal JJ B-adj.all	protein NN B-noun.person	deprivation NN B-noun.state	on IN 0	behaviors NNS B-noun.person	and CC 0	receptor NN B-noun.person	binding NN B-verb.social	with IN 0	relevance NN B-noun.act	to TO 0	schizophrenia NN B-noun.person	. . 0	. . 0
a15009014.s1	Cluster_headache NN 0	is VBZ 0	characterized VBN B-verb.communication	by IN 0	typical JJ B-adj.all	autonomic JJ B-adj.all	dysfunctions NNS B-noun.artifact	including VBG B-verb.stative	facial JJ B-adj.all	and CC 0	intracranial_vascular_disturbances NNS B-noun.artifact	. . 0	. . 0
a19657887.s3	The DT 0	purpose NN B-noun.attribute	of IN 0	this DT 0	report NN B-noun.communication	is VBZ B-verb.stative	to TO 0	describe VB B-verb.motion	two CD 0	cases NNS B-noun.quantity	of IN 0	a DT 0	disulfiram NN B-noun.person	- : 0	like IN 0	syndrome NN 0	following VBG B-verb.stative	occupational JJ B-adj.all	exposure NN B-noun.cognition	to TO 0	hydrogen_cyanamide VB 0	. . 0	. . 0
a17437408.s6	METHODS NNS B-noun.attribute	, , 0	The DT 0	expression NN B-noun.communication	of IN 0	MRP2 NNP B-noun.person	and CC 0	Pgp NNP B-noun.person	in IN 0	brain NN B-noun.food	and CC 0	liver NN B-noun.body	sections NNS B-noun.object	of IN 0	TR(- NN B-noun.location	) ) 0	rats NNS B-noun.animal	and CC 0	normal JJ B-adj.all	Wistar NNP B-noun.person	rats NNS I-noun.person	was VBD 0	determined VBN B-verb.communication	with IN 0	immunohistochemistry NN B-noun.attribute	, , 0	by IN 0	using VBG B-verb.consumption	a DT 0	novel NN B-noun.communication	, , 0	highly RB B-adv.all	selective JJ B-adj.all	monoclonal JJ B-noun.person	MRP2 NNP I-noun.person	antibody NN B-noun.object	and CC 0	the DT 0	monoclonal JJ B-adj.all	Pgp NNP 0	antibody NN 0	C219 NN 0	, , 0	respectively RB B-adv.all	. . 0	. . 0
a1592014.s7	Whereas IN 0	cocaine NN B-noun.person	- : 0	induced VBN B-verb.creation	seizures NNS B-noun.body	were VBD B-verb.stative	best RBS 0	characterized VBN B-verb.communication	as IN 0	brief JJ B-noun.artifact	, , 0	generalized VBD B-verb.communication	, , 0	and CC 0	tonic JJ B-adj.all	and CC 0	resulted VBD B-verb.communication	in IN 0	death NN 0	, , 0	those DT 0	induced VBN B-verb.creation	by IN 0	BE NNP 0	were VBD 0	prolonged VBN B-verb.communication	, , 0	often RB B-adv.all	multiple JJ B-adj.all	and CC 0	mixed JJ B-adj.all	in IN 0	type NN B-noun.person	, , 0	and CC 0	rarely RB B-adv.all	resulted VBD B-verb.communication	in IN 0	death NN 0	. . 0	. . 0
a12536034.s3	The DT 0	gamma NN B-noun.act	- : 0	aminobutyric_acid JJ B-noun.group	- : 0	transmitted VBN B-verb.cognition	thalamocortical JJ 0	circuitry NN B-noun.act	accounts NNS B-noun.person	for IN 0	a DT 0	major JJ B-adj.all	part NN B-noun.act	of IN 0	the DT 0	underlying VBG B-adj.all	neurophysiology NN B-noun.attribute	of IN 0	the DT 0	absence_epilepsy JJ B-noun.artifact	. . 0	. . 0
a7890216.s5	Gall NNP B-noun.person	bladder NN I-noun.person	bile NN B-noun.possession	was VBD 0	obtained VBN B-verb.change	by IN 0	ultrasound NN B-noun.person	guided VBN B-verb.motion	, , 0	fine JJ B-adj.all	needle NN B-noun.artifact	puncture NN B-noun.person	from IN 0	six CD B-adj.all	patients NNS B-noun.person	. . 0	. . 0
a1967484.s1	Sulpiride NNP B-noun.person	is VBZ B-verb.stative	a DT 0	selective JJ B-adj.all	D2-receptor NN B-noun.person	antagonist NN B-noun.person	with IN 0	antipsychotic JJ B-adj.all	and CC 0	antidepressant JJ B-adj.all	properties NNS B-noun.attribute	. . 0	. . 0
a12757899.s2	We PRP 0	compared VBD B-verb.cognition	the DT 0	effects NNS B-noun.phenomenon	of IN 0	17beta JJ 0	- : 0	estradiol NN B-noun.act	in IN 0	adult NN B-noun.act	male NN I-noun.act	and CC 0	ovariectomized JJ B-adj.all	female NN B-noun.person	rats NNS B-noun.person	subjected VBN B-verb.social	to TO 0	lithium NN B-noun.person	- : 0	pilocarpine NN B-noun.person	- : 0	induced VBN B-verb.creation	SE NNP 0	. . 0	. . 0
a7890216.s6	All DT 0	six CD B-adj.all	patients NNS B-noun.person	had VBD 0	supersaturated VBN B-verb.possession	bile NN B-noun.possession	( ( 0	mean VB B-verb.stative	( ( 0	SEM NNP 0	) ) 0	cholesterol NN 0	saturation NN 0	index NN 0	of IN 0	1.19 CD 0	( ( 0	0.08 CD 0	) ) 0	( ( 0	range NN B-noun.attribute	1.01 CD 0	- : 0	1.53 CD 0	) ) 0	) ) 0	and CC 0	all DT 0	had VBD 0	abnormally RB B-adv.all	rapid JJ B-adj.all	cholesterol NN B-noun.phenomenon	microcrystal JJ B-noun.phenomenon	nucleation NN I-noun.phenomenon	times NNS B-noun.event	( ( 0	< $ 0	4 CD B-adj.all	days NNS B-noun.phenomenon	( ( 0	range NN B-noun.communication	1 CD B-adj.all	- : 0	4 LS 0	) ) 0	) ) 0	, , 0	whilst NN B-noun.person	in IN 0	four CD 0	, , 0	the DT 0	bile NN B-noun.communication	contained VBN B-verb.stative	cholesterol NN B-adj.all	microcrystals NNS B-noun.person	immediately RB B-adv.all	after IN 0	sampling VBG B-verb.motion	. . 0	. . 0
a3827439.s1	A DT 0	patient NN B-noun.person	with IN 0	cryptogenic JJ B-adj.all	cirrhosis NN B-noun.cognition	and CC 0	disseminated VBD B-verb.communication	sporotrichosis NN B-noun.person	developed VBD B-verb.change	acute_renal_failure RBR 0	immediately RB B-adv.all	following VBG 0	the DT 0	administration NN B-noun.time	of IN 0	amphotericin NN 0	B NNP 0	on IN 0	four CD 0	separate JJ B-adj.all	occasions NNS B-noun.event	. . 0	. . 0
a10457883.s2	Accumulation NNP B-noun.person	of IN 0	atracurium NN B-noun.food	in IN 0	the DT 0	intravenous JJ B-adj.all	line NN B-noun.communication	led VBN B-verb.stative	to TO 0	recurarization NN B-noun.act	after IN 0	flushing VBG B-verb.motion	the DT 0	line NN B-noun.communication	in IN 0	the DT 0	recovery NN B-noun.artifact	room NN I-noun.artifact	. . 0	. . 0
a12589964.s8	Histology NN B-noun.person	was VBD 0	performed VBN B-verb.social	in IN 0	DOX NNP B-noun.group	- : 0	rats NNS B-noun.animal	at IN 0	6 CD B-adj.all	and CC 0	9 CD B-adj.all	weeks NNS B-noun.time	after IN 0	the DT 0	last JJ B-adj.all	DOX NNP B-noun.group	dose NN B-noun.person	and CC 0	in IN 0	all DT 0	controls NNS B-noun.cognition	. . 0	. . 0
a18083142.s0	Norepinephrine NN B-noun.person	signaling VBG B-verb.perception	through IN 0	beta NN B-noun.act	- : 0	adrenergic JJ B-adj.all	receptors NNS B-noun.person	is VBZ B-verb.stative	critical JJ B-adj.all	for IN 0	expression NN B-noun.communication	of IN 0	cocaine NN B-noun.person	- : 0	induced VBN B-verb.creation	anxiety NN 0	. . 0	. . 0
a7890216.s1	Octreotide NNP B-noun.person	, , 0	an DT 0	effective JJ B-adj.all	treatment NN B-noun.communication	for IN 0	acromegaly RB B-adv.all	, , 0	induces VBZ B-verb.creation	gall_bladder_stones NNS I-verb.creation	in IN 0	13 CD B-adj.all	- : 0	60 CD B-adj.all	% NN 0	of IN 0	patients NNS B-noun.person	. . 0	. . 0
a9660111.s6	does VBZ 0	not RB B-adv.all	antagonize VB B-verb.cognition	the DT 0	reserpine NN B-noun.location	hypothermia NN B-noun.person	in IN 0	mice NNS B-noun.animal	and CC 0	does VBZ 0	not RB B-adv.all	potentiate VB B-verb.communication	the DT 0	5-hydroxytryptophan JJ B-noun.body	head NN I-noun.body	twitches NNS B-verb.motion	in IN 0	rats NNS B-noun.animal	. . 0	. . 0
a3437726.s2	AV_block NN 0	, , 0	severe JJ 0	hypotension NN 0	, , 0	and CC 0	impairment_of_ventricular_function NN B-noun.act	. . 0	. . 0
a3173180.s2	These DT 0	children NNS B-noun.person	were VBD B-verb.stative	older JJR B-adj.all	and CC 0	were VBD B-verb.stative	more RBR B-adv.all	likely JJ B-adj.all	to TO 0	have VB 0	undergone VBN B-verb.cognition	recent JJ B-adj.all	bowel NN B-noun.artifact	surgery NN 0	than IN 0	are VBP 0	other JJ 0	children NNS B-noun.person	with IN 0	this DT 0	condition NN B-noun.communication	. . 0	. . 0
a18020536.s8	Health NNP B-noun.person	, , 0	physical JJ B-noun.body	abilities NNS I-noun.body	and CC 0	cognitive JJ B-adj.all	function NN B-noun.act	were VBD 0	compared VBN B-verb.change	between IN 0	BZD NNP 0	/ ( 0	RD NNP 0	users NNS 0	and CC 0	non NN B-noun.person	- : 0	users NNS B-noun.person	, , 0	and CC 0	adjustments NNS B-noun.person	were VBD 0	made VBN B-verb.social	for IN 0	confounding VBG B-verb.communication	variables NNS B-noun.cognition	. . 0	. . 0
a15188772.s1	Catecholamine SYM 0	- : 0	induced VBN B-verb.creation	cardiomyopathy JJ 0	due JJ 0	to TO 0	chronic VB B-verb.social	excess NN B-noun.act	of IN 0	endogenous JJ B-adj.all	catecholamines NNS B-noun.communication	has VBZ 0	been VBN 0	recognized VBN B-verb.cognition	for IN 0	decades NNS B-noun.time	as IN 0	a DT 0	clinical JJ B-adj.all	phenomenon NN B-noun.person	. . 0	. . 0
a19346865.s5	Follow VB B-verb.cognition	- : 0	up IN 0	MRIs NNP B-noun.person	were VBD 0	performed VBN B-verb.social	on IN 0	5 CD B-adj.all	patients NNS B-noun.person	from IN 0	third JJ 0	to TO 0	14th JJ 0	days NNS B-noun.phenomenon	after IN 0	discontinuation NN B-noun.act	of IN 0	metronidazole JJ B-adj.all	administration NN B-noun.person	. . 0	. . 0
a8437969.s0	Sinus_arrest JJS 0	associated VBN B-verb.cognition	with IN 0	continuous JJ B-adj.pert	- : 0	infusion NN 0	cimetidine NN 0	. . 0	. . 0
a20477932.s3	Therefore RB B-adv.all	NFkappaB JJ B-adj.all	activity NN B-noun.state	, , 0	oxidative JJ B-adj.all	stress NN B-noun.state	, , 0	neuronal JJ B-adj.all	nitric_oxide JJ B-noun.other	synthase NN B-noun.cognition	( ( 0	nNOS NNS B-noun.attribute	) ) 0	activity NN B-noun.quantity	, , 0	spatial JJ B-adj.all	learning NN B-noun.act	and CC 0	memory NN B-noun.person	as RB 0	well RB 0	as IN 0	the DT 0	effect NN B-noun.cognition	of IN 0	topiramate NN B-noun.location	, , 0	a DT 0	previously RB B-adv.all	proposed VBN B-verb.cognition	therapy NN 0	for IN 0	cocaine_addiction NN 0	, , 0	were VBD 0	evaluated VBN B-verb.communication	in IN 0	an DT 0	experimental JJ B-adj.all	model NN B-noun.person	of IN 0	cocaine NN B-noun.phenomenon	administration NN I-noun.phenomenon	in IN 0	rats NNS B-noun.animal	. . 0	. . 0
a2696505.s3	Nitroprusside JJ B-adj.all	infusion NN B-noun.cognition	was VBD 0	associated VBN B-verb.cognition	with IN 0	a DT 0	significant JJ B-adj.all	( ( 0	p IN 0	less JJR B-noun.quantity	than IN 0	0.05 CD 0	) ) 0	increase_in_heart_rate_and_cardiac_output NN B-noun.quantity	, , 0	rebound VB B-verb.communication	hypertension NN B-noun.person	was VBD 0	observed VBN B-verb.perception	in IN 0	three CD 0	patients NNS B-noun.person	after IN 0	discontinuation NN B-noun.act	of IN 0	nitroprusside NN B-noun.person	. . 0	. . 0
a8643971.s2	Preliminary JJ B-adj.all	results NNS B-noun.event	of IN 0	an DT 0	Eastern NNP B-noun.other	Cooperative NNP I-noun.other	Oncology NNP I-noun.other	Group NNP I-noun.other	study NN B-noun.group	of IN 0	single JJ B-noun.act	- : 0	agent NN B-noun.person	paclitaxel NN B-noun.person	( ( 0	Taxol NNP B-noun.person	, , 0	Bristol NNP B-noun.person	- : 0	Myers NNP B-noun.person	Squibb NNP I-noun.person	Company NNP I-noun.person	, , 0	Princeton NNP B-noun.person	, , 0	NJ NNP 0	) ) 0	reported VBD B-verb.communication	a DT 0	37 CD 0	% NN 0	response NN B-adj.all	rate NN B-noun.time	in IN 0	patients NNS B-noun.person	with IN 0	head_and_neck_cancer NN B-noun.person	, , 0	and CC 0	the DT 0	paclitaxel NN B-noun.artifact	/ : 0	cisplatin NN B-adj.all	combination NN B-noun.person	has VBZ 0	been VBN 0	used VBN B-verb.consumption	successfully RB B-adv.all	and CC 0	has VBZ 0	significantly RB B-adv.all	improved VBN B-verb.change	median JJ B-adj.all	response NN B-noun.communication	duration NN 0	in IN 0	ovarian_cancer NN B-noun.location	patients NNS B-noun.person	. . 0	. . 0
a9672936.s3	Both DT 0	plasma NN B-noun.plant	pethidine NN B-noun.body	and CC 0	norpethidine NN B-noun.person	were VBD 0	elevated VBN B-verb.social	in IN 0	the DT 0	range NN B-noun.plant	associated VBN B-verb.cognition	with IN 0	clinical JJ B-adj.all	manifestations NNS B-noun.communication	of IN 0	central JJ B-noun.body	nervous JJ I-noun.body	system NN 0	excitation NN 0	. . 0	. . 0
a12574103.s9	Hypertension NN B-noun.person	was VBD 0	observed VBN B-verb.perception	in IN 0	animals NNS B-noun.animal	that WDT 0	had VBD B-verb.stative	a DT 0	reduction NN B-noun.act	in IN 0	glomeruli JJ 0	as RB 0	well RB 0	as IN 0	in IN 0	a DT 0	group NN B-noun.motive	that WDT 0	did VBD 0	not RB B-adv.all	have VB B-verb.stative	a DT 0	reduction_in_glomerular_number NNP B-noun.person	, , 0	suggesting VBG B-verb.communication	that IN 0	a DT 0	reduction_in_glomerular_number NNP B-noun.person	is VBZ B-verb.stative	not RB I-verb.stative	the DT 0	sole JJ B-adj.all	cause NN B-noun.act	for IN 0	the DT 0	development NN B-noun.process	of IN 0	hypertension NN B-noun.act	. . 0	. . 0
a12617329.s1	In IN 0	the DT 0	present JJ B-adj.all	work NN B-noun.cognition	we PRP 0	assessed VBD B-verb.cognition	the DT 0	effect NN B-noun.cognition	of IN 0	treatment NN B-noun.communication	of IN 0	rats NNS B-noun.plant	with IN 0	gum_Arabic JJ 0	on IN 0	acute_renal_failure NN B-noun.act	induced VBN B-verb.creation	by IN 0	gentamicin NN B-noun.communication	( ( 0	GM NNP 0	) ) 0	nephrotoxicity NN B-noun.quantity	. . 0	. . 0
a2054792.s2	Antitumor NNP B-noun.person	activity NN I-noun.person	was VBD 0	studied VBN B-verb.cognition	using VBG B-verb.consumption	a DT 0	tumor NN B-noun.plant	growth NN 0	delay NN B-noun.act	assay NN I-noun.act	. . 0	. . 0
a18619688.s8	RESULTS NNS B-noun.artifact	, , 0	3MA NNP 0	significantly RB B-adv.all	improved VBN B-verb.change	cardiac JJ B-adj.all	function NN B-noun.act	and CC 0	reduced VBD B-verb.change	mitochondrial JJ B-adj.all	injury NN B-noun.possession	. . 0	. . 0
a17612891.s4	The DT 0	patient NN B-noun.person	recovered VBD B-verb.body	with IN 0	intensive JJ B-adj.all	medical JJ B-adj.all	support NN B-noun.person	. . 0	. . 0
a10721819.s7	Neither DT 0	cardiac JJ B-adj.all	vagal JJ B-adj.all	nor CC 0	sympathetic JJ B-adj.all	tone NN B-noun.attribute	was VBD 0	altered VBN B-verb.change	by IN 0	isoproterenol NN B-noun.person	pretreatment NN B-noun.person	. . 0	. . 0
a10683478.s8	By IN 0	contrast NN 0	, , 0	apomorphine JJ B-noun.person	- : 0	induced VBN B-verb.creation	locomotion NN B-noun.artifact	was VBD B-verb.stative	more RBR B-adv.all	prominent JJ B-adj.all	in IN 0	the DT 0	novel NN B-noun.artifact	exploratory NN B-noun.artifact	box NN I-noun.artifact	. . 0	. . 0
a6640832.s6	No DT 0	systemic JJ B-adj.all	side NN B-noun.body	- : 0	effects NNS B-noun.phenomenon	were VBD 0	observed VBN B-verb.perception	. . 0	. . 0
a1664218.s2	It PRP 0	was VBD 0	administered VBN B-verb.possession	by IN 0	15 CD B-adj.all	min NN 0	infusion NN 0	to TO 0	16 CD B-adj.all	evaluable JJ B-adj.all	patients NNS B-noun.person	with IN 0	non NN B-noun.person	- : 0	small_cell_lung_cancer JJR B-adj.all	( ( 0	NSCLC NNP B-noun.group	) ) 0	( ( 0	7 CD 0	with IN 0	no DT 0	prior JJ B-adj.all	treatment NN B-noun.communication	, , 0	9 CD B-adj.all	patients NNS B-noun.person	in IN 0	relapse NN 0	following VBG 0	surgery NN B-noun.communication	/ : 0	radiotherapy NN B-noun.act	) ) 0	at IN 0	a DT 0	dose NN B-noun.person	( ( 0	648 CD 0	mg IN 0	/ : 0	m2 CC 0	divided VBN B-verb.cognition	over IN 0	3 CD B-adj.all	days NNS B-noun.person	, , 0	repeated VBN B-verb.social	every DT 0	3 CD B-adj.all	weeks NNS B-noun.time	) ) 0	determined VBN B-verb.communication	by IN 0	phase NN B-noun.time	I PRP 0	trial NN B-noun.person	. . 0	. . 0
a15338796.s13	Within IN 0	healthy JJ B-adj.all	adults NNS B-noun.event	no DT 0	age NN B-noun.person	- : 0	dependency NN B-noun.person	could MD 0	be VB 0	found VBN B-verb.possession	( ( 0	b NN 0	= SYM 0	0.262 CD 0	mm NN B-noun.quantity	/ CD 0	year NN B-noun.time	, , 0	P NNP 0	= SYM 0	0.72 CD 0	) ) 0	. . 0	. . 0
a12789195.s4	We PRP 0	present VBP B-verb.creation	a DT 0	patient NN B-noun.person	with IN 0	pseudoacromegaly NN B-noun.act	that WDT 0	resulted VBD B-verb.stative	from IN 0	the DT 0	long JJ B-noun.body	- : 0	term NN B-noun.time	use NN 0	of IN 0	minoxidil NN B-noun.time	at IN 0	an DT 0	unusually RB B-adj.all	high JJ B-adj.all	dose NN B-noun.quantity	. . 0	. . 0
a8558192.s1	PURPOSE NN B-noun.attribute	, , 0	To TO 0	evaluate VB B-verb.communication	the DT 0	response NN B-noun.communication	rate NN B-noun.time	and CC 0	toxic JJ B-adj.all	effects NNS B-noun.phenomenon	of IN 0	vinorelbine NN B-noun.phenomenon	( ( 0	VNB NNP 0	) ) 0	administered VBN B-verb.possession	as IN 0	a DT 0	single JJ B-adj.all	agent NN B-noun.person	in IN 0	metastatic JJ B-adj.all	squamous_cell_esophageal_carcinoma NNP B-noun.group	. . 0	. . 0
a15649445.s8	A DT 0	decreased JJ B-adj.all	glutamate NN B-noun.person	uptake NN B-noun.person	was VBD 0	observed VBN B-verb.perception	in IN 0	the DT 0	subcortical JJ B-adj.all	parts NNS B-noun.relation	of IN 0	animals NNS B-noun.person	treated VBN B-verb.social	with IN 0	reserpine NN B-noun.act	and CC 0	haloperidol NN B-noun.person	, , 0	compared VBN B-verb.cognition	to TO 0	the DT 0	control NN B-noun.act	. . 0	. . 0
a16938416.s3	Aortic JJ B-adj.all	atherosclerosis NN B-noun.event	was VBD 0	diagnosed VBN B-verb.communication	by IN 0	radiographic JJ B-noun.phenomenon	detection NN I-noun.phenomenon	of IN 0	calcified VBN B-verb.communication	deposits NNS B-noun.person	in IN 0	the DT 0	abdominal JJ B-adj.all	aorta NN B-noun.person	, , 0	which WDT 0	have VBP 0	been VBN 0	shown VBN B-verb.perception	to TO 0	reflect VB B-verb.perception	intima JJ B-adj.all	atherosclerosis NN 0	. . 0	. . 0
a16330293.s12	The DT 0	incidence NN B-noun.relation	of IN 0	adverse JJ B-adj.all	events NNS B-noun.person	in IN 0	the DT 0	2 CD B-adj.all	groups NNS B-noun.act	was VBD B-verb.stative	similar JJ B-adj.all	during IN 0	the DT 0	first JJ B-verb.competition	2 CD B-adj.all	weeks NNS B-noun.time	of IN 0	product NN B-noun.substance	use NN B-verb.consumption	( ( 0	evaluation NN 0	population NN 0	, , 0	55.3 CD 0	% NN 0	lozenge NN B-noun.attribute	, , 0	54.7 CD 0	% NN 0	gum NN 0	) ) 0	, , 0	as RB 0	well RB 0	as IN 0	during IN 0	the DT 0	entire JJ B-adj.all	study NN B-noun.cognition	( ( 0	safety NN 0	population NN B-noun.quantity	, , 0	63.8 CD 0	% NN 0	and CC 0	58.6 CD 0	% NN 0	, , 0	respectively RB B-adv.all	) ) 0	. . 0	. . 0
a19356053.s1	BACKGROUND NN 0	, , 0	Sirolimus NNP B-noun.person	is VBZ B-verb.stative	the DT 0	latest JJS B-adj.all	immunosuppressive JJ B-adj.all	agent NN B-noun.person	used VBN B-verb.consumption	to TO 0	prevent VB B-verb.emotion	rejection NN I-verb.emotion	, , 0	and CC 0	may MD 0	have VB B-verb.perception	less JJR B-noun.quantity	nephrotoxicity NN B-noun.attribute	than IN 0	calcineurin JJ B-adj.all	inhibitor NN B-noun.person	( ( 0	CNI)-based JJ B-adj.all	regimens NNS B-noun.artifact	. . 0	. . 0
a18752389.s11	To TO 0	our PRP$ 0	knowledge NN B-noun.artifact	, , 0	this DT 0	is VBZ B-verb.stative	the DT 0	first JJ B-noun.artifact	case NN I-noun.artifact	report NN B-noun.person	of IN 0	simvastatin NN B-noun.act	- : 0	ezetimibe NN B-noun.person	- : 0	induced VBN B-verb.creation	liver_failure NN B-noun.act	that WDT 0	resulted VBD B-verb.stative	in IN 0	liver NN 0	transplantation NN B-noun.act	. . 0	. . 0
a15572383.s8	Proteinuria NNP B-noun.person	was VBD 0	measured VBN B-verb.cognition	every DT 0	2 CD B-adj.all	weeks NNS B-noun.time	. . 0	. . 0
a16867021.s7	R)-alpha SYM 0	- : 0	methylhistamine NN B-noun.attribute	( ( 0	RAMH NNP B-noun.group	) ) 0	( ( 0	5 CD B-adj.all	microg NN B-noun.act	i.c.v NNP I-noun.act	. . 0	) ) 0	. . 0
a9390208.s17	The DT 0	MFL_regimen NNS B-noun.person	achieves VBZ B-adv.all	little RB I-adv.all	palliative JJ B-adj.all	benefit NN B-noun.attribute	and CC 0	induces NNS B-noun.act	severe JJ B-adj.all	toxicity NN B-noun.state	at IN 0	a DT 0	fairly RB B-adv.all	high JJ B-adj.all	rate NN B-noun.time	. . 0	. . 0
a3437726.s3	One CD 0	week NN 0	prior RB 0	to TO 0	admission VB B-verb.possession	a DT 0	therapy NN B-noun.person	with IN 0	standard JJ B-adj.all	doses NNS B-noun.event	of IN 0	metoprolol NN B-noun.cognition	( ( 0	100 CD 0	mg IN 0	t.i.d NNP B-noun.person	. . 0	. . 0
a6518066.s4	Cross NNP B-noun.person	- : 0	sectional JJ B-adj.all	echocardiographic JJ B-adj.all	screening NN B-noun.event	of IN 0	newborns NNS B-noun.animal	exposed VBN B-verb.perception	to TO 0	lithium NN 0	during IN 0	gestation NN B-noun.communication	can MD 0	provide VB B-verb.communication	highly RB B-adj.all	accurate JJ I-adj.all	, , 0	noninvasive JJ B-adj.all	assessment NN B-noun.person	of IN 0	the DT 0	presence NN B-noun.person	or CC 0	absence NN B-noun.act	of IN 0	lithium NN B-noun.substance	- : 0	induced VBN B-verb.creation	cardiac_malformations NNS B-noun.artifact	. . 0	. . 0
a9931093.s2	The DT 0	clinical JJ B-adj.all	utility NN B-noun.attribute	of IN 0	FK_506 NNP B-noun.person	is VBZ 0	complicated VBN B-verb.change	by IN 0	substantial JJ B-adj.all	hypertension NN B-noun.act	and CC 0	nephrotoxicity NN B-noun.person	. . 0	. . 0
a7977601.s1	PURPOSE NN B-noun.attribute	, , 0	We PRP 0	evaluated VBD B-verb.communication	the DT 0	safety NN B-noun.person	of IN 0	indocyanine_green CD 0	for IN 0	use NN 0	in IN 0	fundus NN 0	angiography NN 0	. . 0	. . 0
a10737864.s1	Under IN 0	controlled JJ B-adj.all	conditions NNS B-noun.person	, , 0	infant NN B-noun.person	rats NNS I-noun.person	emit VBP B-verb.stative	ultrasonic JJ B-adj.all	vocalizations NNS B-noun.artifact	during IN 0	extreme JJ B-adj.all	cold JJ B-adj.all	exposure NN B-noun.person	and CC 0	after IN 0	administration NN B-noun.time	of IN 0	the DT 0	alpha(2 NNP B-noun.location	) ) 0	adrenoceptor NN B-noun.quantity	agonist NN B-noun.person	, , 0	clonidine NN B-noun.person	. . 0	. . 0
a2578334.s3	The DT 0	results NNS B-noun.communication	obtained VBD B-verb.possession	indicate VBP B-verb.cognition	that IN 0	with IN 0	all DT 0	three CD B-adj.all	carcinogens NNS B-noun.artifact	, , 0	administration NN B-noun.person	of IN 0	5-AzC NN 0	during IN 0	repair NN B-noun.state	synthesis NN I-noun.state	increased VBD B-verb.change	the DT 0	incidence NN B-noun.event	of IN 0	initiated JJ B-adj.all	hepatocytes NNS B-noun.person	, , 0	for IN 0	example NN B-noun.communication	10 CD B-adj.all	- : 0	20 CD B-adj.all	foci NN B-noun.quantity	/ $ 0	cm2 CD 0	in IN 0	5-AzC NNP B-noun.other	and CC 0	carcinogen NN B-noun.person	- : 0	treated VBN B-verb.communication	rats NNS B-noun.person	compared VBN B-verb.change	with IN 0	3 SYM 0	- : 0	5 CD B-adj.all	foci NN B-noun.quantity	/ $ 0	cm2 CD 0	in IN 0	rats NNS B-noun.animal	treated VBN B-verb.change	with IN 0	carcinogen NN 0	only RB B-adv.all	. . 0	. . 0
a3437726.s0	Severe JJ B-adj.all	complications NNS B-noun.relation	of IN 0	antianginal JJ B-adj.all	drug NN B-noun.person	therapy NN 0	in IN 0	a DT 0	patient NN B-noun.person	identified VBN B-verb.cognition	as IN 0	a DT 0	poor JJ B-adj.all	metabolizer NN B-noun.person	of IN 0	metoprolol NN B-noun.food	, , 0	propafenone NN B-noun.person	, , 0	diltiazem NN B-noun.person	, , 0	and CC 0	sparteine NN B-noun.person	. . 0	. . 0
a20722491.s3	WHAT WP 0	THE DT 0	READER NN B-noun.group	WILL MD 0	GAIN VB B-verb.possession	, , 0	The DT 0	reader NN B-noun.person	will MD 0	gain VB B-verb.stative	better JJR B-adj.all	insight NN B-noun.act	into IN 0	the DT 0	safety NN B-noun.person	of IN 0	capecitabine NN B-noun.act	in IN 0	special JJ B-adj.all	populations NNS B-noun.state	such JJ 0	as IN 0	patients NNS B-noun.person	with IN 0	advanced VBN B-adj.all	age NN B-noun.person	, , 0	renal_and_kidney_disease NNP B-noun.person	. . 0	. . 0
a220563.s3	Improvement NN B-noun.person	was VBD 0	noted VBN B-verb.perception	with IN 0	cessation NN B-noun.act	of IN 0	therapy NN B-noun.act	. . 0	. . 0
a19346865.s0	Reversible JJ B-adj.all	inferior_colliculus_lesion NN B-noun.cognition	in IN 0	metronidazole NN B-noun.attribute	- : 0	induced VBN B-verb.creation	encephalopathy JJ B-adj.all	, , 0	magnetic JJ B-adj.all	resonance NN B-noun.phenomenon	findings NNS B-noun.act	on IN 0	diffusion NN B-noun.person	- : 0	weighted VBN B-verb.communication	and CC 0	fluid NN B-noun.person	attenuated VBD B-verb.emotion	inversion NN I-verb.emotion	recovery NN B-noun.process	imaging NN B-verb.creation	. . 0	. . 0
a19037603.s9	Two CD 0	of IN 0	these DT 0	normalized VBN B-verb.communication	and CC 0	the DT 0	others NNS 0	increased VBN B-verb.change	later RB B-adv.all	. . 0	. . 0
a20196116.s8	Most JJS 0	had VBD 0	hyperacute JJ B-adj.all	presentation NN B-noun.person	, , 0	the DT 0	median JJ B-adj.all	icterus NN B-noun.artifact	encephalopathy JJ B-adj.all	interval NN B-noun.person	was VBD B-verb.stative	4.5 CD 0	( ( 0	0 CD B-noun.quantity	- : 0	30 CD B-adj.all	) ) 0	days NNS B-noun.phenomenon	. . 0	. . 0
a234669.s6	When WRB 0	respiratory_failure NN B-noun.act	was VBD 0	produced VBN B-verb.creation	by IN 0	hypoventilation NN 0	( ( 0	pH $ 0	7.05 CD 0	to TO 0	7.25 CD 0	, , 0	PC02 JJ 0	70 CD B-adj.all	to TO 0	100 CD 0	mm NN B-noun.quantity	Hg NNP 0	, , 0	P02 JJ 0	20 CD B-adj.all	to TO 0	40 CD B-adj.all	mm NN B-noun.quantity	Hg NNP 0	) ) 0	, , 0	infusion NN B-noun.cognition	of IN 0	aminophylline NN B-noun.person	resulted VBD B-verb.communication	in IN 0	an DT 0	even RB B-adv.all	greater JJR B-adj.all	decrease NN B-noun.state	in IN 0	ventricular_fibrillation NN 0	threshold VBD B-verb.communication	to TO 0	60 CD B-adj.all	percent NN B-noun.quantity	of IN 0	the DT 0	control NN B-noun.state	level NN B-noun.state	. . 0	. . 0
a9862868.s0	Different JJ B-adj.all	lobular NN B-noun.event	distributions NNS B-noun.process	of IN 0	altered JJ B-adj.all	hepatocyte NN B-noun.person	tight JJ B-adj.all	junctions NNS B-noun.object	in IN 0	rat NN 0	models NNS 0	of IN 0	intrahepatic_and_extrahepatic_cholestasis NN B-noun.food	. . 0	. . 0
a9351491.s2	Previous JJ B-adj.all	clinical JJ B-adj.all	studies NNS B-noun.group	have VBP 0	proposed VBN B-verb.cognition	that IN 0	risperidone NN 0	's POS 0	pharmacologic JJ B-adj.all	profile NN B-noun.possession	may MD 0	produce VB B-verb.change	improved JJ B-adj.all	efficacy NN B-noun.person	for IN 0	negative JJ B-adj.all	psychotic_symptoms NNS B-noun.plant	and CC 0	decreased VBD B-verb.communication	propensity NN B-noun.person	for IN 0	extrapyramidal JJ B-adj.all	side NN B-noun.location	effects NNS B-noun.phenomenon	, , 0	features NNS B-noun.body	shared VBN B-verb.stative	by IN 0	so RB B-adv.all	- : 0	called VBN B-verb.communication	' POS 0	atypical JJ B-adj.all	' '' 0	neuroleptics NNS B-noun.person	. . 0	. . 0
a322550.s0	Pulmonary JJ B-adj.all	shunt NN B-noun.artifact	and CC 0	cardiovascular JJ B-adj.all	responses NNS B-noun.act	to TO 0	CPAP VB 0	during IN 0	nitroprusside SYM 0	- : 0	induced VBN B-verb.creation	hypotension NN 0	. . 0	. . 0
a9587734.s2	Five CD B-adj.all	days NNS B-noun.phenomenon	after IN 0	the DT 0	onset NN B-noun.event	of IN 0	the DT 0	symptoms NNS B-noun.location	of IN 0	meningitis NN B-noun.food	, , 0	the DT 0	patient NN B-noun.person	aspirated VBD B-verb.communication	stomach NN B-noun.person	contents NNS B-noun.group	and CC 0	needed VBD B-verb.consumption	endotracheal JJ B-adj.all	intubation NN B-noun.act	. . 0	. . 0
a16858720.s2	METHODS NNS B-noun.attribute	, , 0	All DT 0	patients NNS B-noun.person	with IN 0	a DT 0	diagnosed VBN B-verb.consumption	cerebral_haemorrhage NN 0	at IN 0	three CD 0	hospitals NNS B-noun.artifact	during IN 0	the DT 0	period NN B-noun.time	2000 CD 0	- : 0	2002 CD 0	were VBD 0	identified VBN B-verb.cognition	. . 0	. . 0
a16005948.s0	Evaluation NNP B-noun.person	of IN 0	the DT 0	anticocaine JJ B-adj.all	monoclonal JJ B-adj.all	antibody NN 0	GNC92H2 NN 0	as IN 0	an DT 0	immunotherapy NN B-noun.act	for IN 0	cocaine_overdose NN 0	. . 0	. . 0
a3865016.s0	Interaction NN B-noun.act	of IN 0	cyclosporin NN B-noun.person	A DT 0	with IN 0	antineoplastic JJ B-adj.all	agents NNS B-noun.person	. . 0	. . 0
a16403073.s0	Ketoconazole NNP B-noun.person	induced VBD B-verb.creation	torsades_de_pointes NNS B-noun.time	without IN 0	concomitant JJ B-adj.all	use NN 0	of IN 0	QT NNP 0	interval NN 0	- : 0	prolonging VBG B-verb.communication	drug NN B-noun.person	. . 0	. . 0
a18417364.s4	NIN NNP B-noun.person	correlated VBD B-verb.communication	with IN 0	blood NN B-noun.act	oxygen NN B-noun.attribute	level NN I-noun.attribute	- : 0	dependent JJ B-verb.creation	( ( 0	BOLD NNP B-noun.group	) ) 0	activity NN B-noun.state	levels NNS B-noun.state	in IN 0	a DT 0	midpontine NN B-noun.body	site NN 0	in IN 0	the DT 0	posterior JJ B-adj.all	basis NN B-noun.cognition	pontis NN I-noun.cognition	. . 0	. . 0
a3503576.s7	Based VBN B-verb.cognition	on IN 0	these DT 0	data NNS B-noun.cognition	, , 0	a DT 0	plan NN B-noun.cognition	of IN 0	management NN B-noun.person	was VBD 0	developed VBN B-verb.creation	that DT 0	allows VBZ B-verb.social	effective JJ I-verb.social	yet RB 0	safe JJ B-adj.all	administration NN B-noun.time	of IN 0	deferoxamine NN B-noun.act	. . 0	. . 0
a11263551.s4	Bone NN 0	scans NNS B-noun.person	showed VBD B-verb.communication	an DT 0	increased VBN B-adj.all	tracer NN B-noun.artifact	uptake NN B-noun.act	of IN 0	the DT 0	foot NN B-noun.body	bones NNS I-noun.body	. . 0	. . 0
a18186898.s8	Proximal JJ B-adj.all	muscle_weakness NN B-noun.attribute	has VBZ 0	developed VBN B-verb.creation	during IN 0	her PRP$ 0	follow NN B-noun.body	- : 0	up RB B-adv.all	. . 0	. . 0
a18544179.s2	Fentanyl NNP B-noun.person	is VBZ B-verb.stative	a DT 0	commonly RB B-adv.all	used VBN B-verb.consumption	supplement NN B-noun.artifact	that WDT 0	may MD 0	contribute VB B-verb.cognition	to TO 0	this DT 0	, , 0	although IN 0	it PRP 0	may MD 0	also RB B-adv.all	improve VB B-verb.creation	analgesia NN I-verb.creation	. . 0	. . 0
a9390208.s1	For IN 0	previously RB B-adv.all	treated VBN B-verb.social	advanced VBD B-verb.communication	breast_cancer NN B-noun.person	, , 0	there EX 0	is VBZ B-verb.stative	no DT 0	standard JJ B-adj.all	second JJ B-noun.act	- : 0	line NN B-noun.act	therapy NN B-noun.act	. . 0	. . 0
a15275829.s6	Using VBG B-verb.consumption	in IN 0	situ NN 0	hybridization NN 0	probes NNS B-noun.person	for IN 0	the DT 0	alpha3 NN B-noun.artifact	and CC 0	alpha5 JJ B-adj.all	subunits NNS B-noun.person	, , 0	we PRP 0	showed VBD B-verb.communication	that IN 0	alpha5 RB B-adv.all	mRNA JJ B-adj.all	levels NNS B-noun.state	are VBP B-verb.stative	unchanged JJ B-adj.all	, , 0	whereas IN 0	alpha3 JJ B-noun.person	mRNA JJ I-noun.person	levels NNS I-noun.person	are VBP 0	selectively RB B-adv.all	decreased VBN B-verb.change	in IN 0	the DT 0	mitral JJ B-adj.all	cell NN B-noun.person	layer NN I-noun.person	of IN 0	the DT 0	olfactory JJ B-adj.all	bulb NN B-noun.person	, , 0	and CC 0	the DT 0	inferior JJ B-adj.all	and CC 0	the DT 0	superior JJ B-adj.all	colliculus NN B-noun.attribute	of IN 0	beta4 RB 0	-/- JJ 0	brains NNS B-noun.person	. . 0	. . 0
a1592014.s0	Seizures NNS B-noun.person	induced VBN B-verb.creation	by IN 0	the DT 0	cocaine NN 0	metabolite NN 0	benzoylecgonine NN 0	in IN 0	rats NNS B-noun.animal	. . 0	. . 0
a10669626.s12	In IN 0	the DT 0	current JJ B-adj.all	study NN B-noun.artifact	, , 0	we PRP 0	investigated VBD B-verb.communication	the DT 0	synergy NN B-noun.attribute	between IN 0	these DT 0	2 CD B-adj.all	treatments NNS B-noun.plant	and CC 0	found VBD B-verb.communication	that IN 0	concurrent JJ B-noun.person	Warfarin NNP I-noun.person	administration NN B-noun.feeling	dramatically RB B-adv.all	increased VBD B-verb.change	the DT 0	extent NN B-noun.attribute	of IN 0	calcification NN B-noun.communication	in IN 0	the DT 0	media NNS B-noun.location	of IN 0	vitamin NN 0	D NNP 0	- : 0	treated VBN B-verb.communication	rats NNS B-noun.person	at IN 0	3 CD B-adj.all	and CC 0	4 CD B-adj.all	days NNS B-noun.phenomenon	. . 0	. . 0
a18821488.s8	Myoglobinuria NNP B-noun.person	was VBD 0	also RB B-adv.all	observed VBD B-verb.perception	following VBG B-verb.stative	the DT 0	7.0 CD 0	mg FW B-noun.quantity	/ FW 0	kg FW 0	dose FW 0	. . 0	. . 0
a2425813.s0	On IN 0	two CD 0	paradoxical JJ B-adj.all	side NN B-noun.group	- : 0	effects NNS B-noun.phenomenon	of IN 0	prednisolone NN B-noun.substance	in IN 0	rats NNS B-noun.animal	, , 0	ribosomal JJ 0	RNA NNP 0	biosyntheses NNS B-noun.animal	, , 0	and CC 0	a DT 0	mechanism NN B-noun.object	of IN 0	action NN B-noun.process	. . 0	. . 0
a15325671.s10	Routine NNP 0	EKG NNP 0	monitoring NN B-verb.perception	during IN 0	infusional JJ B-adj.all	cyclophosphamide NN B-noun.group	did VBD 0	not RB B-adv.all	predict VB B-verb.creation	CHF NNP 0	development NN B-noun.process	. . 0	. . 0
a15737522.s0	Ceftriaxone NN B-noun.person	- : 0	associated VBN B-verb.cognition	biliary_pseudolithiasis CD 0	in IN 0	paediatric JJ B-adj.all	surgical JJ B-adj.all	patients NNS B-noun.person	. . 0	. . 0
a9522143.s6	The DT 0	average JJ B-adj.all	hearing_loss NN B-noun.person	for IN 0	speech NN B-noun.act	frequencies NNS B-noun.person	was VBD B-verb.stative	about IN 0	10 CD B-adj.all	dB CD B-noun.quantity	after IN 0	prilocaine NN B-noun.person	and CC 0	15 CD B-adj.all	dB CD B-noun.quantity	after IN 0	bupivacaine NN B-noun.person	. . 0	. . 0
a16330293.s7	RESULTS NNS B-noun.artifact	, , 0	Nine CD B-adj.all	hundred CD 0	one CD 0	patients NNS B-noun.person	were VBD 0	randomized VBN B-verb.perception	to TO 0	treatment NN B-noun.communication	, , 0	447 CD 0	who WP 0	received VBD B-verb.possession	the DT 0	lozenge NN B-noun.artifact	and CC 0	454 CD 0	who WP 0	received VBD B-verb.possession	the DT 0	gum NN 0	( ( 0	safety NN 0	population NN B-noun.quantity	) ) 0	. . 0	. . 0
a18754075.s0	Massive JJ B-adj.all	proteinuria NN B-noun.person	and CC 0	acute_renal_failure NN B-noun.act	after IN 0	oral JJ B-adj.all	bisphosphonate NN B-noun.cognition	( ( 0	alendronate VB 0	) ) 0	administration NN B-noun.quantity	in IN 0	a DT 0	patient NN B-noun.person	with IN 0	focal_segmental_glomerulosclerosis NN B-noun.food	. . 0	. . 0
a16330293.s11	The DT 0	nicotine JJ B-adj.all	lozenge NN B-noun.attribute	and CC 0	nicotine NN B-noun.person	gum NN B-noun.person	were VBD B-verb.stative	equally RB B-adv.all	well RB 0	tolerated VBN 0	, , 0	despite IN 0	increased VBN B-verb.change	nicotine JJ B-adj.all	exposure NN B-noun.person	from IN 0	the DT 0	lozenge NN B-noun.artifact	. . 0	. . 0
a16740173.s13	The DT 0	patient NN B-noun.person	was VBD 0	extubated VBN B-verb.consumption	1 CD B-adj.all	week NN 0	later RB B-adv.all	. . 0	. . 0
a3800626.s5	Decompression NNP B-noun.person	and CC 0	neurolysis NN B-noun.person	were VBD 0	performed VBN B-verb.social	with IN 0	good JJ 0	subsequent JJ B-adj.all	recovery NN B-noun.act	of IN 0	function NN B-noun.act	. . 0	. . 0
a8595686.s5	Loss_of_consciousness NN B-noun.attribute	occurred VBD B-verb.cognition	in IN 0	60 CD B-adj.all	- : 0	90 CD B-adj.all	sec NN B-noun.time	. . 0	. . 0
a19445921.s7	In IN 0	addition NN 0	, , 0	mitochondrial JJ B-adj.all	respiratory_dysfunction NN B-noun.act	characterized VBN B-verb.stative	by IN 0	decreased VBN B-verb.change	respiratory JJ B-adj.all	control NN B-noun.act	ratio NN I-noun.act	and CC 0	ADP NNP 0	/ ( 0	O NNP 0	was VBD 0	observed VBN B-verb.perception	in IN 0	isoproterenol NN B-noun.act	- : 0	treated VBN B-verb.communication	rats NNS B-noun.person	. . 0	. . 0
a2572625.s4	This DT 0	observation NN B-noun.group	shows VBZ B-verb.cognition	that IN 0	clotiazepam NN B-noun.person	can MD 0	induce VB B-verb.cognition	acute JJ B-adj.all	hepatitis NN B-noun.food	and CC 0	suggests VBZ B-verb.communication	that IN 0	there EX 0	is VBZ B-verb.stative	no DT 0	cross NN 0	hepatotoxicity NN 0	between IN 0	clotiazepam NN B-noun.person	and CC 0	several JJ B-noun.body	benzodiazepines NNS I-noun.body	. . 0	. . 0
a16904497.s5	INTERVENTION NN B-noun.group	AND CC 0	OUTCOME NNP 0	, , 0	An DT 0	18-gauge JJ 0	Touhy NNP B-noun.person	needle NN I-noun.person	was VBD 0	inserted VBN B-verb.contact	until IN 0	loss NN B-noun.process	of IN 0	resistance NN B-noun.phenomenon	occurred VBD B-verb.change	at IN 0	the DT 0	L4 SYM 0	- : 0	5 CD B-adj.all	level NN B-noun.act	. . 0	. . 0
a2355241.s0	Cause NN B-noun.act	of IN 0	death NN B-noun.phenomenon	among IN 0	patients NNS B-noun.person	with IN 0	Parkinson's_disease NNP B-noun.person	, , 0	a DT 0	rare JJ B-adj.all	mortality NN 0	due JJ 0	to TO 0	cerebral_haemorrhage NN 0	. . 0	. . 0
a12589964.s20	Analysis NN 0	of IN 0	data NNS B-noun.cognition	revealed VBD B-verb.communication	a DT 0	significant JJ B-adj.all	correlation NN B-noun.cognition	between IN 0	maximal JJ B-adj.all	cTnT NN B-noun.person	and CC 0	ED NNP 0	and CC 0	ES NNP 0	LV NNP 0	diameters NNS 0	/ IN 0	BW NNP 0	( ( 0	r=0.81 JJ 0	and CC 0	0.65 CD 0	, , 0	p<0.0001 NNP 0	) ) 0	. . 0	. . 0
a11007689.s9	Introduction NN 0	of IN 0	tacrolimus NN B-noun.animal	as IN 0	an DT 0	alternative JJ B-adj.all	immunosuppressive JJ B-adj.all	agent NN B-noun.person	resulted VBD B-verb.social	in IN 0	the DT 0	recurrence NN B-noun.act	of IN 0	TMA NNP B-noun.group	and CC 0	the DT 0	subsequent JJ B-adj.all	loss NN B-noun.process	of IN 0	the DT 0	renal JJ B-adj.all	allograft NN B-noun.act	. . 0	. . 0
a234669.s7	These DT 0	experiments NNS B-noun.person	suggest VBP B-verb.communication	that IN 0	although IN 0	many JJ 0	factors NNS B-noun.person	may MD 0	contribute VB B-verb.cognition	to TO 0	the DT 0	increased VBN B-verb.change	incidence NN B-noun.attribute	of IN 0	ventricular_arrhythmias NNS B-noun.food	in IN 0	respiratory_failure NN B-noun.other	, , 0	pharmacologic JJ B-adj.pert	agents NNS B-noun.person	, , 0	particularly RB B-adv.all	aminophylline JJ B-adj.all	, , 0	may MD 0	play VB B-verb.creation	a DT 0	significant JJ B-adj.all	role NN B-noun.attribute	. . 0	. . 0
a11206082.s3	Our PRP$ 0	aim NN B-noun.artifact	was VBD B-verb.stative	to TO 0	characterize VB B-verb.cognition	both DT 0	lines NNS B-noun.group	' POS 0	sensitivities NNS B-noun.person	to TO 0	various JJ B-adj.all	physiological JJ B-adj.pert	effects NNS B-noun.phenomenon	of IN 0	other JJ 0	ligands NNS B-noun.person	of IN 0	the DT 0	GABA(A NN B-noun.artifact	) ) 0	receptor NN B-noun.quantity	. . 0	. . 0
a9862868.s11	This DT 0	study NN B-noun.communication	is VBZ B-verb.stative	the DT 0	first JJ B-adj.all	to TO 0	demonstrate VB B-verb.communication	that DT 0	impairment NN B-noun.state	of IN 0	hepatocyte NN B-noun.person	TJs NNP I-noun.person	occurs VBZ B-verb.competition	heterogenously RB I-verb.competition	in IN 0	the DT 0	liver NN B-noun.possession	lobule NN I-noun.possession	after IN 0	BDL NNP B-noun.group	and CC 0	suggests VBZ B-verb.communication	that IN 0	BDL NNP 0	and CC 0	EE NNP 0	treatments NNS B-noun.plant	produce VBP B-verb.stative	different JJ B-adj.all	lobular NN B-noun.body	distributions NNS B-noun.process	of IN 0	increased VBN B-verb.change	paracellular JJ B-adj.all	permeability NN B-noun.person	. . 0	. . 0
a7083920.s2	His PRP$ 0	bundle NN B-noun.person	recordings NNS B-noun.person	showed VBD B-verb.communication	an DT 0	atrial_tachycardia NNP B-noun.person	with IN 0	intermittent JJ B-adj.all	exit NN B-noun.artifact	block NN B-noun.person	and CC 0	greatly RB B-adv.all	prolonged VBN B-verb.change	BH NNP 0	and CC 0	HV NNP 0	intervals NNS 0	( ( 0	40 CD B-adj.all	and CC 0	100 CD 0	msec NN B-noun.quantity	, , 0	respectively RB B-adv.all	) ) 0	. . 0	. . 0
a18186898.s5	Lamivudine NN 0	was VBD 0	added VBN B-verb.change	because IN 0	of IN 0	de FW 0	nova FW 0	hepatitis_B_infection NN 0	during IN 0	her PRP$ 0	follow NN B-noun.body	- : 0	up RB B-adv.all	. . 0	. . 0
a150790.s7	Metabolic JJ B-adj.all	studies NNS B-noun.group	suggested VBD B-verb.communication	a DT 0	block NN B-noun.person	in IN 0	the DT 0	kynurenine NN B-noun.artifact	pathway NN B-noun.artifact	of IN 0	tryptophan JJ B-adj.all	metabolism NN B-noun.artifact	. . 0	. . 0
a15859940.s1	OBJECTIVES NNS B-noun.artifact	, , 0	Thrombotic_microangiopathy JJ 0	is VBZ B-verb.stative	a DT 0	well RB 0	- : 0	known VBN B-verb.cognition	problem NN B-noun.person	in IN 0	patients NNS B-noun.artifact	following VBG B-verb.stative	renal JJ B-adj.all	transplantation NN B-noun.act	. . 0	. . 0
a12653683.s8	Sodium NN B-noun.person	retention NN B-noun.person	occurred VBD B-verb.cognition	on IN 0	days NNS B-noun.time	2 CD 0	, , 0	3 CD B-adj.all	and CC 0	6 CD B-adj.all	after IN 0	PAN NNP B-noun.group	injection NN B-noun.act	. . 0	. . 0
a17562951.s5	Secondary JJ B-adj.all	outcomes NNS B-noun.event	were VBD B-verb.stative	a DT 0	postdose JJ B-adj.all	SCr NNP B-noun.other	increase NN B-noun.event	> : 0	or CC 0	= $ 0	25 CD B-adj.all	% NN 0	, , 0	a DT 0	postdose NN B-noun.person	estimated VBD B-verb.cognition	glomerular JJ B-adj.all	filtration NN B-noun.process	rate NN B-noun.time	decrease NN B-noun.process	of IN 0	> CD 0	or CC 0	= $ 0	25 CD B-adj.all	% NN 0	, , 0	and CC 0	the DT 0	mean JJ B-adj.all	peak JJ B-adj.all	change NN B-noun.artifact	in IN 0	SCr NNP B-noun.person	. . 0	. . 0
a18821488.s11	It PRP 0	is VBZ 0	concluded VBN B-verb.cognition	that IN 0	WR242511 NN B-noun.location	should MD 0	not RB 0	be VB 0	pursued VBN B-verb.social	as IN 0	a DT 0	pretreatment NN B-noun.person	for IN 0	CN NNP 0	poisoning VBG B-verb.communication	unless IN 0	the DT 0	anti NNS B-noun.person	- : 0	CN NN 0	characteristics NNS 0	of IN 0	this DT 0	compound NN B-noun.communication	can MD 0	be VB 0	successfully RB B-adv.all	dissociated VBN B-verb.cognition	from IN 0	those DT 0	producing VBG B-verb.creation	undesirable JJ B-adj.all	toxicity NN B-noun.attribute	. . 0	. . 0
a2385256.s2	The DT 0	serum NN B-noun.body	magnesium NN I-noun.body	concentration NN B-noun.event	was VBD B-verb.stative	3.0 CD 0	mEq CD 0	/ IN 0	L NNP B-noun.quantity	, , 0	which WDT 0	is VBZ B-verb.stative	usually RB B-adv.all	well RB 0	tolerated VBN 0	. . 0	. . 0
a20633755.s0	Suxamethonium NN 0	induced VBN B-verb.creation	prolonged JJ B-adj.all	apnea NN B-noun.person	in IN 0	a DT 0	patient NN B-noun.person	receiving VBG B-verb.body	electroconvulsive JJ B-adj.all	therapy NN B-noun.person	. . 0	. . 0
a2054792.s4	Whole JJ B-adj.all	body NN 0	hyperthermia NN 0	( ( 0	120 CD 0	min NN 0	at IN 0	41.5 CD 0	degrees NNS B-noun.quantity	C NNP 0	) ) 0	enhanced VBD B-verb.change	both DT 0	Adriamycin NNP B-noun.person	- : 0	mediated VBN B-verb.cognition	antitumor NN B-noun.attribute	activity NN B-noun.process	and CC 0	toxic JJ B-adj.all	side NN B-noun.body	effects NNS B-noun.phenomenon	. . 0	. . 0
a9812111.s3	For IN 0	the DT 0	subsequent JJ B-adj.all	6-week JJ 0	double JJ B-adj.all	- : 0	blind JJ B-adj.all	crossover NN B-noun.state	phase NN B-noun.time	( ( 0	phase NN 0	B NNP 0	) ) 0	, , 0	patients NNS B-noun.person	taking VBG B-verb.social	standard- JJ I-verb.social	or CC 0	low JJ B-adj.all	- : 0	dose NN 0	haloperidol NN 0	were VBD 0	switched VBN B-verb.motion	to TO 0	placebo VB B-verb.cognition	, , 0	and CC 0	patients NNS B-noun.person	taking VBG B-verb.social	placebo NN B-noun.plant	were VBD B-verb.stative	randomly RB B-adv.all	assigned VBN B-verb.social	to TO 0	standard- VB B-verb.motion	or CC 0	low JJ B-adj.all	- : 0	dose NN 0	haloperidol NN 0	. . 0	. . 0
a8387218.s6	A DT 0	positive JJ B-adj.all	weight NN B-noun.artifact	response NN I-noun.artifact	was VBD 0	seen VBN B-verb.perception	in IN 0	16 CD B-adj.all	% NN 0	of IN 0	patients NNS B-noun.person	. . 0	. . 0
a6747681.s1	Because IN 0	of IN 0	the DT 0	rapid JJ B-adj.all	systemic JJ B-adj.all	clearance NN B-noun.attribute	of IN 0	BCNU NNP B-noun.group	( ( 0	1,3-bis-(2-chloroethyl)-1-nitrosourea JJ 0	) ) 0	, , 0	intra JJ B-adj.all	- : 0	arterial JJ B-adj.all	administration NN B-noun.feeling	should MD 0	provide VB B-verb.stative	a DT 0	substantial JJ B-adj.all	advantage NN 0	over IN 0	intravenous JJ B-adj.all	administration NN B-noun.person	for IN 0	the DT 0	treatment NN B-noun.communication	of IN 0	malignant_gliomas NNS B-noun.other	. . 0	. . 0
a2515254.s4	No DT 0	early JJ B-adj.all	onset NN B-noun.event	migraine NN 0	was VBD 0	observed VBN B-verb.perception	. . 0	. . 0
a7234705.s3	In IN 0	the DT 0	remaining VBG B-verb.stative	three CD 0	patients NNS B-noun.person	, , 0	procainamide NN B-noun.person	was VBD 0	administered VBN B-verb.possession	orally RB B-adv.all	for IN 0	treatment NN B-noun.act	of IN 0	chronic JJ B-adj.pert	premature_ventricular_contractions NNS B-noun.state	or CC 0	atrial_flutter JJR B-adj.all	. . 0	. . 0
a16274958.s3	To TO 0	our PRP$ 0	knowledge NN B-noun.artifact	, , 0	this DT 0	is VBZ B-verb.stative	the DT 0	first JJ B-noun.artifact	case NN I-noun.artifact	of IN 0	acitretin NN B-noun.person	- : 0	induced VBN B-verb.creation	dysphonia NN B-noun.artifact	. . 0	. . 0
a14596845.s4	Locomotor NNP B-noun.person	activity NN I-noun.person	was VBD 0	measured VBN B-verb.cognition	again RB 0	for IN 0	30 CD B-adj.all	min NN B-noun.quantity	at IN 0	the DT 0	beginning NN B-noun.cognition	of IN 0	days NNS B-noun.time	1 CD 0	and CC 0	21 CD 0	of IN 0	sugar NN B-noun.phenomenon	access NN B-noun.process	. . 0	. . 0
a20098969.s0	Oral JJ B-noun.body	manifestations NNS I-noun.body	of IN 0	" : 0	meth_mouth RB 0	" RB 0	, , 0	a DT 0	case NN B-noun.state	report NN B-noun.communication	. . 0	. . 0
a7802851.s5	Treatment NN B-noun.person	was VBD B-verb.stative	from IN 0	weeks NNS B-noun.time	0 CD 0	to TO 0	8 CD B-adj.all	and CC 0	was VBD 0	then RB B-adv.all	tapered VBN B-verb.possession	from IN 0	weeks NNS B-noun.time	8 CD 0	to TO 0	16 CD B-adj.all	. . 0	. . 0
a19058010.s0	Effect NN 0	of IN 0	green_tea NN B-noun.food	and CC 0	vitamin NN 0	E NN 0	combination NN 0	in IN 0	isoproterenol NN 0	induced VBN B-verb.creation	myocardial_infarction NN B-noun.process	in IN 0	rats NNS B-noun.animal	. . 0	. . 0
a16858720.s8	A DT 0	warfarin NN B-noun.communication	- : 0	drug NN 0	interaction NN 0	could MD 0	have VB 0	contributed VBN B-verb.communication	to TO 0	the DT 0	haemorrhage NN B-noun.food	in IN 0	24 CD B-adj.all	( ( 0	41 CD 0	% NN 0	) ) 0	of IN 0	the DT 0	warfarin NN B-noun.location	patients NNS B-noun.person	and CC 0	in IN 0	7 CD 0	of IN 0	these DT 0	( ( 0	12 CD B-adj.all	% NN 0	) ) 0	the DT 0	bleeding VBG B-verb.contact	complication NN B-noun.person	was VBD 0	considered VBN B-verb.cognition	being VBG B-verb.stative	possible JJ B-adj.all	to TO 0	avoid VB B-verb.social	. . 0	. . 0
a2224762.s1	A DT 0	Phase NN B-noun.person	I PRP 0	study NN B-verb.cognition	of IN 0	intravenous JJ B-adj.all	( ( 0	IV NNP 0	) ) 0	bolus FW 0	4'-0-tetrahydropyranyladriamycin FW 0	( ( 0	Pirarubicin NNP 0	) ) 0	was VBD 0	done VBN B-verb.social	in IN 0	55 CD 0	patients NNS B-noun.person	in IN 0	good JJ B-adj.all	performance NN B-noun.person	status NN B-noun.person	with IN 0	refractory JJ B-adj.all	tumors NNS B-noun.person	. . 0	. . 0
a11706060.s1	Highly RB B-adv.all	active JJ B-adj.all	antiretroviral JJ B-adj.all	therapy NN B-noun.cognition	( ( 0	HAART NNP 0	) ) 0	is VBZ 0	implicated VBN B-verb.change	in IN 0	cardiomyopathy JJ B-adj.all	( ( 0	CM NNP 0	) ) 0	and CC 0	in IN 0	elevated JJ B-adj.all	plasma NN B-noun.person	lactate NN B-noun.person	( ( 0	LA NNP 0	) ) 0	in IN 0	AIDS NNP B-verb.social	through IN 0	mechanisms NNS B-noun.person	of IN 0	mitochondrial_dysfunction NN B-noun.act	. . 0	. . 0
a20667451.s8	At IN 0	the DT 0	end NN B-noun.time	of IN 0	study NN B-noun.artifact	period NN B-noun.person	, , 0	serum NN 0	phenobarbitone NN 0	and CC 0	carbamazepine NN B-noun.person	, , 0	whole JJ B-adj.all	brain NN B-noun.person	malondialdehyde NN B-noun.person	and CC 0	reduced VBD B-verb.change	glutathione NN 0	levels NNS B-noun.attribute	were VBD 0	estimated VBN B-verb.cognition	. . 0	. . 0
a20098969.s11	Dental JJ B-adj.all	practitioners NNS B-noun.person	also RB B-adv.all	may MD 0	be VB B-verb.stative	skeptical JJ B-adj.all	about IN 0	the DT 0	reliability NN B-noun.state	of IN 0	appointment NN B-noun.person	keeping VBG B-verb.stative	by IN 0	these DT 0	patients NNS B-noun.person	, , 0	as IN 0	they PRP 0	frequently RB B-adv.all	miss VBP B-verb.stative	their PRP$ 0	appointments NNS B-noun.artifact	without IN 0	reasonable JJ B-adj.all	justification NN B-noun.person	. . 0	. . 0
a18791946.s2	A DT 0	30-year JJ 0	old JJ B-adj.all	Caucasian JJ B-adj.all	man NN 0	reported VBN B-verb.communication	with IN 0	abdominal_pain NN B-noun.food	and CC 0	jaundice NN B-noun.act	after IN 0	3-day JJ B-noun.time	administration NN B-noun.time	of IN 0	oral JJ B-adj.all	ciprofloxacin NN B-noun.person	for IN 0	a DT 0	suspect NN 0	of IN 0	urinary_tract_infection NN B-noun.act	. . 0	. . 0
a11773892.s2	Their PRP$ 0	use NN 0	in IN 0	orthotopic JJ B-adj.all	liver NN B-noun.relation	transplantation NN I-noun.relation	( ( 0	OLTX NNP 0	) ) 0	has VBZ 0	dramatically RB B-adv.all	improved VBD B-verb.change	success NN B-noun.process	rates NNS B-noun.time	. . 0	. . 0
a10526274.s4	METHODS NNS B-noun.attribute	, , 0	Forty NNP B-noun.person	- : 0	nine CD B-adj.all	patients NNS B-noun.person	with IN 0	advanced JJ B-adj.all	NSCLC NNP B-noun.group	were VBD 0	included VBN B-verb.stative	, , 0	38 CD 0	of IN 0	whom WP 0	were VBD B-verb.stative	age NN B-noun.person	> : 0	/= $ 0	70 CD B-adj.all	years NNS B-noun.time	and CC 0	11 CD B-noun.quantity	were VBD B-verb.stative	age NN B-noun.relation	< $ 0	70 CD B-adj.all	years NNS B-noun.quantity	but CC 0	who WP 0	had VBD B-verb.perception	some DT 0	contraindication NN 0	to TO 0	receiving VBG B-verb.perception	cisplatin NN I-verb.perception	. . 0	. . 0
a17437408.s9	No DT 0	such JJ 0	obvious JJ B-adj.all	upregulation NN B-noun.location	of IN 0	Pgp NNP B-noun.person	was VBD 0	observed VBN B-verb.perception	in IN 0	liver NN B-noun.animal	sections NNS B-noun.object	. . 0	. . 0
a18186898.s1	Advances NNS B-noun.person	in IN 0	the DT 0	field NN B-noun.cognition	of IN 0	transplantation NN B-noun.act	provide VBP B-verb.stative	a DT 0	better JJR B-adj.all	quality NN B-noun.state	of IN 0	life NN B-noun.person	and CC 0	allow VB B-verb.possession	more RBR B-adv.all	favorable JJ B-adj.all	conditions NNS B-noun.communication	for IN 0	growth NN 0	and CC 0	development NN B-noun.person	in IN 0	children NNS B-noun.animal	. . 0	. . 0
a16330293.s6	Safety NN B-noun.person	assessments NNS I-noun.person	were VBD 0	made VBN B-verb.social	at IN 0	baseline NN B-noun.act	and CC 0	at IN 0	2 CD B-adj.all	, , 0	4 CD B-adj.all	, , 0	6 CD B-adj.all	, , 0	and CC 0	12 CD B-adj.all	weeks NNS B-noun.time	after IN 0	the DT 0	start NN B-noun.attribute	of IN 0	product NN B-noun.artifact	use NN I-noun.artifact	. . 0	. . 0
a20080983.s5	For IN 0	comparison NN B-noun.relation	of IN 0	sleep JJ B-adj.all	architecture NN B-noun.act	variables NNS B-noun.cognition	, , 0	12 CD B-adj.all	healthy JJ B-adj.all	comparison NN B-noun.person	participants NNS B-noun.person	underwent VBD B-verb.social	a DT 0	single JJ B-adj.all	night NN B-noun.time	of IN 0	experimental JJ B-adj.all	polysomnography NN B-noun.cognition	that WDT 0	followed VBD B-verb.stative	1 CD B-adj.all	night NN B-noun.time	of IN 0	accommodation NN B-noun.artifact	polysomnography NN I-noun.artifact	. . 0	. . 0
a1616457.s4	In IN 0	Group NNP 0	2 CD 0	the DT 0	rats NNS B-noun.plant	were VBD 0	trained VBN B-verb.cognition	to TO 0	approach VB B-verb.social	different JJ B-adj.all	shelves NNS B-noun.artifact	in IN 0	different JJ B-adj.all	drug NN B-noun.artifact	states NNS B-noun.location	. . 0	. . 0
a17600377.s7	Taking VBG 0	these DT 0	in IN 0	vitro NN B-noun.animal	and CC 0	in IN 0	vivo JJ B-adj.all	results NNS B-noun.location	together RB B-adv.all	, , 0	our PRP$ 0	study NN B-noun.artifact	suggests VBZ B-verb.communication	that IN 0	maltolyl_p JJ B-noun.person	- : 0	coumarate NN B-noun.person	is VBZ B-verb.stative	a DT 0	potentially RB B-adv.all	effective JJ B-adj.all	candidate NN B-noun.person	against IN 0	Alzheimer's_disease NN B-noun.time	that WDT 0	is VBZ 0	characterized VBN B-verb.communication	by IN 0	wide JJ B-adj.all	spread NN B-noun.artifact	neuronal_death NN 0	and CC 0	progressive JJ B-adj.all	decline_of_cognitive_function NN B-noun.group	. . 0	. . 0
a19058010.s1	The DT 0	present JJ B-adj.all	study NN B-noun.artifact	was VBD 0	aimed VBN B-verb.cognition	to TO 0	investigate VB B-verb.communication	the DT 0	combined VBN B-verb.change	effects NNS B-noun.phenomenon	of IN 0	green_tea NN B-noun.food	and CC 0	vitamin NN 0	E NN 0	on IN 0	heart NN 0	weight NN B-noun.attribute	, , 0	body NN 0	weight NN B-noun.artifact	, , 0	serum NN B-noun.body	marker NN I-noun.body	enzymes NNS B-noun.person	, , 0	lipid JJ B-adj.all	peroxidation NN B-noun.person	, , 0	endogenous JJ B-adj.all	antioxidants NNS B-noun.person	and CC 0	membrane NN B-noun.person	bound VBD B-verb.communication	ATPases NNS B-noun.person	in IN 0	isoproterenol NN 0	( ( 0	ISO)-induced JJ B-noun.group	myocardial_infarction NN I-noun.group	in IN 0	rats NNS B-noun.animal	. . 0	. . 0
a7352670.s5	During IN 0	the DT 0	SNP NNP 0	infusion NN 0	the DT 0	control NN B-noun.food	animals NNS B-noun.artifact	demonstrated VBD B-verb.perception	a DT 0	progressive JJ B-adj.all	increase_in_blood_pressure NN B-noun.quantity	to TO 0	61 CD 0	torr NN B-noun.person	, , 0	whereas IN 0	the DT 0	saralasin NN B-noun.person	- : 0	treated JJ B-verb.communication	animals NNS B-noun.person	showed VBD B-verb.communication	no DT 0	change NN B-noun.act	. . 0	. . 0
a17439425.s6	Thirty NNP 0	male NN 0	Sprague NNP B-noun.person	- : 0	Dawley NN B-noun.person	rats NNS I-noun.person	were VBD 0	divided VBN B-verb.social	randomly RB B-adv.all	into IN 0	four CD 0	treatment NN B-adj.all	groups NNS B-noun.group	, , 0	saline NN B-noun.act	, , 0	dexamethasone NN 0	( ( 0	dex NN 0	) ) 0	, , 0	allopurinol NN B-noun.person	plus CC 0	saline NN B-noun.act	, , 0	and CC 0	allopurinol NN B-noun.person	plus CC 0	dex NN B-noun.person	. . 0	. . 0
a17241784.s5	In IN 0	all DT 0	cases NNS B-noun.event	there EX 0	was VBD B-verb.stative	diffuse NN B-noun.state	or CC 0	multifocal JJ B-adj.all	up IN 0	- : 0	regulation NN B-noun.act	of IN 0	MHC NNP B-noun.group	- : 0	I PRP 0	expression VBP B-verb.cognition	even RB B-adv.all	in IN 0	non NN B-noun.person	- : 0	necrotic JJ B-adj.all	fibres NNS B-noun.body	. . 0	. . 0
a11379838.s5	Sex NN B-noun.person	, , 0	age NN B-noun.person	, , 0	diagnosis NN B-noun.person	( ( 0	bipolar JJ 0	I PRP 0	vs. FW 0	bipolar_II NNP 0	) ) 0	, , 0	and CC 0	additional JJ B-adj.all	treatment NN B-noun.attribute	did VBD 0	not RB B-adv.all	affect VB B-verb.change	the DT 0	risk NN 0	of IN 0	switching VBG B-verb.motion	. . 0	. . 0
a17111419.s9	Upon IN 0	additional JJ B-adj.all	retrospective JJ B-noun.act	analysis NN I-noun.act	, , 0	it PRP 0	was VBD 0	noted VBN B-verb.communication	that IN 0	bumetanide NN B-noun.person	is VBZ B-verb.stative	a DT 0	loop_diuretic JJ B-adj.all	that WDT 0	may MD 0	cause VB B-verb.communication	significant JJ B-adj.all	hypocalcemia NN B-noun.state	. . 0	. . 0
a1919871.s6	This DT 0	study NN B-noun.artifact	shows NNS I-noun.artifact	that WDT 0	prolonged VBD B-verb.creation	analgesic JJ B-adj.all	treatment NN B-noun.communication	in IN 0	Fischer NNP 0	344 CD 0	rats NNS B-noun.animal	causes VBZ B-verb.contact	progressive JJ B-adj.all	and CC 0	irreversible JJ B-adj.all	damage NN B-noun.person	to TO 0	the DT 0	interstitial JJ B-adj.all	matrix NN B-noun.person	and CC 0	type NN B-noun.cognition	1 CD B-adj.all	interstitial JJ B-adj.all	cells NNS B-noun.body	leading VBG B-verb.stative	to TO 0	RPN NNP 0	. . 0	. . 0
a9351491.s6	Drug NN B-noun.person	- : 0	induced_parkinsonism NN B-noun.act	was VBD 0	observed VBN B-verb.perception	in IN 0	subjects NNS B-noun.person	treated VBN B-verb.social	with IN 0	risperidone NN 0	( ( 0	42 CD 0	% NN 0	) ) 0	and CC 0	haloperidol NN B-noun.person	( ( 0	29 CD B-noun.quantity	% NN 0	) ) 0	and CC 0	was VBD 0	observed VBN B-verb.perception	at IN 0	occupancy NN B-noun.state	levels NNS B-noun.state	above IN 0	60 CD B-adj.all	% NN 0	. . 0	. . 0
a17562951.s8	In IN 0	patients NNS B-noun.person	with IN 0	diabetes NNS B-noun.person	, , 0	SCr NNP B-noun.person	increases VBZ B-verb.change	> : 0	or CC 0	= $ 0	0.5 CD 0	mg PRP B-noun.quantity	/ : 0	dL PRP 0	were VBD B-verb.stative	5.1 CD 0	% NN 0	( ( 0	4 CD 0	of IN 0	78 CD 0	patients NNS B-noun.quantity	) ) 0	with IN 0	iopamidol NN B-noun.person	and CC 0	13.0 CD 0	% NN 0	( ( 0	12 CD 0	of IN 0	92 CD 0	patients NNS B-noun.quantity	) ) 0	with IN 0	iodixanol NN B-noun.substance	( ( 0	P=0.11 NN 0	) ) 0	, , 0	whereas IN 0	SCr NNP B-noun.person	increases VBZ B-verb.change	> : 0	or CC 0	= $ 0	25 CD B-adj.all	% NN 0	were VBD B-verb.stative	10.3 CD 0	% NN 0	and CC 0	15.2 CD 0	% NN 0	, , 0	respectively RB B-adv.all	( ( 0	P=0.37 NNP 0	) ) 0	. . 0	. . 0
a7582165.s0	Pseudo NNP B-noun.person	- : 0	allergic_reactions NNS B-noun.group	to TO 0	corticosteroids NNS B-noun.person	, , 0	diagnosis NN B-noun.person	and CC 0	alternatives NNS B-noun.person	. . 0	. . 0
a2266990.s2	We PRP 0	conducted VBD B-verb.creation	a DT 0	12-month JJ 0	controlled JJ B-adj.all	trial NN B-noun.act	of IN 0	mazindol NN B-noun.person	, , 0	a DT 0	putative JJ B-adj.all	growth NN 0	hormone NN 0	secretion NN 0	inhibitor NN 0	, , 0	in IN 0	83 CD 0	boys NNS B-noun.person	with IN 0	Duchenne_dystrophy NN B-noun.group	. . 0	. . 0
a1085609.s1	A DT 0	17-day JJ 0	- : 0	old JJ B-adj.all	infant NN B-noun.person	on IN 0	isoniazid NN B-noun.act	therapy RB 0	13 CD 0	mg IN 0	/ : 0	kg PRP 0	daily RB B-adv.all	from IN 0	birth NN 0	because IN 0	of IN 0	maternal JJ B-adj.pert	tuberculosis NN B-noun.cognition	was VBD 0	admitted VBN B-verb.creation	after IN 0	4 CD B-adj.all	days NNS B-noun.time	of IN 0	clonic_fits NNS B-noun.object	. . 0	. . 0
a9698967.s4	Postoperatively RB B-adj.all	, , 0	the DT 0	patient NN B-noun.person	refused VBD B-verb.body	DC NNP 0	cardioversion NN 0	and CC 0	was VBD 0	treated VBN B-verb.change	medically RB B-adv.all	. . 0	. . 0
a9672936.s5	This DT 0	method NN B-noun.attribute	allowed VBD B-verb.change	frequent JJ B-adj.all	self NN B-noun.person	- : 0	dosing NN B-noun.act	of IN 0	pethidine NN B-noun.person	at IN 0	short JJ B-adj.all	time NN B-noun.time	intervals NNS B-noun.person	and CC 0	rapid JJ B-adj.all	accumulation NN 0	of IN 0	pethidine NN B-noun.person	and CC 0	norpethidine NN B-noun.person	. . 0	. . 0
a16938416.s4	Hormone NN B-noun.person	therapy NN I-noun.person	users NNS B-noun.person	were VBD 0	compared VBN B-verb.change	with IN 0	never RB B-adj.all	users NNS B-noun.person	. . 0	. . 0
a19767176.s9	In IN 0	conclusion NN 0	, , 0	the DT 0	NF NNP B-noun.group	- : 0	kappaB JJ B-adj.all	inhibitor NN B-noun.person	and CC 0	antioxidant JJ B-adj.all	PDTC NNP B-noun.group	protected VBD B-verb.competition	the DT 0	piriform NN B-noun.body	cortex NN I-noun.body	, , 0	whereas IN 0	it PRP 0	did VBD 0	not RB B-adv.all	affect VB B-verb.change	hilar JJ B-adj.all	neuronal_loss NN B-noun.person	. . 0	. . 0
a6640832.s7	Recurrence NN B-noun.person	was VBD 0	studied VBN B-verb.cognition	in IN 0	82 CD 0	evaluable JJ B-adj.all	patients NNS B-noun.person	after IN 0	1 CD B-adj.all	year NN B-noun.time	of IN 0	follow NN B-noun.shape	- : 0	up RB B-adv.all	and CC 0	in IN 0	72 CD 0	patients NNS B-noun.person	followed VBD B-verb.stative	for IN 0	2 CD B-adj.all	- : 0	3 CD B-adj.all	years NNS B-noun.time	( ( 0	mean VB B-verb.stative	32 CD 0	months NNS B-noun.quantity	) ) 0	. . 0	. . 0
a1833784.s7	Nicotine SYM 0	- : 0	induced VBN B-verb.communication	hyperactivity NN B-noun.person	was VBD 0	blocked VBN B-verb.contact	by IN 0	the DT 0	selective JJ B-adj.all	D1 NN 0	antagonist JJ B-adj.all	SCH_23390 NN B-noun.person	, , 0	the DT 0	selective JJ B-adj.all	D2 NN 0	antagonist JJ B-adj.all	raclopride NN B-noun.person	and CC 0	the DT 0	D1/D2 JJ B-adj.all	antagonist JJ B-adj.pert	fluphenazine NN B-noun.person	. . 0	. . 0
a15325671.s5	RESULTS NNS B-noun.artifact	, , 0	Six CD 0	of IN 0	61 CD 0	women NNS B-noun.person	( ( 0	10 CD B-adj.all	% NN 0	) ) 0	developed VBD B-verb.creation	clinically RB B-adv.all	reversible JJ B-adj.all	grade NN B-noun.communication	3 CD 0	CHF NNP 0	following VBG B-verb.stative	infusional JJ B-adj.all	cyclophosphamide NN 0	with IN 0	a DT 0	median JJ B-adj.all	percent NN B-noun.person	decline NN B-noun.person	in IN 0	ejection NN 0	fraction NN B-noun.artifact	of IN 0	31 CD 0	% NN 0	. . 0	. . 0
a15899738.s8	The DT 0	patient NN B-noun.person	was VBD 0	admitted VBN B-verb.social	to TO 0	the DT 0	hospital NN B-noun.artifact	, , 0	anticoagulated VBN B-verb.cognition	with IN 0	unfractionated JJ B-adj.all	heparin NN B-noun.person	, , 0	and CC 0	given VBN B-verb.possession	intravenous JJ B-adj.all	diltiazem NN B-noun.communication	for IN 0	rate NN B-noun.time	control NN B-noun.act	and CC 0	intravenous JJ B-adj.all	amiodarone NN B-noun.person	for IN 0	rate NN B-noun.time	and CC 0	rhythm NN B-noun.act	control NN B-noun.act	. . 0	. . 0
a19759529.s8	In IN 0	contrast NN 0	, , 0	SSR103800 NNP B-noun.person	failed VBD B-verb.social	to TO 0	affect VB B-verb.change	hyperactivity NN 0	induced VBN B-verb.creation	by IN 0	amphetamine JJ B-adj.all	or CC 0	naturally RB B-adv.all	observed VBN B-verb.perception	in IN 0	dopamine NN 0	transporter NN 0	( ( 0	DAT(-/- NNP 0	) ) 0	) ) 0	knockout IN 0	mice NNS B-noun.person	( ( 0	10 CD B-adj.all	- : 0	30 CD 0	mg FW 0	/ FW 0	kg FW 0	p.o FW 0	. . 0	) ) 0	. . 0	. . 0
a9698967.s2	After IN 0	intravenous JJ B-adj.all	administration NN B-noun.time	of IN 0	labetalol NN B-noun.act	, , 0	metoprolol NN B-noun.person	and CC 0	midazolam NN B-noun.body	the DT 0	patient NN B-noun.person	's POS 0	condition NN B-noun.communication	improved VBN B-verb.change	, , 0	and CC 0	15 CD B-adj.all	min NN 0	later RB 0	he PRP 0	woke VBD B-verb.competition	up RP I-verb.competition	. . 0	. . 0
a88336.s2	Three CD 0	patients NNS B-noun.person	received VBD B-verb.possession	high JJ B-adj.all	doses NNS B-noun.attribute	of IN 0	chlormethiazole NN B-noun.food	for IN 0	alcohol NN B-noun.person	withdrawal_symptoms NNS I-noun.person	, , 0	and CC 0	one PRP 0	took VBD B-verb.contact	a DT 0	suicidal NN B-noun.artifact	overdose NN B-noun.act	of IN 0	nitrazepam NN B-noun.person	. . 0	. . 0
a8919272.s8	Fragments NNS B-noun.person	of IN 0	necrotic JJ B-adj.all	endothelial JJ B-adj.all	cells NNS B-noun.body	were VBD B-verb.stative	in IN 0	the DT 0	vascular JJ B-adj.all	lumens NNS B-noun.artifact	and CC 0	in IN 0	these DT 0	there EX 0	was VBD 0	loosening VBG B-verb.perception	and CC 0	breaking NN B-noun.person	of IN 0	tight JJ B-adj.all	cellular JJ B-noun.body	junctions NNS I-noun.body	. . 0	. . 0
a12684739.s1	RATIONALE NNP B-noun.group	, , 0	gamma NN B-noun.act	- : 0	Vinyl_GABA NN 0	( ( 0	GVG NNP 0	) ) 0	irreversibly RB B-adv.all	inhibits VBZ B-verb.change	GABA NNP B-noun.group	- : 0	transaminase NN B-noun.communication	. . 0	. . 0
a1428568.s5	In IN 0	a DT 0	double JJ B-adj.all	blind JJ B-adj.all	cross NN B-noun.person	- : 0	over IN 0	study NN B-noun.artifact	with IN 0	control NN B-noun.substance	group NN I-noun.substance	, , 0	the DT 0	patients NNS B-noun.person	under IN 0	timolol NN 0	treatment NN B-noun.communication	presented VBD B-verb.perception	higher JJR B-adj.all	depression NN B-noun.possession	values NNS B-noun.attribute	measured VBN B-verb.cognition	through IN 0	the DT 0	Beck NNP B-noun.person	and CC 0	the DT 0	Zung NNP B-noun.person	- : 0	Conde JJ B-noun.other	scales NNS B-noun.relation	( ( 0	p IN 0	< $ 0	0.001 CD 0	vs DT 0	control NN B-noun.act	) ) 0	. . 0	. . 0
a12707296.s2	We PRP 0	investigate VBP B-verb.communication	whether IN 0	abnormalities NNS B-noun.person	in IN 0	L NNP 0	- : 0	arginine NN 0	uptake NN 0	contribute VBP 0	to TO 0	this DT 0	deficiency NN B-noun.event	. . 0	. . 0
a15130900.s4	Nested NNP B-noun.person	within IN 0	the DT 0	cohort NN B-noun.person	, , 0	a DT 0	matched VBN B-noun.artifact	case NN I-noun.artifact	- : 0	control NN B-noun.act	study NN B-noun.artifact	was VBD 0	performed VBN B-verb.social	to TO 0	estimate VB B-verb.cognition	the DT 0	association NN B-noun.state	between IN 0	cyclophosphamide NN B-noun.person	and CC 0	bladder_cancer NN B-noun.person	using VBG B-verb.consumption	odds JJ B-adj.all	ratios NNS B-noun.time	( ( 0	ORs NNP 0	) ) 0	as IN 0	relative JJ B-adj.all	risk NN B-noun.person	. . 0	. . 0
a3409645.s3	Sexual_dysfunctions NNS B-noun.artifact	were VBD 0	found VBN B-verb.perception	to TO 0	be VB B-verb.stative	common JJ B-noun.person	among IN 0	patients NNS B-noun.person	and CC 0	controls NNS B-noun.artifact	, , 0	the DT 0	majority NN B-noun.quantity	in IN 0	both DT 0	groups NNS B-noun.group	reporting VBG B-verb.communication	one CD 0	or CC 0	more JJR B-noun.quantity	dysfunctions NNS B-noun.communication	. . 0	. . 0
a12198388.s0	The DT 0	relationship NN B-noun.state	between IN 0	hippocampal JJ B-adj.pert	acetylcholine NN B-noun.state	release NN I-noun.state	and CC 0	cholinergic JJ B-adj.all	convulsant JJ B-adj.all	sensitivity NN B-noun.feeling	in IN 0	withdrawal NN 0	seizure NN B-noun.act	- : 0	prone NN B-noun.person	and CC 0	withdrawal NN B-noun.act	seizure NN B-noun.act	- : 0	resistant NN B-noun.person	selected VBN B-verb.cognition	mouse NN 0	lines NNS B-noun.communication	. . 0	. . 0
a19767176.s1	Pyrrolidine_dithiocarbamate JJ B-adj.all	( ( 0	PDTC NNP 0	) ) 0	has VBZ B-verb.stative	a DT 0	dual JJ B-adj.all	mechanism NN B-noun.attribute	of IN 0	action NN B-noun.state	as IN 0	an DT 0	antioxidant JJ B-adj.all	and CC 0	an DT 0	inhibitor NN B-noun.person	of IN 0	the DT 0	transcription NN B-noun.act	factor NN B-noun.person	kappa NN B-noun.person	- : 0	beta NN B-noun.person	. . 0	. . 0
a12639165.s4	DISCUSSION NN B-noun.artifact	, , 0	Cholestatic_hepatitis NN 0	is VBZ B-verb.stative	a DT 0	rare JJ B-adj.all	complication NN B-noun.act	of IN 0	the DT 0	antiplatelet NN B-noun.relation	agent NN I-noun.relation	ticlopidine NN 0	, , 0	several JJ B-adj.all	cases NNS B-noun.event	have VBP 0	been VBN 0	reported VBN B-verb.communication	but CC 0	few JJ 0	in IN 0	the DT 0	English JJ B-adj.all	literature NN B-noun.person	. . 0	. . 0
a7890216.s9	This DT 0	corresponds VBZ B-verb.stative	, , 0	by IN 0	actuarial JJ B-noun.process	( ( 0	life NN B-noun.person	table NN B-noun.group	) ) 0	analysis NN B-noun.animal	, , 0	to TO 0	a DT 0	combined VBN B-verb.stative	gall_stone JJ B-adj.all	dissolution NN B-noun.event	rate NN B-noun.time	of IN 0	58.3 CD 0	( ( 0	15.9 CD 0	% NN 0	) ) 0	. . 0	. . 0
a8701950.s2	In IN 0	both DT 0	cases NNS B-noun.state	, , 0	discontinuation NN B-noun.act	of IN 0	FK506 NNP B-noun.person	and CC 0	treatment NN B-noun.plant	with IN 0	plasma NN B-noun.substance	exchange NN I-noun.substance	, , 0	fresh JJ B-adj.all	frozen NN B-noun.person	plasma NN B-noun.person	replacement NN B-noun.person	, , 0	corticosteroids NNS B-noun.person	, , 0	aspirin NN B-noun.person	, , 0	and CC 0	dipyridamole NN B-noun.person	led VBN B-verb.motion	to TO 0	resolution NN B-noun.act	of IN 0	MAHA NNP B-noun.group	. . 0	. . 0
a8752018.s4	METHOD NNP B-noun.attribute	, , 0	Open NNP B-noun.person	, , 0	case NN B-noun.communication	series NN B-noun.communication	design NN B-noun.communication	. . 0	. . 0
a19387625.s1	Perceived VBN B-verb.perception	pain NN B-noun.cognition	intensity NN I-noun.cognition	is VBZ 0	modulated VBN B-verb.change	by IN 0	attention NN 0	. . 0	. . 0
a17600377.s6	We PRP 0	found VBD B-verb.cognition	that IN 0	maltolyl_p JJ B-noun.person	- : 0	coumarate NN B-noun.person	significantly RB B-adv.all	decreased VBD B-verb.change	apoptotic JJ B-adj.all	cell NN B-noun.body	death NN 0	and CC 0	reduced VBD B-verb.change	reactive JJ B-adj.all	oxygen NN B-noun.body	species NNS I-noun.body	, , 0	cytochrome JJ B-adj.all	c NN 0	release NN 0	, , 0	and CC 0	caspase NN B-noun.communication	3 CD B-adj.all	activation NN B-noun.act	. . 0	. . 0
a11928786.s8	We PRP 0	report VBP B-verb.communication	a DT 0	case NN B-noun.state	of IN 0	a DT 0	31 CD B-adj.all	year NN B-noun.time	old JJ B-adj.all	female NN B-noun.person	who WP 0	required VBD B-verb.stative	admission NN 0	to TO 0	the DT 0	Intensive NNP B-noun.other	Care NNP I-noun.other	Unit NNP I-noun.other	for IN 0	ventilation NN B-noun.possession	and CC 0	full JJ B-adj.all	supportive JJ 0	therapy NN 0	, , 0	following VBG 0	ingestion NN B-noun.act	of IN 0	13.5 CD 0	g DT 0	bupropion NN B-noun.act	. . 0	. . 0
a7352670.s1	The DT 0	role NN B-noun.attribute	of IN 0	the DT 0	renin NN B-noun.person	-- : 0	angiotensin NN B-noun.communication	system NN B-noun.cognition	in IN 0	the DT 0	maintenance NN B-noun.act	of IN 0	blood NN B-noun.act	pressure NN B-noun.act	during IN 0	halothane NN 0	anesthesia NN 0	and CC 0	sodium_nitroprusside RB 0	( ( 0	SNP)-induced JJ 0	hypotension NN B-noun.person	was VBD 0	evaluated VBN B-verb.change	. . 0	. . 0
a19058010.s6	together RB B-adv.all	for IN 0	30 CD B-adj.all	consecutive JJ B-adj.all	days NNS B-noun.person	and CC 0	challenged VBN B-verb.change	with IN 0	ISO NNP B-noun.group	on IN 0	the DT 0	day NN 0	29th JJ 0	and CC 0	30th JJ 0	, , 0	showed VBD B-verb.communication	a DT 0	significant JJ B-adj.all	( ( 0	P<0.05 NN 0	) ) 0	decrease NN B-noun.state	in IN 0	heart NN 0	weight NN B-noun.attribute	, , 0	serum NN B-noun.body	marker NN I-noun.body	enzymes NNS B-noun.person	, , 0	lipid JJ B-adj.all	peroxidation NN B-noun.person	, , 0	Ca+2 NNP B-noun.person	ATPase NNP I-noun.person	and CC 0	a DT 0	significant JJ B-adj.all	increase NN B-noun.event	in IN 0	the DT 0	body NN 0	weight NN B-noun.artifact	, , 0	endogenous JJ B-adj.all	antioxidants NNS B-noun.person	, , 0	Na+//K+ NNP B-noun.person	ATPase NNP I-noun.person	and CC 0	Mg+2 NNP B-noun.person	ATPase NNP I-noun.person	when WRB 0	compared VBN B-verb.cognition	with_ISO NN B-noun.person	treated VBD B-verb.communication	group NN B-noun.person	and_green_tea NNP I-noun.person	or_vitamin NNP I-noun.person	E NNP I-noun.person	alone RB 0	treated VBN B-verb.communication	groups NNS B-noun.group	. . 0	. . 0
a1378968.s3	Corresponding VBG B-verb.communication	non RB 0	- : 0	lithium NN B-noun.substance	pretreated VBN B-verb.creation	groups NNS B-noun.group	were VBD 0	generated VBN B-verb.communication	. . 0	. . 0
a19473225.s2	This DT 0	pilot NN B-adj.all	trial NN B-noun.person	aimed VBN B-verb.cognition	to TO 0	evaluate VB B-verb.communication	the DT 0	role NN B-noun.attribute	of IN 0	glutamate JJ B-adj.all	supplementation NN B-noun.person	for IN 0	preventing VBG B-verb.creation	PAC NNP B-noun.group	- : 0	induced VBN B-verb.creation	peripheral_neuropathy JJ 0	in IN 0	a DT 0	randomized VBN B-verb.cognition	, , 0	placebo NN B-noun.person	- : 0	controlled VBN B-verb.social	, , 0	double RB 0	- : 0	blinded VBD B-verb.communication	clinical JJ B-noun.person	and CC 0	electro NN B-noun.person	- : 0	diagnostic JJ B-adj.all	study NN B-noun.artifact	. . 0	. . 0
a8643971.s13	The DT 0	overall JJ B-adj.all	response NN B-noun.communication	rate NN B-noun.time	is VBZ B-verb.stative	72 CD 0	% NN 0	. . 0	. . 0
a3800626.s3	In IN 0	a DT 0	37-year JJ 0	- : 0	old JJ B-adj.all	woman NN B-noun.person	with IN 0	documented VBN B-verb.social	pentazocine NN B-noun.person	- : 0	induced VBN B-verb.creation	fibrous_myopathy JJ 0	of IN 0	triceps NNS B-noun.act	and CC 0	deltoid VB B-verb.possession	muscles NNS B-noun.body	bilaterally RB B-adv.all	and CC 0	a DT 0	three CD 0	- : 0	week NN B-noun.time	history NN B-noun.cognition	of IN 0	right JJ B-adj.all	wrist NN B-noun.artifact	drop NN I-noun.artifact	, , 0	electrodiagnostic JJ B-adj.all	examination NN B-noun.person	showed VBD B-verb.communication	a DT 0	severe JJ 0	but CC 0	partial JJ B-adj.all	lesion NN B-noun.act	of IN 0	the DT 0	right JJ B-adj.all	radial JJ B-adj.all	nerve NN B-noun.attribute	distal NN I-noun.attribute	to TO 0	the DT 0	branches NNS B-noun.shape	to TO 0	the DT 0	triceps NNS B-noun.act	, , 0	in IN 0	addition NN 0	to TO 0	the DT 0	fibrous_myopathy JJ 0	. . 0	. . 0
a17261653.s1	BACKGROUND NN 0	, , 0	Inhibition NNP B-noun.person	of IN 0	cardiac JJ B-adj.all	sympathetic JJ B-adj.all	tone NN B-noun.state	represents VBZ B-verb.communication	an DT 0	important JJ B-adj.all	strategy NN B-noun.attribute	for IN 0	treatment NN B-noun.act	of IN 0	cardiovascular_disease NNP B-noun.communication	, , 0	including VBG B-verb.change	arrhythmia NN I-verb.change	, , 0	coronary_heart_disease NNP B-noun.person	, , 0	and CC 0	chronic JJ B-adj.pert	heart_failure NN B-noun.state	. . 0	. . 0
a9672936.s4	No DT 0	other JJ 0	risk NN 0	factors NNS B-noun.person	for IN 0	CNS NNP 0	toxicity NN 0	were VBD 0	identified VBN B-verb.cognition	. . 0	. . 0
